<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Iodine supplementation for women during the preconception, pregnancy and postpartum period - Harding, KB - 2017 | Cochrane Library</title> <meta content="Iodine supplementation for women during the preconception, pregnancy and postpartum period - Harding, KB - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011761.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Iodine supplementation for women during the preconception, pregnancy and postpartum period - Harding, KB - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011761.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011761.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Iodine supplementation for women during the preconception, pregnancy and postpartum period" name="citation_title"/> <meta content="Kimberly B Harding" name="citation_author"/> <meta content="Micronutrient Initiative" name="citation_author_institution"/> <meta content="Juan Pablo Peña‐Rosas" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="penarosasj@who.int" name="citation_author_email"/> <meta content="Angela C Webster" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Constance MY Yap" name="citation_author"/> <meta content="Westmead Hospital" name="citation_author_institution"/> <meta content="Brian A Payne" name="citation_author"/> <meta content="Ministry of Health Barbados" name="citation_author_institution"/> <meta content="Erika Ota" name="citation_author"/> <meta content="St. Luke's International University, Graduate School of Nursing Sciences" name="citation_author_institution"/> <meta content="Luz Maria De‐Regil" name="citation_author"/> <meta content="Micronutrient Initiative" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD011761.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/03/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011761.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011761.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011761.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Dietary Supplements [adverse effects]; Hyperthyroidism [epidemiology]; Hypothyroidism [epidemiology]; Infant, Newborn, Diseases [epidemiology]; Iodine [*administration &amp; dosage, adverse effects, deficiency]; Perinatal Mortality; Postpartum Period; Preconception Care [*methods]; Pregnancy Complications [epidemiology]; Premature Birth [epidemiology]; Prenatal Care [*methods]; Randomized Controlled Trials as Topic; Thyroid Hormones [blood]; Thyrotropin [blood]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011761.pub2&amp;doi=10.1002/14651858.CD011761.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="IYhCEbRn";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011761\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011761\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","fr","pl","ms","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011761.pub2",title:"Iodine supplementation for women during the preconception, pregnancy and postpartum period",firstPublishedDate:"Mar 5, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011761.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011761.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011761.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011761.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011761.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011761.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011761.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011761.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011761.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011761.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13429 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011761.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-sec-0281"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-sec-0050"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-sec-0051"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-sec-0092"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-sec-0275"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/appendices#CD011761-sec-0286"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/table_n/CD011761StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/table_n/CD011761StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Iodine supplementation for women during the preconception, pregnancy and postpartum period </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#CD011761-cr-0002">Kimberly B Harding</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#CD011761-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Juan Pablo Peña‐Rosas</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#CD011761-cr-0004">Angela C Webster</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#CD011761-cr-0005">Constance MY Yap</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#CD011761-cr-0006">Brian A Payne</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#CD011761-cr-0007">Erika Ota</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information#CD011761-cr-0008">Luz Maria De‐Regil</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information/en#CD011761-sec-0289">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 March 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011761.pub2">https://doi.org/10.1002/14651858.CD011761.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011761-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011761-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011761-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011761-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011761-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011761-abs-0014">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011761-abs-0001" lang="en"> <section id="CD011761-sec-0001"> <h3 class="title" id="CD011761-sec-0001">Background</h3> <p>Iodine is an essential nutrient required for the biosynthesis of thyroid hormones, which are responsible for regulating growth, development and metabolism. Iodine requirements increase substantially during pregnancy and breastfeeding. If requirements are not met during these periods, the production of thyroid hormones may decrease and be inadequate for maternal, fetal and infant needs. The provision of iodine supplements may help meet the increased iodine needs during pregnancy and the postpartum period and prevent or correct iodine deficiency and its consequences. </p> </section> <section id="CD011761-sec-0002"> <h3 class="title" id="CD011761-sec-0002">Objectives</h3> <p>To assess the benefits and harms of supplementation with iodine, alone or in combination with other vitamins and minerals, for women in the preconceptional, pregnancy or postpartum period on their and their children's outcomes. </p> </section> <section id="CD011761-sec-0003"> <h3 class="title" id="CD011761-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth's Trials Register (14 November 2016), and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (17 November 2016), contacted experts in the field and searched the reference lists of retrieved studies and other relevant papers. </p> </section> <section id="CD011761-sec-0004"> <h3 class="title" id="CD011761-sec-0004">Selection criteria</h3> <p>Randomized and quasi‐randomized controlled trials with randomisation at either the individual or cluster level comparing injected or oral iodine supplementation (such as tablets, capsules, drops) during preconception, pregnancy or the postpartum period irrespective of iodine compound, dose, frequency or duration. </p> </section> <section id="CD011761-sec-0005"> <h3 class="title" id="CD011761-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trial eligibility, risk of bias, extracted data and conducted checks for accuracy. We used the GRADE approach to assess the quality of the evidence for primary outcomes. </p> <p>We anticipated high heterogeneity among trials, and we pooled trial results using random‐effects models and were cautious in our interpretation of the pooled results. </p> </section> <section id="CD011761-sec-0006"> <h3 class="title" id="CD011761-sec-0006">Main results</h3> <p>We included 14 studies and excluded 48 studies. We identified five ongoing or unpublished studies and two studies are awaiting classification. Eleven trials involving over 2700 women contributed data for the comparisons in this review (in three trials, the primary or secondary outcomes were not reported). </p> <p><b>Maternal primary outcomes</b> </p> <p>Iodine supplementation decreased the likelihood of the adverse effect of postpartum hyperthyroidism by 68% (average risk ratio (RR) 0.32; 95% confidence interval (CI) 0.11 to 0.91, three trials in mild to moderate iodine deficiency settings, 543 women, no statistical heterogeneity, low‐quality evidence) and increased the likelihood of the adverse effect of digestive intolerance in pregnancy by 15 times (average RR 15.33; 95% CI 2.07 to 113.70, one trial in a mild‐deficiency setting, 76 women, very low‐quality evidence). </p> <p>There were no clear differences between groups for hypothyroidism in pregnancy or postpartum (pregnancy: average RR 1.90; 95% CI 0.57 to 6.38, one trial, 365 women, low‐quality evidence, and postpartum: average RR 0.44; 95% CI 0.06 to 3.42, three trials, 540 women, no statistical heterogeneity, low‐quality evidence), preterm birth (average RR 0.71; 95% CI 0.30 to 1.66, two trials, 376 women, statistical heterogeneity, low‐quality evidence) or the maternal adverse effects of elevated thyroid peroxidase antibodies (TPO‐ab) in pregnancy or postpartum (average RR 0.95; 95% CI 0.44 to 2.07, one trial, 359 women, low‐quality evidence, average RR 1.01; 95% CI 0.78 to 1.30, three trials, 397 women, no statistical heterogeneity, low‐quality evidence), or hyperthyroidism in pregnancy (average RR 1.90; 95% CI 0.57 to 6.38, one trial, 365 women, low‐quality evidence). All of the trials contributing data to these outcomes took place in settings with mild to moderate iodine deficiency. </p> <p><b>Infant/child primary outcomes</b> </p> <p>Compared with those who did not receive iodine, those who received iodine supplements had a 34% lower likelihood of perinatal mortality, however this difference was not statistically significant (average RR 0.66; 95% CI 0.42 to 1.03, two trials, 457 assessments, low‐quality evidence). All of the perinatal deaths occurred in one trial conducted in a severely iodine‐deficient setting. There were no clear differences between groups for low birthweight (average RR 0.56; 95% CI 0.26 to 1.23, two trials, 377 infants, no statistical heterogeneity, low‐quality evidence), neonatal hypothyroidism/elevated thyroid‐stimulating hormone (TSH) (average RR 0.58; 95% CI 0.11 to 3.12, two trials, 260 infants, very low‐quality evidence) or the adverse effect of elevated neonatal thyroid peroxidase antibodies (TPO‐ab) (average RR 0.61; 95% CI 0.07 to 5.70, one trial, 108 infants, very low‐quality evidence). All of the trials contributing data to these outcomes took place in areas with mild to moderate iodine deficiency. No trials reported on hypothyroidism/elevated TSH or any adverse effect beyond the neonatal period. </p> </section> <section id="CD011761-sec-0007"> <h3 class="title" id="CD011761-sec-0007">Authors' conclusions</h3> <p>There were insufficient data to reach any meaningful conclusions on the benefits and harms of routine iodine supplementation in women before, during or after pregnancy. The available evidence suggested that iodine supplementation decreases the likelihood of postpartum hyperthyroidism and increases the likelihood of the adverse effect of digestive intolerance in pregnancy ‐ both considered potential adverse effects. We considered evidence for these outcomes low or very low quality, however, because of study design limitations and wide confidence intervals. In addition, due to the small number of trials and included women in our meta‐analyses, these findings must be interpreted with caution. There were no clear effects on other important maternal or child outcomes though these findings must also be interpreted cautiously due to limited data and low‐quality trials. Additionally, almost all of the evidence came from settings with mild or moderate iodine deficiency and therefore may not be applicable to settings with severe deficiency. </p> <p>More high‐quality randomised controlled trials are needed on iodine supplementation before, during and after pregnancy on maternal and infant/child outcomes. However, it may be unethical to compare iodine to placebo or no treatment in severe deficiency settings. Trials may also be unfeasible in settings where pregnant and lactating women commonly take prenatal supplements with iodine. Information is needed on optimal timing of initiation as well as supplementation regimen and dose. Future trials should consider the outcomes in this review and follow children beyond the neonatal period. Future trials should employ adequate sample sizes, assess potential adverse effects (including the nature and extent of digestive intolerance), and be reported in a way that allows assessment of risk of bias, full data extraction and analysis by the subgroups specified in this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011761-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011761-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011761-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011761-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011761-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011761-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011761-abs-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011761-abs-0009">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011761-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011761-abs-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011761-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011761-abs-0004" lang="en"> <h3>Iodine supplementation for women before, during or after pregnancy</h3> <p><b>What is the issue?</b> </p> <p>It is estimated that over 1.8 billion people worldwide do not get enough iodine in their diet, putting them at risk of iodine deficiency. Iodine is an essential nutrient needed in small amounts for the body to make thyroid hormones. The World Health Organization (WHO) recommends that iodine is added to salt to prevent problems caused by lack of iodine. Women who are pregnant or breastfeeding need extra iodine, which puts them at greater risk of deficiency. The breast milk contains iodine for the infant. </p> <p><b>Why is this important?</b> </p> <p>Thyroid function is increased during pregnancy as thyroid hormones produced by the mother (and the baby as the pregnancy progresses) are essential for growth and development of the baby and to regulate the development of the brain and nervous system. Nervous tissue begins to develop as early as the second month of pregnancy. If women have too little iodine during pregnancy or infants have too little during early childhood, the damage may be irreversible. Research has shown that severe iodine deficiency can stunt children's normal physical growth as well as harm normal mental development, resulting in lower intelligence quotients. Less is known about the consequences of mild or moderate deficiency. Too much iodine can also cause harm and have negative effects on mothers and babies, for example by causing the thyroid to become overactive. </p> <p>Although salt is the commonly the main source of iodine, expert medical groups recommend that women in many countries take iodine supplements during and following pregnancy to help ensure their iodine needs are met. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for evidence in November 2016 and identified 14 randomised controlled trials of iodine supplements in the form of tablets, capsules, drops or injections before, during or after pregnancy. Eleven trials with over 2700 women contributed findings to the review. Eight trials compared iodine with no treatment or a placebo and three trials compared iodine given with other vitamins and minerals against only the vitamins and minerals. </p> <p>Women who received iodine supplements were less likely to develop the unwanted effect of hyperthyroidism (an overactive thyroid gland) after giving birth (three trials involving 543 women) but they were more likely to experience nausea or vomiting during pregnancy (one trial involving 76 women) when compared to those who did not receive iodine. One trial (365 women) did not find any difference in the number of women with an overactive thyroid gland during pregnancy. The number of women with an underactive thyroid gland (hypothyroidism) was not clearly different either during pregnancy (one trial involving 365 women) or after giving birth (three trials involving 540 women) when iodine supplements were given. A similar number of women had raised thyroid antibodies during pregnancy (one trial, 359 women) and after giving birth (three trials, 397 women). We found no clear differences between women given iodine supplements and those not when looking at preterm births (two trials, 376 women) or deaths around the time of giving birth (two trials, 457 women), babies born with a low birthweight (two trials, 377 babies), newborn babies with an underactive thyroid gland (two trials, 260 babies) or with raised thyroid antibodies (one trial, 108 babies). </p> <p>The quality of the evidence was low to very low, mostly because few trials looked at each outcome or because of limitations in the study designs. Most of the findings were from one or two trials and small numbers of women were included. This means we are not confident in the results. </p> <p><b>What does this mean?</b> </p> <p>The potential benefits and harms of any intervention must be weighed as part of deciding whether to use it. Our Cochrane Review provides a summary of the evidence but there were not enough data for any meaningful conclusions on the benefits and harms of routine iodine supplementation in women before, during or after pregnancy. The limited information we found suggests there are benefits and risks of iodine supplementation. More research will clarify the effects and safety of this intervention. Future research should use randomised controlled trial designs where practical and ethical, and include the outcomes from this review. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011761-sec-0281" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011761-sec-0281"></div> <h3 class="title" id="CD011761-sec-0282">Implications for practice</h3> <section id="CD011761-sec-0282"> <p>Overall, there were insufficient data for any meaningful conclusions on the benefits and harms of routine iodine supplementation in women before, during or after pregnancy. Based on the information available for our primary outcomes, we found evidence of benefit (reduced likelihood of postpartum hyperthyroidism) and harm (increased likelihood of digestive intolerance) in settings with mild to moderate iodine deficiency. We also found effects, mostly positive, on some indicators of iodine intake and iodine or thyroid status. All of our findings must be interpreted with caution due to the small number of trials and included women and low (or very low) quality of the evidence. We did not identify any trials that reported on growth (using anthropometric Z scores) or infant death, and no trials reported on elevated thyroid‐stimulating hormone/hypothyroidism or adverse effects in children beyond the neonatal period. </p> <p>Medical bodies in several countries have concluded that the potential benefits of iodine supplementation in pregnancy and breastfeeding (and in some countries in women before pregnancy) outweigh the potential harms. In many countries, especially in high‐resource settings, it is common practice for women to take multiple‐micronutrient supplements during and after pregnancy and these supplements often contain iodine. </p> <p>Decisions on recommending or taking iodine supplements should be informed by the likelihood and severity of potential benefits as well as harms, and are influenced by values and preferences. For some, knowledge that iodine supplements during these periods can help ensure adequate intake may be sufficient, given the scientific basis behind the recommended intakes. Others may want more direct evidence on functional outcomes. Though we were unable to explore the role of the women's initial iodine status in our review, it is an important factor to consider. This information would generally not be available for individuals but may be known for the population. </p> </section> <h3 class="title" id="CD011761-sec-0283">Implications for research</h3> <section id="CD011761-sec-0283"> <p>This review highlights the need for additional high‐quality randomised controlled trials of iodine supplementation before, during and after pregnancy on maternal and infant/child outcomes. However given the body of evidence including and beyond this review, it may be unethical to compare iodine to placebo or no treatment in severe deficiency settings. Such trials may also be unfeasible in any setting where pregnant and lactating women commonly take prenatal supplements with iodine. Information is also needed on optimal timing of initiation as well as supplementation regimen and dose. We recommend future trials include the outcomes from this review, especially the primary outcomes, and follow children beyond the neonatal period. All trials should assess potential adverse effects, including the nature and extent of digestive intolerance. Future research should be reported in a way that allows assessment of risk of bias, full data extraction and analysis by the subgroups specified in this review. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011761-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011761-sec-0029"></div> <div class="table" id="CD011761-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (maternal outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (maternal outcomes) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women during the preconception, pregnancy and postpartum period<br/> <b>Setting:</b> Denmark, Germany, Morocco, New Zealand, Thailand, Zaire<br/> <b>Intervention:</b> any supplement containing iodine<br/> <b>Comparison:</b> same supplement without iodine or no treatment/placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with same supplement without iodine or no treatment/placebo</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any supplement containing iodine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal hypothyroidism ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 1.90<br/> (0.57 to 6.38) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>365<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 134) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal hypothyroidism ‐ postpartum</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.44<br/> (0.06 to 3.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>540<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 34) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/> (1 to 37) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Preterm birth</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.71<br/> (0.30 to 1.66) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>376<br/> (2 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/> (33 to 184) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>122 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/> (37 to 202) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.95<br/> (0.44 to 2.07) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>359<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (30 to 142) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (30 to 142) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: elevated TPO‐ab ‐ postpartum</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 1.01<br/> (0.78 to 1.30) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>397<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>301 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>304 per 1000<br/> (235 to 391) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>77 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/> (60 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: hyperthyroidism ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 1.90<br/> (0.57 to 6.38) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>365<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 134) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: hyperthyroidism ‐ postpartum</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.32<br/> (0.11 to 1.91) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>543<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/> (5 to 45) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (1 to 7) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: digestive intolerance ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average</p> <p>RR 15.33<br/> (2.07 to 113.70) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>76<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>2, 5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>22 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>333 per 1,000<br/> (45 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>25 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>383 per 1000</p> <p>(52 to 1,000)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>TPO‐ab</b>: thyroid peroxidase antibodies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One study with design limitations (high risk for attrition bias).<br/> <i><sup>2</sup> </i> Wide confidence interval.<br/> <sup>3</sup>Most studies contributing data had design limitations (high risk for attrition bias and unclear for selection bias).<br/> <sup>4</sup>Most studies contributing data had design limitations (high risk for attrition bias and selection bias).<br/> <sup>5</sup>One study with high risk of blinding and attrition bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011761-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (child outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (child outcomes) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women during the preconception, pregnancy and postpartum period<br/> <b>Setting:</b> Germany, New Zealand, Thailand, Zaire<br/> <b>Intervention:</b> any supplement containing iodine<br/> <b>Comparison:</b> same supplement without iodine or no treatment/placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with same supplement without iodine or no treatment/placebo</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any supplement containing iodine</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Perinatal mortality</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.66<br/> (0.42 to 1.03) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>399<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""></td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>208 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>137 per 1000<br/> (87 to 214) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>208 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>137 per 1000<br/> (87 to 214) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Low birthweight</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.56<br/> (0.26 to 1.23) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>377<br/> (2 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (24 to 111) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000<br/> (25 to 118) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Neonatal hypothyroidism or elevated TSH</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.58<br/> (0.11 to 3.12) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>219<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>2, 3, 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (4 to 106) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (4 to 106) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Neonatal adverse effect: elevated TPO‐ab</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.61<br/> (0.07 to 5.70) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>108<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>2, 4, 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (3 to 244) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (3 to 245) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Child adverse effect: hyperthyroidism</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>See comments</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>No trials reported this outcome</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>TPO‐ab</b> : thyroid peroxidase antibodies; <b>TSH</b>: thyroid‐stimulating hormone </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Design limitations (high risk of attrition bias and unclear for selection bias).<br/> <sup>2</sup>Wide confidence interval.<br/> <sup>3</sup>One study had design limitations (high risk for attrition bias).<br/> <sup>4</sup>One study with design limitations (high risk for selection bias).<br/> <sup>5</sup>Small number of events. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011761-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011761-sec-0030"></div> <section id="CD011761-sec-0031"> <h3 class="title" id="CD011761-sec-0031">Description of the condition</h3> <p>Iodine is an essential nutrient required for the biosynthesis of thyroid hormones thyroxine (T4) and triiodothyronine (T3), which are responsible for regulating growth, development and metabolism. Very little iodine is required to meet the body's needs, ranging from 90 µg to 290 µg per day depending on age and physiological status (<a href="./references#CD011761-bbs2-0095" title="Institute of Medicine (IOM). Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C.: National Academy Press, 2001. ">IOM 2001</a>). However it can be challenging to meet these needs given that naturally‐occurring iodine is low in most foods and beverages, with the exception of seafood, including fish, shellfish and plants from the ocean (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). For many people, the major source of dietary iodine is added, from salt fortified with iodine or from dairy products in settings where iodine is added to animal feed or where iodine‐containing antiseptics are used. </p> <section id="CD011761-sec-0032"> <h4 class="title">Iodine in preconception, pregnancy and breastfeeding</h4> <p>Throughout pregnancy there are major alterations in thyroid function as a result of metabolic demands and hormonal changes (<a href="./references#CD011761-bbs2-0083" title="GlinoerD . The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews1997;18(3):404‐33. ">Glinoer 1997</a>). The concentrations of T4 and T3 rise significantly until approximately mid‐gestation and then remain relatively stable until the end of gestation at term. Iodine requirements increase substantially during pregnancy; initially as a result of a 50% increase in thyroid hormone production and a 30% to 50% increase in the renal excretion of iodine (<a href="./references#CD011761-bbs2-0085" title="GlinoerD . The importance of iodine nutrition during pregnancy. Public Health Nutrition2007;10(12A):1542‐6. ">Glinoer 2007</a>), and later in gestation when iodine passes through the placenta for fetal production of thyroid hormones (<a href="./references#CD011761-bbs2-0083" title="GlinoerD . The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews1997;18(3):404‐33. ">Glinoer 1997</a>). Maternal and fetal thyroid hormones are essential in regulating the development of the fetal brain and nervous system including the creation and growth of nerve cells, the formation of synapses, which are required for communication between nerve cells, and myelination, which is the formation of a fat‐based layer that allows for fast communication between nerve cells (<a href="./references#CD011761-bbs2-0106" title="PradoEL , DeweyKG . Nutrition and brain development in early life. Nutrition Reviews2014;72(4):267‐84. [DOI: doi:10.1111/nure.12102] ">Prado 2014</a>). Some of these events begin in the second month of gestation (<a href="./references#CD011761-bbs2-0106" title="PradoEL , DeweyKG . Nutrition and brain development in early life. Nutrition Reviews2014;72(4):267‐84. [DOI: doi:10.1111/nure.12102] ">Prado 2014</a>), so may be influenced by iodine status and thyroid hormone production prior to conception (or prior to knowledge of pregnancy). </p> <p>During breastfeeding, thyroid hormone production and urinary iodine excretion return to non‐pregnancy levels, but iodine requirements remain elevated because iodine is concentrated in the mammary gland for excretion in breast milk (<a href="./references#CD011761-bbs2-0100" title="LeungAM , PearceEN , BravermanLE . Iodine nutrition in pregnancy and lactation. Endocrinology and Metabolism Clinics of North America2011;40(4):765‐77. ">Leung 2011</a>). Breastmilk iodine content varies with maternal dietary iodine intake and is lowest in iodine‐deficient areas and highest where additional iodine is routinely provided through supplements or universal salt iodization (<a href="./references#CD011761-bbs2-0074" title="AziziF , SmythP . Breastfeeding and maternal and infant iodine nutrition. Clinical Endocrinology2009;70(5):803‐9. ">Azizi 2009</a>). As long as maternal iodine intake is adequate, breast milk can meet infant iodine needs. </p> </section> <section id="CD011761-sec-0033"> <h4 class="title">Recommended iodine intakes</h4> <p>Minute amounts of iodine are required to meet iodine needs and prevent deficiency. Different agencies have recommended different intakes to meet iodine needs of non‐pregnant, pregnant and breastfeeding women, ranging from 150 μg to 290 μg a day. The International Council for Control of Iodine Deficiency Disorders (ICCIDD), World Health Organization (WHO), and United Nations Children's Fund (UNICEF) recommended a daily iodine intake of 250 μg for pregnant women and those breastfeeding their babies (<a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). The US Institute of Medicine established a recommended dietary allowance of 220 μg a day for women during pregnancy and 290 μg a day whilst breastfeeding (<a href="./references#CD011761-bbs2-0095" title="Institute of Medicine (IOM). Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C.: National Academy Press, 2001. ">IOM 2001</a>). The European Food Safety Authority set the adequate intake among pregnant women and women who are breastfeeding their infants at 200 μg/day (<a href="./references#CD011761-bbs2-0081" title="European Food Safety Authority (EFSA). Scientific opinion on dietary reference values for iodine. www.efsa.europa.eu/en/efsajournal/doc/3660.pdf (accessed 17 October 2014). ">EFSA 2014</a>). All three recommendations suggest 150 μg a day for non‐pregnant adult women though recommended intakes for the adolescent period differ. </p> <p>Both the US Institute of Medicine and the European Commission Scientific Committee on Food have set tolerable upper intake levels for iodine, which are the highest levels of daily intake not likely to pose a risk of adverse health effects in the general population (<a href="./references#CD011761-bbs2-0095" title="Institute of Medicine (IOM). Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C.: National Academy Press, 2001. ">IOM 2001</a>; <a href="./references#CD011761-bbs2-0110" title="Scientific Committee on Food (SCF). Tolerable upper intake levels for vitamins and minerals. www.efsa.europa.eu/en/ndatopics/docs/ndatolerableuil.pdf (accessed 17 October 2014). ">SCF 2006</a>). These two organizations' recommendations vary greatly for non‐pregnant, pregnant and breastfeeding women though, with the US Institute of Medicine level at 1100 µg a day and the European Commission level set at 600 µg a day. These recommended intakes are not intended for iodine‐deficient populations however, as metabolic adaptations to deficiency could result in adverse health effects at lower intakes (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). </p> </section> <section id="CD011761-sec-0034"> <h4 class="title">Burden of iodine deficiency</h4> <p>It is estimated that over 1.8 billion people worldwide have an insufficient iodine intake, putting them at risk of iodine deficiency (<a href="./references#CD011761-bbs2-0071" title="AnderssonM , KarumbunathanV , ZimmermannMB . Global iodine status in 2011 and trends over the past decade. Journal of Nutrition2012;142(4):744‐50. ">Andersson 2012</a>). Europe is the region with the highest proportion of individuals with insufficient intake (44%), whereas Southeast Asia has the highest number (540 million). Given the elevated iodine requirements during pregnancy and breastfeeding and the importance of thyroid hormones for growth and development of the nervous system, ensuring adequate status in women and young children is critical. However, as only a limited number of countries have completed surveys in pregnant women and women of reproductive age on national or large sub‐national levels, there are insufficient data to directly estimate the regional or global prevalence of low iodine intake in these important target groups (<a href="./references#CD011761-bbs2-0125" title="WongEM , SullivanKM , PerrineCG , RogersLM , Peña‐RosasJP . Comparison of median urinary iodine concentration as an indicator of iodine status among pregnant women, school‐age children, and nonpregnant women. Food and Nutrition Bulletin2011;32(3):206‐12. ">Wong 2011</a>). </p> </section> <section id="CD011761-sec-0035"> <h4 class="title">Consequences of iodine deficiency</h4> <p>The consequences of iodine deficiency, which result from inadequate thyroid hormone production and can affect individuals of any age, sex, and physiological status, are collectively known as iodine deficiency disorders (<a href="./references#CD011761-bbs2-0089" title="HetzelBS . Iodine deficiency disorders (IDD) and their eradication. Lancet1983;2(8359):1126‐9. ">Hetzel 1983</a>; <a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). They are most serious and may be irreversible if they occur during pregnancy or early childhood, though the effects depend on the timing and severity of iodine deficiency (<a href="./references#CD011761-bbs2-0133" title="ZimmermannMB . The effects of iodine deficiency in pregnancy and infancy. Paediatric and Perinatal Epidemiology2012;26(Suppl 1):108‐17. ">Zimmermann 2012a</a>). If the increased iodine requirements during pregnancy are not met, the concentration of T4 diminishes (hypothyroxinaemia) in both mother and fetus, which can lead to irreversible brain damage with intellectual disability and neurologic abnormalities (<a href="./references#CD011761-bbs2-0085" title="GlinoerD . The importance of iodine nutrition during pregnancy. Public Health Nutrition2007;10(12A):1542‐6. ">Glinoer 2007</a>; <a href="./references#CD011761-bbs2-0124" title="WilliamsGR . Neurodevelopmental and neurophysiological actions of thyroid hormone. Journal of Neuroendocrinology2008;20(6):784‐94. ">Williams 2008</a>). Iodine deficiency in pregnancy has been associated with maternal and fetal goitre and hypothyroidism, increased pregnancy loss and infant mortality, and impairments in child development (<a href="./references#CD011761-bbs2-0079" title="DunnJT . Iodine supplementation and the prevention of cretinism. Annals of New York Academy of Sciences1993;678:158‐68. ">Dunn 1993</a>; <a href="./references#CD011761-bbs2-0080" title="DunnJT , DelangeF . Damaged reproduction: the most important consequence of iodine deficiency. Journal of Clinical Endocrinology and Metabolism2001;86(6):2360‐3. ">Dunn 2001</a>). Symptoms of hypothyroidism, or an underactive thyroid, include tiredness, weakness, poor memory and difficulty concentrating, weight gain, feeling cold, dry skin and hair loss (<a href="./references#CD011761-bbs2-0096" title="JamesonJL , WeetmanAP . Disorders of the thyroid gland. In: KasperDL , HarrisonTR editor(s). Harrison's Principles of Internal Medicine. 16th Edition. New York: McGraw‐Hill, 2005. ">Jameson 2005</a>). Globally, iodine deficiency is the most common cause of hypothyroidism (<a href="./references#CD011761-bbs2-0096" title="JamesonJL , WeetmanAP . Disorders of the thyroid gland. In: KasperDL , HarrisonTR editor(s). Harrison's Principles of Internal Medicine. 16th Edition. New York: McGraw‐Hill, 2005. ">Jameson 2005</a>) and the most common preventable cause of impaired brain development and mental function (<a href="./references#CD011761-bbs2-0122" title="World Health Organization and United Nations Children's Fund. Reaching optimal iodine nutrition in pregnant and lactating women and young children. www.who.int/nutrition/publications/WHOStatement__IDD_pregnancy.pdf (accessed 17 October 2014). ">WHO/UNICEF 2007</a>). </p> <p>The effect of iodine deficiency on child development can manifest itself as anything from mild intellectual blunting to cretinism, with a large proportion of the population experiencing intellectual impairment somewhere in between these extremes (<a href="./references#CD011761-bbs2-0084" title="GlinoerD , DelangeF . The potential repercussions of maternal, fetal, and neonatal hypothyroxinemia on the progeny. Thyroid2000;10(10):871‐7. ">Glinoer 2000</a>). Endemic cretinism, the most serious iodine deficiency disorder, is a permanent condition of severely stunted physical and mental development that results from an untreated congenital deficiency of thyroid hormones caused by severe maternal iodine deficiency (<a href="./references#CD011761-bbs2-0089" title="HetzelBS . Iodine deficiency disorders (IDD) and their eradication. Lancet1983;2(8359):1126‐9. ">Hetzel 1983</a>). It is still unclear whether mild‐to‐moderate maternal iodine deficiency in humans produces changes in cognitive function. Some evidence suggests that children with chronic severe iodine deficiency have significantly lower intelligence quotient (IQ) scores than those with adequate iodine status (<a href="./references#CD011761-bbs2-0132" title="ZimmermannMB . Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. American Journal of Clinical Nutrition2009;89(2):668S‐72S. ">Zimmermann 2009</a>). Some randomised clinical studies conducted in school‐age children indicate that cognitive performance may improve with iodine supplementation, even in mildly deficient areas (<a href="./references#CD011761-bbs2-0086" title="GordonRC , RoseMC , SkeaffSA , GrayAR , MorganKM , RuffmanT . Iodine supplementation improves cognition in mildly iodine‐deficient children. American Journal of Clinical Nutrition2009;90(5):1264‐71. ">Gordon 2009</a>; <a href="./references#CD011761-bbs2-0101" title="Melse‐BoonstraA , JaiswalN . Iodine deficiency in pregnancy, infancy and childhood and its consequences for brain development. Clinical Endocrinology and Metabolism2010;24(1):29‐38. ">Melse‐Boonstra 2010</a>). In the absence of iodine these effects are largely preventable by immediate thyroid hormone replacement, although deficits in memory and IQ may persist over time (<a href="./references#CD011761-bbs2-0124" title="WilliamsGR . Neurodevelopmental and neurophysiological actions of thyroid hormone. Journal of Neuroendocrinology2008;20(6):784‐94. ">Williams 2008</a>). It is also thought that iodine deficiency could be associated with autism (<a href="./references#CD011761-bbs2-0114" title="SullivanKM . The interaction of agricultural pesticides and marginal iodine nutrition status as a cause of autism spectrum disorders. Environmental Health Perspectives2008; Vol. 116, issue 4:A155. ">Sullivan 2008</a>) and with children's attention deficit and hyperactivity disorder (<a href="./references#CD011761-bbs2-0056" title="VermiglioF , Lo PrestiVP , MoletiM , SidotiM , TortorellaG , ScaffidiG , et al. Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild‐moderate iodine deficiency: a possible novel iodine deficiency disorder in developed countries. Journal of Clinical Endocrinology and Metabolism2004;89(12):6054‐60. ">Vermiglio 2004</a>). </p> <p>A variety of factors affect iodine metabolism and thyroid function and can exacerbate iodine deficiency. Other nutritional deficiencies, including of selenium and iron, can lead to decreased thyroid hormone production and cause damage to the thyroid because key enzymes required for thyroid hormone synthesis and metabolism depend on these nutrients (<a href="./references#CD011761-bbs2-0128" title="ZimmermannMB , KöhrleJ . The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid2002;12(10):867‐78. ">Zimmermann 2002</a>). Iron supplementation has been shown to improve the efficacy of iodine supplementation or salt iodization in iodine‐ and iron‐deficient children (<a href="./references#CD011761-bbs2-0088" title="HessSY , ZimmermannMB , AdouP , TorresaniT , HurrellRF . Treatment of iron deficiency in goitrous children improves the efficacy of iodized salt in Côte d'Ivoire. American Journal of Clinical Nutrition2002;75(4):743‐8. ">Hess 2002</a>; <a href="./references#CD011761-bbs2-0127" title="ZimmermannM , AdouP , TorresaniT , ZederC , HurrellR . Iron supplementation in goitrous, iron‐deficient children improves their response to oral iodized oil. European Journal of Endocrinology2000;142(3):217‐23. ">Zimmermann 2000</a>). </p> <p>Compounds found naturally in some foods such as cassava, sorghum, soy and millet, and pollutants in food and water such as perchlorate and nitrate can also negatively affect iodine metabolism and thyroid function (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). Collectively known as goitrogens, these substances can compete with iodine for uptake by the thyroid and impair the activity of key enzymes required to produce thyroid hormones. Infants and young children appear particularly vulnerable to the effects of goitrogens, and effects are generally only seen where there is pre‐existing iodine deficiency. </p> </section> <section id="CD011761-sec-0036"> <h4 class="title">Consequences of excess iodine</h4> <p>Excess iodine exposure can also cause serious negative health effects, and can occur through ingestion of supplements, water or foods with high iodine content or via medical treatments or procedures. Acute iodine poisoning may cause gastrointestinal or cardiovascular symptoms, or even coma, after ingestion of many grams of iodine (<a href="./references#CD011761-bbs2-0131" title="ZimmermannMB . Methods to assess iron and iodine status. British Journal of Nutrition2008;99(Suppl 3):S2‐9. ">Zimmermann 2008</a>). Excess iodine can also cause the thyroid to become over or underactive (hyper or hypothyroidism). Hypothyroidism symptoms are described above. Symptoms of excess thyroid hormone production as a result of hyperthyroidism include hyperactivity, irritability, heat intolerance, palpitations, weakness, fatigue and weight loss (<a href="./references#CD011761-bbs2-0096" title="JamesonJL , WeetmanAP . Disorders of the thyroid gland. In: KasperDL , HarrisonTR editor(s). Harrison's Principles of Internal Medicine. 16th Edition. New York: McGraw‐Hill, 2005. ">Jameson 2005</a>). </p> <p>In iodine sufficiency, the thyroid is able to adjust to a wide range of iodine intakes, so healthy individuals may tolerate up to 1 mg daily (<a href="./references#CD011761-bbs2-0131" title="ZimmermannMB . Methods to assess iron and iodine status. British Journal of Nutrition2008;99(Suppl 3):S2‐9. ">Zimmermann 2008</a>). In areas of chronic iodine deficiency however, individuals are less tolerant to high iodine intake, especially older adults with longstanding goitre. Iodine‐induced hyperthyroidism has been reported in the initial phases of salt iodization programmes, though it is nearly always temporary (<a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). It was estimated that 11 countries have excessive iodine intakes (up from seven in 2007) as presented at the Sixty‐sixth World Health Assembly in a progress report from the WHO in 2013. </p> </section> <section id="CD011761-sec-0037"> <h4 class="title">Indicators of iodine status</h4> <section id="CD011761-sec-0038"> <h5 class="title">Urinary iodine concentration (UIC)</h5> <p>In conditions of iodine sufficiency, over 90% of ingested iodine is excreted in the urine, whereas in chronic iodine deficiency the excretion may be less than 20%, making urinary iodine concentration (UIC) a good indicator of recent iodine intake, or short‐term iodine status (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). UIC has limited utility in assessing individual intake or status because of large variations within and between days (<a href="./references#CD011761-bbs2-0120" title="World Health Organization. Urinary iodine concentrations for determining iodine status deficiency in populations. www.who.int/nutrition/vmnis/ indicators/urinaryiodine (accessed 18 October 2014). ">WHO 2013</a>). These variations level out in large population samples though, making UIC a useful population‐level indicator. UIC is not a direct indicator of thyroid function, but low values suggest a greater risk of developing thyroid disorders (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). </p> <p>UIC is commonly collected from school age children and extrapolated to the general population or other population groups; however, neither this group nor non‐pregnant women serve as an adequate proxy for pregnant women (<a href="./references#CD011761-bbs2-0125" title="WongEM , SullivanKM , PerrineCG , RogersLM , Peña‐RosasJP . Comparison of median urinary iodine concentration as an indicator of iodine status among pregnant women, school‐age children, and nonpregnant women. Food and Nutrition Bulletin2011;32(3):206‐12. ">Wong 2011</a>). For pregnant women, a median UIC below 150 μg/L is indicative of insufficient iodine intake, 150 μg/L to 249 μg/L adequate iodine intake, 250 μg/L to 499 μg/L above iodine requirements, and 500 μg/L or higher concentrations suggest an excessive intake (beyond that needed for prevention and control of iodine deficiency) (<a href="./references#CD011761-bbs2-0120" title="World Health Organization. Urinary iodine concentrations for determining iodine status deficiency in populations. www.who.int/nutrition/vmnis/ indicators/urinaryiodine (accessed 18 October 2014). ">WHO 2013</a>). For women who are breastfeeding their infants and children under two years of age, a median UIC of below 100 μg/L indicates insufficient iodine intake, and 100 μg/L or more indicates adequate iodine intake. For these population groups, the category of iodine intake is not extrapolated to category of iodine status. </p> </section> <section id="CD011761-sec-0039"> <h5 class="title">Goitre</h5> <p>The development of goitre, or enlargement of the thyroid gland, begins as an adaptive response when iodine available to the thyroid is not sufficient for adequate thyroid hormone production (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). Goitre responds slowly to changes in iodine intake and is therefore an indicator of longer‐term iodine status. In areas of chronic iodine deficiency it can take years for thyroid size to return to normal, and goitre may never completely disappear (<a href="./references#CD011761-bbs2-0134" title="ZimmermannMB , AnderssonM . Assessment of iodine nutrition in populations: past, present, and future. Nutrition Reviews2012;70(10):553‐70. ">Zimmermann 2012b</a>). </p> <p>The presence of goitre can be determined by neck inspection and palpation or by thyroid ultrasonography (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>; <a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). This method however has poor sensitivity and specificity in areas of mild‐to‐moderate iodine deficiency. In these settings, assessment of thyroid size by ultrasonography is preferred and technology is available for use in field settings. International reference values for thyroid volume using ultrasound are available only for school age children though (<a href="./references#CD011761-bbs2-0129" title="ZimmermannMB , HessSY , MolinariL , deBenoistB , DelangeF , BravermanLE , et al. New reference values for thyroid volume by ultrasound in iodine‐sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report. American Journal of Clinical Nutrition2004;79(2):231‐7. ">Zimmermann 2004</a>). </p> </section> <section id="CD011761-sec-0040"> <h5 class="title">Thyroid‐stimulating hormone (TSH)</h5> <p>This hormone, also known as thyrotropin, is produced by the pituitary gland and stimulates thyroid hormone production and release by the thyroid gland (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). Serum TSH levels increase in response to low thyroid hormone concentration and decrease in response to high concentration; it is a very sensitive indicator of thyroid function and is the primary screening test for thyroid dysfunction (<a href="./references#CD011761-bbs2-0096" title="JamesonJL , WeetmanAP . Disorders of the thyroid gland. In: KasperDL , HarrisonTR editor(s). Harrison's Principles of Internal Medicine. 16th Edition. New York: McGraw‐Hill, 2005. ">Jameson 2005</a>). Though TSH levels may rise in response to iodine deficiency, they are often in the normal range, therefore TSH is not considered a sensitive indicator of iodine status (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>; <a href="./references#CD011761-bbs2-0131" title="ZimmermannMB . Methods to assess iron and iodine status. British Journal of Nutrition2008;99(Suppl 3):S2‐9. ">Zimmermann 2008</a>). TSH is a useful indicator of iodine nutrition in neonates though because they have high thyroidal iodine turnover (<a href="./references#CD011761-bbs2-0078" title="DelangeF . Screening for congenital hypothyroidism used as an indicator of the degree of iodine deficiency and of its control. Thyroid1998;8(12):1185‐92. ">Delange 1998</a>). Moderately elevated levels (higher than 5 mIU/L in whole blood) indicate neonatal iodine deficiency, which is a direct reflection of iodine deficiency during pregnancy (<a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). A prevalence of less than 3% of infants with moderately elevated TSH is expected in iodine‐sufficient regions (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>; <a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). Neonatal TSH screening for congenital hypothyroidism is standard practice in many developed countries (<a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). This condition, which has genetic causes, is relatively rare (one in 4000 births) and indicated by highly elevated TSH levels (20 mIU/L or higher), and requires immediate treatment to prevent permanent neurological damage. </p> <p>Because of a physiological surge in newborns, neonatal TSH assessment must take place at least 48 hours following birth (<a href="./references#CD011761-bbs2-0123" title="World Health Organization, United Nations Children'sFund , and International Council for Control of Iodine Deficiency Disorders. Assessment of iodine deficiency disorders and monitoring their elimination. World Health Organization, 2007. ">WHO/UNICEF/ICCIDD 2007</a>). In some countries elevated neonatal TSH may be attributed to the use of beta‐iodine‐containing antiseptics so results need to be interpreted cautiously in these contexts. </p> </section> <section id="CD011761-sec-0041"> <h5 class="title">Thyroid hormones</h5> <p>Triiodothyronine (T3) and its prohormone, thyroxine (T4), are hormones produced and secreted by the thyroid gland (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). T4 is converted to T3, the active hormone, in peripheral tissues. A very small amount (less than 1%) of T4 and T3 in the blood is not bound to protein, and therefore biologically active. In the past, thyroid hormone assessments typically measured total amounts because the free levels were too low to detect. However, with the advent of newer techniques, free T4 and free T3, which better reflect the physiological effects of thyroid hormones than total hormone concentrations, are usually measured nowadays. </p> <p>T3 and T4 levels are direct clinical indicators of thyroid function, but levels are protected in the early stages of thyroid dysfunction and changes occur only at later stages (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). Therefore these thyroid hormones are not good indicators of iodine status, except in cases of severe iodine deficiency. A diagnosis of subclinical hypothyroidism is based on elevated TSH with normal T4 and T3 levels. Overt hypothyroidism occurs when thyroid function further diminishes, as indicated by falling free T4 levels, and the diagnosis is based on high TSH and low T4. T3 levels are typically maintained even longer than T4 levels. Some research has shown that neonatal T4 levels are lower in iodine‐deficient compared to iodine‐sufficient areas; however, validated norms have not been established for comparison. </p> </section> <section id="CD011761-sec-0042"> <h5 class="title">Thyroglobulin (Tg)</h5> <p>Tg is a protein matrix for thyroid hormone synthesis (<a href="./references#CD011761-bbs2-0083" title="GlinoerD . The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews1997;18(3):404‐33. ">Glinoer 1997</a>). Tg levels rise early in pregnancy, and the increase is most pronounced towards the end of gestation. In newborns, Tg levels are normally increased in the first few days, possibly in response to the physiological TSH surge (<a href="./references#CD011761-bbs2-0104" title="PezzinoV , FilettiS , BelfioreA , ProtoS , DonzelliG , VigneriR . Serum thyroglobulin levels in the newborn. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 2:364‐6. ">Pezzino 1981</a>). </p> <p>Tg is an indirect indicator of thyroid function and Tg levels are positively correlated with thyroid volume (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). Tg is elevated in iodine‐deficient populations and is also an indirect indicator of iodine status. Levels respond more quickly (weeks to months) to iodine repletion than TSH or goitre (<a href="./references#CD011761-bbs2-0131" title="ZimmermannMB . Methods to assess iron and iodine status. British Journal of Nutrition2008;99(Suppl 3):S2‐9. ">Zimmermann 2008</a>). Assays can be performed on samples collected on dried blood spots and international reference ranges are available for school‐age children (<a href="./references#CD011761-bbs2-0129" title="ZimmermannMB , HessSY , MolinariL , deBenoistB , DelangeF , BravermanLE , et al. New reference values for thyroid volume by ultrasound in iodine‐sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report. American Journal of Clinical Nutrition2004;79(2):231‐7. ">Zimmermann 2004</a>). The presence of anti‐Tg antibodies, however, is reported to complicate interpretation of Tg values (<a href="./references#CD011761-bbs2-0109" title="RohnerF , ZimmermannM , JoosteP , PandavC , CaldwellK , RaghavanR , et al. Biomarkers of nutrition for development ‐ iodine review. Journal of Nutrition2014;144(8):1322S‐42S. ">Rohner 2014</a>). </p> <p>Complex changes in thyroid physiology can make interpretation of thyroid function and iodine status in pregnancy and early infancy difficult, therefore special considerations should to be taken into account to avoid misinterpreting results (<a href="./references#CD011761-bbs2-0098" title="LaurbergP , AndersenS , BjarnadóttirRI , CarléA , HreidarssonAB , KnudsenN , et al. Evaluating iodine deficiency in pregnant women and young infants ‐ complex physiology with a risk of misinterpretation. Public Health Nutrition2007;10(12A):1547‐52. ">Laurberg 2007</a>). Though Stinca and colleagues recently reported that dried blood spot Tg is a sensitive indicator of iodine status in pregnant women and that Tg antibodies may not be necessary in this assessment (<a href="./references#CD011761-bbs2-0112" title="StincaS , AnderssonM , WeibelS , Aeberli‐HerterI , FingerhutR , GowachirapantS , et al. Dried blood spot thyroglobulin as a biomarker of iodine status in pregnant women. Journal of Clinical Endocrinology and Metabolism2016;Epub ahead of print:jc20162829. ">Stinca 2016</a>). </p> </section> </section> </section> <section id="CD011761-sec-0043"> <h3 class="title" id="CD011761-sec-0043">Description of the intervention</h3> <section id="CD011761-sec-0044"> <h4 class="title">Guidance and recommendations</h4> <p>Since 1993, universal salt iodization, or the addition of iodine to all salt for human and animal consumption including food industry salt, has been recommended for preventing and controlling iodine deficiency (<a href="./references#CD011761-bbs2-0117" title="United Nations Children's Fund ‐ World Health Organization Joint Committee on Health Policy. World Summit for Children ‐ Mid‐Decade Goal: Iodine Deficiency Disorders (IDD). www.ceecis.org/iodine/01_global/01_pl/01_01_1994_summit.pdf (accessed 17 October 2014). ">UNICEF/WHO 1994</a>; <a href="./references#CD011761-bbs2-0121" title="WHO . Guideline: fortification of food‐grade salt with iodine for the prevention and control of iodine deficiency disorders. Geneva: World Health Organization, 2014. ">WHO 2014</a>). As a result of this long‐standing recommendation and the related support for its implementation, most countries have some form of salt iodization program in place to prevent and control iodine deficiency and its consequences (<a href="./references#CD011761-bbs2-0116" title="United Nations Children'sFund . Sustainable elimination of iodine deficiency. www.unicef.org/iran/Sustainable_Elimination_of_Iodine_Deficiency_053008(1).pdf (accessed 17 October 2014). ">UNICEF 2008</a>). Universal salt iodization is widely acknowledged as a cost‐effective, feasible, and sustainable approach to control iodine deficiency, and research suggests that successful salt iodization programmes can meet the needs of population groups susceptible to iodine deficiency and its consequences, specifically pregnant and breastfeeding women and infants (<a href="./references#CD011761-bbs2-0130" title="ZimmermannMB . The impact of iodised salt or iodine supplements on iodine status during pregnancy, lactation and infancy. Public Health Nutrition2007;10(12A):1584‐95. ">Zimmermann 2007</a>). However, it has been recognized that these groups may need to be targeted with other iodine interventions (<a href="./references#CD011761-bbs2-0118" title="UntoroJ , MangasaryanN , deBenoistB , Darnton‐HillI . Reaching optimal iodine nutrition in pregnant and lactating women and young children: programmatic recommendations. Public Health Nutrition2007;10(12A):1527‐9. ">Untoro 2007</a>). WHO and UNICEF recommend considering iodine supplementation in pregnant women, women breastfeeding their infants and children from six to 23 months of age, alongside efforts to scale up salt iodization, in settings where large proportions of the population do not have access to iodized salt (<a href="./references#CD011761-bbs2-0122" title="World Health Organization and United Nations Children's Fund. Reaching optimal iodine nutrition in pregnant and lactating women and young children. www.who.int/nutrition/publications/WHOStatement__IDD_pregnancy.pdf (accessed 17 October 2014). ">WHO/UNICEF 2007</a>). In addition, where pregnant women are difficult to reach, WHO and UNICEF recommend that supplementation be extended to all women of reproductive age. In some countries, for example the USA, Canadian and Australian medical bodies have issued specific recommendations for iodine supplementation in women who are pregnant or breastfeeding (and women considering becoming pregnant in Australia) (<a href="./references#CD011761-bbs2-0073" title="Public Health Committee of the American Thyroid Association (ATA). Iodine supplementation for pregnancy and lactation ‐ United States and Canada: recommendations of the American Thyroid Association. Thyroid2006;16(10):949‐51. ">ATA 2006</a>; <a href="./references#CD011761-bbs2-0103" title="Australian Government National Health and Medical Research Council (NHMRC). NHMRC Public Statement: Iodine Supplementation for Pregnant and Breastfeeding Women. www.nhmrc.gov.au/_files_nhmrc/publications/attachments/new45_statement.pdf (accessed 17 October 2014). ">NHMRC 2010</a>). </p> </section> <section id="CD011761-sec-0045"> <h4 class="title">Supplement form, dose, and regimen</h4> <section id="CD011761-sec-0046"> <h5 class="title">Oral supplements</h5> <p>Several different types of oral iodine supplements are available for public health purposes. These can be broadly divided into frequent low dose (such as daily or weekly), or infrequent high dose (such as annually or only once). The low‐dose formulations usually contain iodine as potassium iodide and come in the form of tablets or drops for oral consumption. Many commercially available multiple‐micronutrient supplements including prenatal formulations also contain iodine, often 150 μg for a daily dose (<a href="./references#CD011761-bbs2-0099" title="LeungAM , PearceEN , BravermanLE . Iodine content of prenatal multivitamins in the United States. New England Journal of Medicine2009;360(9):939‐40. ">Leung 2009</a>). </p> <p>High‐dose iodine supplements usually come in the form of oral iodized oil capsules; the iodine is stored mainly in the thyroid gland and can meet needs for up to a year. The above‐mentioned WHO/UNICEF guidance recommends a single annual dose of 400 mg or a daily dose of 250 μg for pregnant and breastfeeding women (or 150 μg a day for non‐pregnant women) (<a href="./references#CD011761-bbs2-0122" title="World Health Organization and United Nations Children's Fund. Reaching optimal iodine nutrition in pregnant and lactating women and young children. www.who.int/nutrition/publications/WHOStatement__IDD_pregnancy.pdf (accessed 17 October 2014). ">WHO/UNICEF 2007</a>), whereas the USA, Canadian and Australian recommendations suggest 150 μg/day (<a href="./references#CD011761-bbs2-0073" title="Public Health Committee of the American Thyroid Association (ATA). Iodine supplementation for pregnancy and lactation ‐ United States and Canada: recommendations of the American Thyroid Association. Thyroid2006;16(10):949‐51. ">ATA 2006</a>; <a href="./references#CD011761-bbs2-0103" title="Australian Government National Health and Medical Research Council (NHMRC). NHMRC Public Statement: Iodine Supplementation for Pregnant and Breastfeeding Women. www.nhmrc.gov.au/_files_nhmrc/publications/attachments/new45_statement.pdf (accessed 17 October 2014). ">NHMRC 2010</a>). </p> </section> <section id="CD011761-sec-0047"> <h5 class="title">Injectable supplements</h5> <p>Much of the early iodine supplementation research used high‐dose intramuscular iodized oil injections (e.g. <a href="./references#CD011761-bbs2-0105" title="PharoahPO , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;1(7694):308‐10. ">Pharoah 1971</a> and <a href="./references#CD011761-bbs2-0107" title="PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:246‐65. ">Pretell 1972</a>) and this approach was used in public health programmes especially in the 1970s and 1980s. This would currently be considered a medical intervention that should be provided under medical supervision. Other forms of medical iodine interventions are available including sodium iodide solution used in intravenous parenteral nutrition. </p> </section> </section> </section> <section id="CD011761-sec-0048"> <h3 class="title" id="CD011761-sec-0048">How the intervention might work</h3> <p>Iodine requirements increase during pregnancy because of increased thyroid hormone production and iodine excretion, and during breastfeeding because iodine is concentrated in the mammary gland for excretion in breast milk. If maternal iodine requirements are not met during this period, the production of thyroid hormones may decrease and be inadequate for maternal, fetal and infant needs (<a href="./references#CD011761-bbs2-0085" title="GlinoerD . The importance of iodine nutrition during pregnancy. Public Health Nutrition2007;10(12A):1542‐6. ">Glinoer 2007</a>). Consequences may include maternal or child hypothyroidism or goitre, pregnancy loss, low birthweight, infant mortality, and developmental delays ranging from mild intellectual impairment to cretinism. </p> <p>Additional iodine intake through iodine supplementation may help meet the increased iodine needs for thyroid hormone production and transfer to the fetus/infant during pregnancy and the postpartum period and prevent or correct iodine deficiency and its consequences. Iodine supplementation prior to conception could increase iodine stores and thyroid hormone production before the additional demands of pregnancy. This may be especially important in severely iodine‐deficient areas to allow time for correction of long‐standing deficiency. Even where iodine deficiency is less severe though, additional iodine intake prior to pregnancy may be warranted because thyroid hormones are important for brain and nervous system development events starting as early as the seventh week of gestation (<a href="./references#CD011761-bbs2-0106" title="PradoEL , DeweyKG . Nutrition and brain development in early life. Nutrition Reviews2014;72(4):267‐84. [DOI: doi:10.1111/nure.12102] ">Prado 2014</a>), when women may not know or share with others that they are pregnant. </p> <p>Previous evidence reviews reported that high‐dose iodine supplementation through intramuscular injection prior to, or early in pregnancy reduced the incidence of cretinism and improved child cognitive development scores in severely iodine‐deficient areas (<a href="./references#CD011761-bbs2-0075" title="BougmaK , AboudFE , HardingKB , MarquisGS . Iodine and mental development of children 5 years old and under: a systematic review and meta‐analysis. Nutrients2013;5(4):1384‐416. [DOI: 10.3390/nu5041384] ">Bougma 2013</a>; <a href="./references#CD011761-bbs2-0133" title="ZimmermannMB . The effects of iodine deficiency in pregnancy and infancy. Paediatric and Perinatal Epidemiology2012;26(Suppl 1):108‐17. ">Zimmermann 2012a</a>). There is also evidence of improved birthweight, through oral iodine supplementation, and decreased child mortality, through injected iodized oil (<a href="./references#CD011761-bbs2-0133" title="ZimmermannMB . The effects of iodine deficiency in pregnancy and infancy. Paediatric and Perinatal Epidemiology2012;26(Suppl 1):108‐17. ">Zimmermann 2012a</a>). </p> <p>From an implementation perspective, pregnant and postpartum women often have contact with the healthcare system, which generally provides or recommends prenatal and sometimes postnatal micronutrient supplementation ‐ usually iron and folic acid. Similarly, where indicated, iodine supplementation could be integrated into routine antenatal and postnatal care. To reach women prior to pregnancy, existing contacts with the healthcare system or other platforms could be used to provide or recommend iodine supplementation for those planning on becoming pregnant or to all women of reproductive age, or both, because pregnancies are often unplanned (as is done with folic acid supplementation recommendations in many settings). </p> </section> <section id="CD011761-sec-0049"> <h3 class="title" id="CD011761-sec-0049">Why it is important to do this review</h3> <p>It is important to assess the effects and safety of iodine supplementation in women before or during pregnancy and in the postpartum period for optimal maternal and child outcomes and to inform policy making towards the achievement of the WHO global targets for maternal, infant and young child nutrition by 2025 (<a href="./references#CD011761-bbs2-0119" title="World Health Assembly. Resolution WHA65.6. Comprehensive implementation plan on maternal, infant and young child nutrition. Sixty‐fifth World Health Assembly, Geneva, 21–26 May 2012. Resolutions and decisions, annexes. Vol. WHA65/2012/REC/1, Geneva: World Health Organization, 2012:55‐68. ">WHA 2012</a>). </p> <p>This review will complement the findings of other existing reviews assessing the provision of iodine through a variety of interventions. Mahomed and colleagues conducted one of the first Cochrane Reviews on the topic (now withdrawn), examining maternal iodine supplementation in areas of iodine deficiency (<a href="./references#CD011761-bbs2-0136" title="MahomedK , GülmezogluAM . Maternal iodine supplements in areas of deficiency. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD000135.pub2] ">Mahomed 2006</a>). More recently a non‐Cochrane review examined the effect of prenatal or periconceptional iodine supplementation on child development, growth and other clinical outcomes (<a href="./references#CD011761-bbs2-0126" title="ZhouSJ , AndersonAJ , GibsonRA , MakridesM . Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials. American Journal of Clinical Nutrition2013;98(5):1241‐54. [DOI: 10.3945/ajcn.113.065854] ">Zhou 2013</a>). The effects of iodine supplementation for preventing iodine deficiency disorders in children (<a href="./references#CD011761-bbs2-0072" title="AngermayrL , ClarC . Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD003819.pub2] ">Angermayr 2004</a>) and mortality and adverse neurodevelopmental outcomes in preterm infants (<a href="./references#CD011761-bbs2-0094" title="IbrahimM , SinnJ , McGuireW . Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD005253.pub2] ">Ibrahim 2006</a>) are addressed in other Cochrane Reviews. A review on salt iodization for prevention of iodine deficiency disorders is published elsewhere (<a href="./references#CD011761-bbs2-0070" title="AburtoN , AbudouM , CandeiasV , WuT . Effect and safety of salt iodization to prevent iodine deficiency disorders: a systematic review with meta‐analyses. http://apps.who.int/iris/bitstream/10665/148175/1/9789241508285_eng.pdf (accessed 23 February 2017). Geneva: World Health Organization, 2014:1‐151. ">Aburto 2014</a>) and a Cochrane Review on fortification of foods and condiments (other than salt) with iodine for prevention of iodine deficiency disorders (<a href="./references#CD011761-bbs2-0097" title="LandMA , ChristoforouA , DownsS , WebsterJ , BillotL , LiM , et al. Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders. Cochrane Database of Systematic Reviews2013, Issue 9. [DOI: 10.1002/14651858.CD010734] ">Land 2013</a>) is being conducted. Furthermore, a review on the effect of iodized salt or iodine supplements on prenatal and postnatal growth (<a href="./references#CD011761-bbs2-0082" title="FarebrotherJ , NaudeCE , NicolL , SangZ , YangZ , AnderssonM , et al. Systematic review of the effects of iodised salt and iodine supplements on prenatal and postnatal growth: study protocol. BMJ Open2015;5:e007238. ">Farebrother 2015</a>) is also underway. Cochrane reviews have also been conducted on point‐of‐use fortification of foods with multiple‐micronutrient powders (<a href="./references#CD011761-bbs2-0113" title="SuchdevPS , Peña‐RosasJP , De‐RegilLM . Multiple micronutrient powders for home (point‐of‐use) fortification of foods in pregnant women. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD011158.pub2] ">Suchdev 2015</a>) and multiple‐micronutrient supplementation (<a href="./references#CD011761-bbs2-0087" title="HaiderBA , BhuttaZA . Multiple‐micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD004905.pub4] ">Haider 2015</a>) for women during pregnancy. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011761-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011761-sec-0050"></div> <p>To assess the benefits and harms of supplementation with iodine, alone or in combination with other vitamins and minerals, for women in the preconceptional, pregnancy or postpartum period on their and their children's outcomes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011761-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011761-sec-0051"></div> <section id="CD011761-sec-0052"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011761-sec-0053"> <h4 class="title">Types of studies</h4> <p>We included randomised and quasi‐randomized controlled trials with randomisation at either the individual or cluster level. We intended to include eligible cross‐over trials (and use only the results from the first period) however we did not identify any such studies. </p> </section> <section id="CD011761-sec-0054"> <h4 class="title">Types of participants</h4> <p>Women who become pregnant, or pregnant or postpartum women of any chronological age and parity (number of births), regardless as to the iodine status of the study population or setting. We included studies that randomised women to receive treatment starting at any point prior to conception, during pregnancy or within the first six weeks postpartum. We planned to exclude studies specifically targeting women screened for and diagnosed with thyroid disorders (as defined by trial authors) or other health problems (e.g. thyroid disease, HIV, tuberculosis) however we did not identify any such studies. </p> </section> <section id="CD011761-sec-0055"> <h4 class="title">Types of interventions</h4> <p>Injected or oral iodine supplementation (such as tablets, capsules, drops) during preconception, pregnancy or the postpartum period irrespective of compound, dose, frequency or duration. </p> <p>Specifically, where data were available we planned to assess the following comparisons:</p> <p> <ol id="CD011761-list-0001"> <li> <p>any supplement containing iodine versus same supplement without iodine or no intervention/placebo;</p> </li> <li> <p>any oral iodine supplement versus same supplement without iodine or no intervention/placebo;</p> </li> <li> <p>oral iodine‐only supplement versus no intervention or placebo;</p> </li> <li> <p>oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals (exact same formulation of other vitamins/minerals, but no iodine); </p> </li> <li> <p>any injected iodine supplement versus same supplement without iodine or no intervention/placebo;</p> </li> <li> <p>injected iodine‐only supplement versus no intervention or placebo;</p> </li> <li> <p>injected iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals (exact same formulation of other vitamins/minerals, but no iodine). </p> </li> </ol> </p> <p>We only identified data for comparisons 1 through 6. Because we did not identify any studies for comparison 7, comparisons 5 and 6 include the exact same data and we have only reported comparison 5. We have summarized comparisons 2, 3, 4 and 5 in comparison 1, and we have summarized comparisons 3 and 4 in comparison 2. We have summarized comparison 1, the main comparison, in the 'Summary of findings' tables (<a href="./full#CD011761-tbl-0001">summary of findings Table for the main comparison</a> and <a href="./full#CD011761-tbl-0002">summary of findings Table 2</a>). </p> <p>We included interventions that combined iodine supplementation with co‐interventions (e.g. education), only if the co‐interventions were the same across study arms. We excluded studies that examined tube feeding, parenteral nutrition, or food‐based interventions (e.g. fortified or bio fortified foods, point‐of‐use fortification with micronutrient powders or lipid‐based nutrient supplements). </p> </section> <section id="CD011761-sec-0056"> <h4 class="title">Types of outcome measures</h4> <p>We included studies which met the above‐mentioned criteria regardless of outcomes reported, though we only extracted the outcomes described below. </p> <section id="CD011761-sec-0057"> <h5 class="title">Primary outcomes</h5> <section id="CD011761-sec-0058"> <h6 class="title">Maternal</h6> <p> <ol id="CD011761-list-0002"> <li> <p>Hypothyroidism (as defined by trial authors)</p> </li> <li> <p>Preterm birth (as defined by trial authors)</p> </li> <li> <p>Adverse effects</p> <ol id="CD011761-list-0003"> <li> <p>Elevated thyroid peroxidase antibodies (TPO‐ab) (as defined by trial authors)</p> </li> <li> <p>Hyperthyroidism (as defined by trial authors)</p> </li> <li> <p>Digestive intolerance (as defined by trial authors)</p> </li> </ol> </li> </ol> </p> </section> <section id="CD011761-sec-0059"> <h6 class="title">Infants and children ‐ to 23 months of age</h6> <p> <ol id="CD011761-list-0004"> <li> <p>Perinatal mortality (including stillbirth/fetal death and neonatal death, as defined by trial authors) </p> </li> <li> <p>Low birthweight (less than 2500 g)</p> </li> <li> <p>Hypothyroidism or elevated TSH (as defined by trial authors)</p> </li> <li> <p>Adverse effects</p> <ol id="CD011761-list-0005"> <li> <p>Elevated TPO‐ab (as defined by trial authors)</p> </li> <li> <p>Hyperthyroidism (as defined by trial authors)</p> </li> </ol> </li> </ol> </p> </section> </section> <section id="CD011761-sec-0060"> <h5 class="title">Secondary outcomes</h5> <section id="CD011761-sec-0061"> <h6 class="title">Maternal</h6> <p> <ol id="CD011761-list-0006"> <li> <p>Spontaneous miscarriage (as defined by trial authors)</p> </li> <li> <p>Thyroid size (assessed by any method)</p> </li> <li> <p>Thyroglobulin (Tg) (μg/L)</p> </li> <li> <p>Insufficient iodine intake (pregnancy: median urinary iodine concentration (UIC) less than 150 μg/L, breastfeeding: median UIC less than 100 μg/L) </p> </li> <li> <p>Excessive iodine intake (pregnancy only: median UIC greater than or equal to 500 μg/L)</p> </li> </ol> </p> </section> <section id="CD011761-sec-0062"> <h6 class="title">Infants and children ‐ to 23 months of age</h6> <p> <ol id="CD011761-list-0007"> <li> <p>Small‐for‐gestational age (as defined by trial authors)</p> </li> <li> <p>Congenital anomalies (including cretinism, as defined by trial authors)</p> </li> <li> <p>Growth (anthropometric Z scores)</p> </li> <li> <p>Thyroid size (assessed by any method)</p> </li> <li> <p>Insufficient iodine intake (median UIC less than 100 μg/L)</p> </li> <li> <p>Mental or motor development (as defined by trial authors)</p> </li> <li> <p>Infant death (death in the first year of life)</p> </li> </ol> </p> <p>For relevant maternal outcomes, we included both the pregnancy and postpartum period. If maternal outcomes were assessed at multiple time points, unless otherwise specified, we used the last assessment during pregnancy and the last assessment in the postpartum period. We planned to include the last assessment during the intervention period and the last assessment during the follow‐up period though did not because many of the trials were single dose and therefore this distinction was not relevant, and also because of the way data were presented in most of the trials. We did not include any outcomes during the preconception period. For infant and child outcomes assessed at multiple time points, where relevant we planned to include the neonatal period (to 28 days), infancy (under one year), and childhood (beyond one year). We summarized primary outcomes in 'Summary of findings' tables (<a href="./full#CD011761-tbl-0001">summary of findings Table for the main comparison</a>, <a href="./full#CD011761-tbl-0002">summary of findings Table 2</a>). </p> <p>We planned to include any adverse event, such as iodine‐induced hyperthyroidism, in the mother and child as primary outcomes. None of the trials which reported on hyperthyroidism indicated whether it was or suspected to be iodine‐induced (none of these trials took place in severely‐deficient women so it is unlikely that the hyperthyroidism would have been caused by the supplemental iodine). The only other reported outcomes considered by the trial or review authors to be potentially adverse were elevated TPO‐ab and digestive intolerance. Therefore we replaced any adverse effects with hyperthyroidism and elevated TPO‐ab (and digestive intolerance for women), and extracted these outcomes separately to avoid losing potentially important information. </p> <p>Urinary and breast milk iodine concentrations are probably the most common indicators of iodine status; they provide important information on the adherence and biological response to the intervention or potential contamination in the control group. However these indicators are generally highly skewed and are typically reported as median with some description of the range. As we did not have access to primary data, we have presented these outcomes in <a href="#CD011761-tbl-0003">Table 1</a> but they were not included in a meta‐analysis and did not directly inform the conclusions of the review. </p> <div class="table" id="CD011761-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Urinary iodine concentration and breast milk iodine concentration following prepregnancy, pregnancy or postpartum iodine supplementation</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Setting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Intervention timing</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Intervention description</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Timing of assessment</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Urinary iodine concentration</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Breast milk iodine concentration</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Southern Morocco</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iodine: single dose oral 400 mg, control: single dose placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 37 μg/L, IQR: 22‐77 (n = 119)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 30 μg/L, IQR: 18‐61 (n = 115)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 58 μg/L, IQR: 34‐135 (n = 94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 39 μg/L, IQR 24‐62 (n = 81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 39.4 μg/L, IQR: 23.5‐66.7 (n = 94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 26.2 μg/L, IQR: 17.7‐42.7 (n = 81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Nice, France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Iodine: daily dose 150 μg of iodine, control: vitamin mix but no iodine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline: before 12 weeks of amenorrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 111 μg/L, IQR: 28‐399 (n = 32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 103 μg/L, IQR: 14‐355 (n = 54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 3rd trimester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 160.5 μg/L, IQR: 18‐358 (n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 76 μg/L, IQR: 16‐303 (n = 46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 58 μg/L, IQR: 34‐135 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 58 μg/L, IQR: 34‐135 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brussels, Belgium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine: single dose 1 mL iodized oil, control: multivitamin injection no iodine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 3‐6 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 77 μg/L, SEM: +/‐ 8 (n = 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 43 μg/L, SEM: +/‐ 4 (n = 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 61 μg/L, SEM: +/‐10, (n = 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 29 μg/L, SEM: +/‐2, (n = 60)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Berlin, Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily dose oral 300 µg KI, control: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: mean 11 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 104.5 μg/dl, IQR: NR (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: In fig only (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.3 μg/dl, IQR: In fig only (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 6.5 μg/dl, IQR: In fig only (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Dunedin, New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iodine: daily 75 or 150 µg/d iodine, control: placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 24 weeks (75 µg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 78 μg/L, 25th 75th %: 50,126 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 34 μg/L, 25th 75th %: 26, 57 (n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 24 weeks (150 µg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 84 μg/L, 25th‐75th %: 60,157 (n = 19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 34 μg/L, 25th 75th %: 26,57 (n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In figure only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In figure only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Aalborg, Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Pregnancy or pregnancy and postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine: daily oral 150 µg elemental iodine and micronutrient supplement, control: micronutrient supplement no iodine </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 35 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 86 μg/24 h, 25th‐75th %: 66–147 (n = 22) pregnancy and postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 88 μg/24 h, 25th 75th %: 68‐123 (n = 24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 83 μg/24 h, 25th 75th %: 54–145 (n = 20) pregnancy only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 50 μg/L, 25th 75th %: 35‐101 (n = 22) pregnancy and postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 51 μg/L, 25th 75th %: 30–80 (n = 20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 52 μg/L, 25th 75th %: 36–81 (n = 20) pregnancy only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>East Jutland, Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Iodine: daily drops 200 μg iodine, control: no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 37 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 106 μg/L, 95 %: NR (n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 54 μg/L, 95 %: NR (n = 26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 56 μg/L, 95 %: NR (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 54 μg/L, 95 %: NR (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 41 μg/L, 95 %: 31‐74 (n = 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 28 μg/L, 95 %: 19‐46 (n = 26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 64 μg/L, 95 %: 34‐70 (n = 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 27 μg/L, 95 %: 21‐56 (n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Eastern Greater</p> <p>Santiago, Chile</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iodine: daily drops approximately 300 µg iodine, control: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 15‐40 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 376 μg iodine/g creatinine, SD: 456 (n = 36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 56 μg iodine/g creatinine, SD: 25 (n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: at delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 493 μg iodine/g creatinine, SD: 586 (n = not specified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 127 μg iodine/g creatinine, SD: 94 (n = not specified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adelaide, New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine: daily tablet 150 μg iodine, control: placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 106.0 (84.0‐146.0), n = 19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 124.0 (76.0‐155.0), n = 22</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Bangkok, Thailand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Iodine: daily 200 µg iodine and multivitamin‐mineral tablets, control: multivitamin‐mineral tablets with no iodine </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 30 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 233.3 μg/L, IQR: 140.0, 314.8 (n = 171)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 154.6 μg/L, IQR: 107.9, 212.4 (n = 185)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 115.5 μg/L, IQR: 73.0, 155.3 (n = 129)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 93.6 μg/L, IQR: 60.3, 159.8 (n = 135)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 168.7 μg/L, IQR: 97.7, 305.7 (n = 83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 193.3 μg/L, IQR: 136.7, 303.5 (n = 76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p>IQR: interquartile range<br/> KI: potassium iodide<br/> NR: not reported<br/> SD: standard deviation<br/> SEM: standard error of the mean </p> </div> </div> </section> </section> </section> </section> <section id="CD011761-sec-0063"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD011761-sec-0064"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (14 November 2016). </p> <p>The Register is a database containing over 22,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<b><i>Specialized Register</i> </b> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD011761-list-0008"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<a href="./references#CD011761-bbs1-0001" title="">Included studies</a>; <a href="./references#CD011761-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD011761-bbs1-0003" title="">Studies awaiting classification</a>; <a href="./references#CD011761-bbs1-0004" title="">Ongoing studies</a>). </p> <p>In addition, we searched the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (17 November 2016) for unpublished, planned and ongoing trials using search terms as described in <a href="./appendices#CD011761-sec-0287">Appendix 1</a>. </p> </section> <section id="CD011761-sec-0065"> <h4 class="title">Searching other resources</h4> <p>We searched through the bibliographies of existing reviews on similar topics and of retrieved studies. We contacted experts in the field as well as authors of retrieved studies for lists of other studies that should be considered for inclusion. </p> <p>For assistance in identifying ongoing or unpublished studies, we also contacted the WHO Departments of Reproductive Health and Research and Nutrition for Health and Development, the Iodine Global Network, the nutrition section of the United Nations Children's Fund (UNICEF), the World Food Programme (WFP), the US Centers for Disease Control and Prevention (CDC), the Micronutrient Initiative (MI), the Global Alliance for Improved Nutrition (GAIN), Hellen Keller International (HKI), and Sight and Life (28 November 2016). </p> <p>We did not apply any date or language restrictions.</p> </section> </section> <section id="CD011761-sec-0066"> <h3 class="title" id="CD011761-sec-0066">Data collection and analysis</h3> <p>The following methods section is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD011761-sec-0067"> <h4 class="title">Selection of studies</h4> <p>Two review authors (KBH and LDR) independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion and, if required, consulted with a third review author (ACW). For one study (<a href="./references#CD011761-bbs2-0036" title="MohammedH , MarquisG , AboudF , BougmaK , SamuelA . A cluster RCT evaluating the effect of iodized salt on infant development in amhara region of Ethiopia. FASEB Journal2015;29(1 Suppl):LB264. ">Mohammed 2015</a>), funded by the organization of the two authors doing the eligibility, another author (JPP) assessed and determined it was excluded. We included studies published as abstracts but if we could not assess quality and extract information (after attempting to contact study authors), these studies were marked as "awaiting classification". </p> </section> <section id="CD011761-sec-0068"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data and record information requested from study authors. For eligible studies, data were extracted once using the agreed form by three review authors (KBH, BAP and CMYY). Two review authors (KBH and BAP) entered the data into Review Manager 5 (RevMan 5) software (<a href="./references#CD011761-bbs2-0108" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We resolved discrepancies through discussion or, if required, consulted a third person. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD011761-sec-0069"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011761-bbs2-0092" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). We resolved any disagreement by discussion or by involving a third assessor. </p> <section id="CD011761-sec-0070"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD011761-list-0009"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011761-sec-0071"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assess whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD011761-list-0010"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively‐numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011761-sec-0072"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. Where relevant, we planned to assess blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD011761-list-0011"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD011761-sec-0073"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. Where relevant, we planned to assess blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD011761-list-0012"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011761-sec-0074"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD011761-list-0013"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data were less than 20% and were balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as‐treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias (e.g. level of missing data was unclear).</p> </li> </ul> </p> </section> <section id="CD011761-sec-0075"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD011761-list-0014"> <li> <p>low risk of bias (where it was clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review were reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes were reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD011761-sec-0076"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD011761-list-0015"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there was risk of other bias.</p> </li> </ul> </p> </section> <section id="CD011761-sec-0077"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011761-bbs2-0092" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011a</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it was likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses however we considered only one trial at low overall risk of bias therefore this analysis would not have been meaningful. </p> </section> <section id="CD011761-sec-0078"> <h5 class="title">Assessing the quality of the evidence using GRADE</h5> <p>We assessed the overall quality of the evidence for primary outcomes using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the quality of the body of evidence relating to the primary outcomes for any supplement containing iodine versus same supplement without iodine or no intervention/placebo. Two review authors independently assessed the quality of the evidence for each of the maternal and child primary outcomes. </p> <p>Maternal outcomes</p> <p> <ol id="CD011761-list-0016"> <li> <p>Hypothyroidism (as defined by trial authors)</p> </li> <li> <p>Preterm birth (as defined by trial authors)</p> </li> <li> <p>Adverse effects</p> <ol id="CD011761-list-0017"> <li> <p>Elevated thyroid peroxidase antibodies (TPO‐ab) (as defined by trial authors)</p> </li> <li> <p>Hyperthyroidism (as defined by trial authors)</p> </li> <li> <p>Digestive intolerance (as defined by trial authors)</p> </li> </ol> </li> </ol> </p> <p>Infant/child outcomes</p> <p> <ol id="CD011761-list-0018"> <li> <p>Perinatal mortality (including stillbirth/fetal death and neonatal death, as defined by trial authors) </p> </li> <li> <p>Low birthweight (less than 2500 g)</p> </li> <li> <p>Hypothyroidism or elevated TSH (as defined by trial authors)</p> </li> <li> <p>Adverse effects</p> <ol id="CD011761-list-0019"> <li> <p>Elevated TPO‐ab (as defined by trial authors)</p> </li> <li> <p>Hyperthyroidism (as defined by trial authors)</p> </li> </ol> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from RevMan 5 (<a href="http://archie.cochrane.org/sections/documents/view?version=z1410160858569838861675544863963%26format=REVMAN#REF-RevMan-2014" target="_blank">RevMan 2014</a>) in order to create 'Summary of findings' tables (<a href="./full#CD011761-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011761-tbl-0002">summary of findings Table 2</a>). We produced a summary of the intervention effect and a measure of quality for each of the above outcomes using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD011761-sec-0079"> <h4 class="title">Measures of treatment effect</h4> <section id="CD011761-sec-0080"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we have presented results as summary risk ratio (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD011761-sec-0081"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference (MD) if outcomes were measured in the same way between trials. We planned to use the standardized mean difference to combine trials that measured the same outcome, but used different methods. </p> <p>Where trials reported median, we included this information in additional tables and a narrative summary of the findings. </p> </section> </section> <section id="CD011761-sec-0082"> <h4 class="title">Unit of analysis issues</h4> <section id="CD011761-sec-0083"> <h5 class="title">Cluster‐randomized trials</h5> <p>We included cluster‐randomized trials in the analyses along with individually‐randomized trials. Cluster‐randomized trials are labelled with a (C). We had planned to adjust their standard errors and determine effective sample size using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> using an estimate of the intra cluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population to take into account the design effect (<a href="./references#CD011761-bbs2-0093" title="HigginsJPT , DeeksJJ , Altman DG(editors) . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011b</a>). If we used ICCs from other sources, we planned to report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. However we identified only two cluster‐randomized trials. In one, family was the unit of allocation, and it was not possible to know if there was more than one pregnant women per family and therefore any clustering effect (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). Therefore we did not adjust data from this trial for clustering. In the other cluster‐randomized study, the reported analysis accounted for clustering therefore no additional adjustments were necessary (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>). </p> <p>We synthesized the relevant information from the cluster‐randomized and individually‐randomized trials. </p> <p>We considered it reasonable to combine the results from both if there was little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit was considered to be unlikely. We also acknowledged heterogeneity in the randomisation unit. </p> </section> <section id="CD011761-sec-0084"> <h5 class="title">Cross‐over trials</h5> <p>We planned to include cross‐over trials which would be otherwise eligible for inclusion and use only data from the first period (if the data were presented in this way) and anticipated that additional methods for 'Risk of bias' assessment and analysis would not be needed. We did not identify any eligible cross‐over trials though. </p> </section> <section id="CD011761-sec-0085"> <h5 class="title">Other unit of analysis issues</h5> <p>For studies with more than two intervention groups (multi‐arm studies, e.g. using different doses), we included only directly relevant arms. For studies with more than one relevant arm we combined the arms into a single pair‐wise comparison (<a href="./references#CD011761-bbs2-0091" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and included the disaggregated data in the corresponding subgroup category. To avoid double counting participants, if the control group was shared by different study arms, we divided the control group (events and total population) over the number of relevant subgroup categories. </p> <p>For studies that included non‐pregnant women, we only included those who became pregnant.</p> <p>If a study examined supplementing both the mother and infant, and was otherwise eligible, we included that study arm and the maternal data but excluded the infant data, as it would have been affected by the infant intervention. </p> <p>We included all relevant details in the <a href="./references#CD011761-sec-0295" title="">Characteristics of included studies</a> tables. </p> </section> </section> <section id="CD011761-sec-0086"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition in the <a href="./references#CD011761-sec-0295" title="">Characteristics of included studies</a> tables. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, that is, we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD011761-sec-0087"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² (<a href="./references#CD011761-bbs2-0090" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>) and Chi² statistics (<a href="./references#CD011761-bbs2-0077" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). We considered heterogeneity as substantial if an I² statistic was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. We planned to explore any identified substantial heterogeneity (above 30%) by pre‐specified subgroup analysis. </p> </section> <section id="CD011761-sec-0088"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to investigate reporting biases (such as publication bias) using funnel plots if there were 10 or more studies in the meta‐analysis. We planned to assess funnel plot asymmetry visually and if asymmetry was suggested by a visual assessment, we planned to perform exploratory analyses to investigate it. However there were no meta‐analyses with 10 or more studies so we were unable to assess reporting bias. </p> </section> <section id="CD011761-sec-0089"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the RevMan 5 software (<a href="./references#CD011761-bbs2-0108" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We intended to use fixed‐effect meta‐analysis for combining data where it would be reasonable to assume that studies were estimating the same underlying treatment effect: that is, where trials were examining the same intervention, and we judged the trials’ populations and methods sufficiently similar. Since we identified both clinical heterogeneity (sufficient to expect that the underlying treatment effects differed between trials) or substantial statistical heterogeneity, or both, we used random‐effects meta‐analysis to produce overall summaries if we considered an average treatment effect across trials to be clinically meaningful. We treated the random‐effects summary as the average of the range of possible treatment effects and we have discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. </p> <p>As we used random‐effects analyses, we have presented the results as the average treatment effect with 95% CIs, and the estimates of Tau² and I². </p> </section> <section id="CD011761-sec-0090"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we planned to attempt to investigate it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful and, if it was, used random‐effects analysis to produce it. </p> <p>We planned to carry out the following subgroup analyses, when information was available, and using only information reported by the trial. </p> <p> <ol id="CD011761-list-0020"> <li> <p>By period of supplementation: only before pregnancy versus only during pregnancy versus only during the postpartum period versus mixed. </p> </li> <li> <p>By supplementation regimen: daily versus weekly versus annual or single dose.</p> </li> <li> <p>By access to iodized salt: less than 50% versus 50% to 69% versus greater than or equal to 70% versus not reported. </p> </li> <li> <p>By iodine status of the participants at the start of the intervention: adequate versus mild or moderate deficiency versus severe deficiency versus unknown (as defined by trial authors, or following WHO‐recommended criteria). </p> </li> <li> <p>By breastfeeding status: yes at any time versus never versus mixed/not reported. Note: this factor is not related to pregnancy outcomes therefore this analysis was performed only on maternal postpartum and child outcomes. </p> </li> </ol> </p> <p>We planned to include only the primary outcomes in subgroup analyses.</p> <p>If we found substantial heterogeneity for any primary outcome, we planned to assess subgroup differences by interaction tests available within RevMan 5 (<a href="./references#CD011761-bbs2-0108" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We planned to report the results of subgroup analyses quoting the Chi<sup>2</sup> statistic and P value, and the interaction test I² value. </p> <p>We decided to add subgroups for a given outcome only where there were at least four studies as we considered anything less to be insufficient to conduct meaningful analysis by the covariate. However no outcome with statistical heterogeneity included data from four or more trials, so we did not perform any subgroup analyses. </p> </section> <section id="CD011761-sec-0091"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analysis based on the risk of bias of the studies. We considered a study to be of high quality if it was graded as 'low risk of bias' in both randomisation and allocation concealment and in either blinding or loss to follow‐up. However we only considered one trial at low risk of bias therefore did not conduct this sensitivity analysis. We planned to conduct other sensitivity analyses based on the studies included, for example, if we identified and included any cluster‐randomized trials we would carry out sensitivity analysis using a range of ICC values. </p> <p>We planned to carried out sensitivity analysis for primary outcomes only.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011761-sec-0092" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011761-sec-0092"></div> <section id="CD011761-sec-0093"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD011761-sec-0295" title="">Characteristics of included studies</a>; <a href="./references#CD011761-sec-0296" title="">Characteristics of excluded studies</a>; <a href="./references#CD011761-sec-0298" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD011761-sec-0094"> <h4 class="title">Results of the search</h4> <p>The search of Cochrane Pregnancy and Childbirth's Trials Register retrieved 43 reports and the additional search strategy identified another 53 reports. See: <a href="#CD011761-fig-0001">Figure 1</a> which shows the process for assessing and selecting the studies (<a href="./references#CD011761-bbs2-0102" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG , The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta‐Analyses: The PRISMA Statement. PLoS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed1000097] ">Moher 2009</a>). We have included 14 and excluded 48 trials; five are ongoing or have not yet been published and two are awaiting classification. Eleven trials involving over 2000 women contributed data for the comparisons in this review (three trials did not report any primary or secondary outcomes (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). </p> <div class="figure" id="CD011761-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD011761-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD011761-sec-0095"> <h4 class="title">Included studies</h4> <section id="CD011761-sec-0096"> <h5 class="title">Design</h5> <p>Most of the included studies were randomised controlled trials, except for four which were quasi‐randomized (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). Individuals were the unit of allocation for all except for two cluster‐randomized trials which allocated clinic days (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>) and families (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). The <a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a> analysis adjusted for clustering. Seven of the trials were reportedly double‐blinded (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Samples sizes were generally small (eight trials were 120 or less) and ranged from 54 to 671. Two trials which recruited families or communities did not specify how many pregnant women, or women who became pregnant, were initially included (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). One trial stopped at a sample size of 59 women (planned n = 1098) and was unblinded (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>). Three trials were assessed as eligible for inclusion but did not contribute data because they did not report on any prespecified primary or secondary outcomes (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). </p> </section> <section id="CD011761-sec-0097"> <h5 class="title">Settings</h5> <p>Six trials were conducted in Europe, in Belgium (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>), Denmark (<a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>), France (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>), Germany (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) and Sweden (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>). The other trials took place in Australia (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>), Chile (<a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>), Morocco (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>), New Zealand (<a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>), Papua New Guinea (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>), Peru (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>), Thailand (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>), and Zaire (<a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). The trials which reported when the research took place did so from 1966 through 2011. </p> </section> <section id="CD011761-sec-0098"> <h5 class="title">Participants</h5> <p>Most of the trials recruited women during pregnancy through antenatal care contacts at clinics or hospitals (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Two trials recruited postpartum women at the infant's first vaccination visit (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>) or via advertisements (<a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>). Two included entire families or communities and as a result, pregnant or non‐pregnant women who later became pregnant were included (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). </p> <p>Average age of participants, where reported, ranged from 23 to 32 years. Information on socioeconomic status was generally not reported. Five trials reported on anthropometric nutritional status at baseline, though different indicators were used. Women in the Danish trials were pregnant and average weight ranged from 62 kg to 68 kg (<a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>), body mass index (kg/m2) of postpartum women in the Moroccan trial was 25.6 (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>) and of pregnant women in the French trial was 22 (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>). In the Thai trial, 14% to 17% of pregnant women were overweight or obese (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). </p> <p>Information on baseline iodine status of the participants or the study area was provided in all but one trial (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>). Where mean UIC was reported, it ranged from 30 µg/L to approximately 130 µg/L and women had insufficient iodine intake, as indicated by median UIC below 150 μg/L for pregnant women or below 100 μg/L for breastfeeding women (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>). Three trials only reported goitre prevalence which ranged from 20% to 70% (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). One study area was reported as high in endemic cretinism (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). </p> <p>Only four trials reported information on household coverage of iodized salt. Coverage was above 80% in the three trials that used participant‐reported information (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). <a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a> collected and analysed household salt samples in a sub‐sample and found that 57% contained some iodine (6% with "adequate" or at least 15 ppm iodine and 51% with iodine less than 15 ppm). </p> <p>Two trials screened women for thyroid peroxidase antibodies (TPO‐ab) and recruited only women with elevated levels (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>). </p> </section> <section id="CD011761-sec-0099"> <h5 class="title">Interventions</h5> <p>Seven trials included iodine supplementation during pregnancy only (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>), three included iodine supplementation only during the postpartum period (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>) and four gave iodine to the same women in both pregnancy and the postpartum period (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>). Two trials provided iodine supplementation to women who later became pregnant (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). </p> <p>Most of the included trials used daily oral iodine supplementation, mainly in the form of tablets (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) though one used capsules (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>), two used drops (<a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>) and one trial reported using a daily supplement but did not specify the form (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>). The daily iodine dose ranged from 75 µg to 300 µg and the duration ranged from approximately one to 17 months. Where the iodine compound was reported, it was mostly potassium iodide (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) though one trial used potassium iodate (<a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>). One trial used a single high dose oral iodine supplement, in the form of two soft gel capsules containing iodized poppyseed oil with 400 mg iodine (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>). </p> <p>The three earliest trials, which took place in the 1960s and 1970s, used single high‐dose intramuscular injections of iodized oil (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). One trial repeated this intervention in the same communities three years later (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>). The iodine dose in these trials ranged from 475 mg to 1600 mg, though in one study adult women with nodular goitre were given a lower dose of 95 mg (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>). <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a> specified that the iodine was slowly resorbable. </p> <p>Most of the included trials used iodine‐only supplementation, except for three which provided the same additional vitamins and minerals to the intervention and control groups, either as part of the supplement containing iodine (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>) or as a separate supplement (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). </p> </section> <section id="CD011761-sec-0100"> <h5 class="title">Comparisons</h5> <p>Most studies had two trial arms comparing an iodine intervention with a no‐iodine comparison in the same population group though two trials also included an additional intervention arm (one included two different iodine doses (<a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>) and one included iodine in pregnancy only and in pregnancy and postpartum (<a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>)). Two trials also had a third arm with thyroxine (or thyroxine and iodine) supplementation (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>) however these arms were not eligible and therefore were not included in this review. </p> <p>Seven trials reported use of a placebo comparison group (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>), four used no intervention (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>), and two used other micronutrients (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>). For one study, we found conflicting information about the control supplement composition as some reports stated it was a placebo and some stated it included vitamins (<a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). For the purposes of this review, we have considered the control for this trial as placebo. </p> <section id="CD011761-sec-0101"> <h6 class="title">Comparison 1</h6> <p>Eleven studies compared the effects of any supplement containing iodine versus same supplement without iodine or no treatment/placebo (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Three trials were otherwise eligible but did not contribute any data for this comparison (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). </p> </section> <section id="CD011761-sec-0102"> <h6 class="title">Comparison 2</h6> <p>Eight trials compared the effects of any oral iodine supplement versus the same supplement without iodine or no treatment/placebo (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Three trials were otherwise eligible but did not contribute any data for this comparison (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). </p> </section> <section id="CD011761-sec-0103"> <h6 class="title">Comparison 3</h6> <p>Five trials compared an oral iodine‐only supplement versus no intervention or placebo (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>). Three trials were otherwise eligible but did not contribute any data for this comparison (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). </p> </section> <section id="CD011761-sec-0104"> <h6 class="title">Comparison 4</h6> <p>Three trials compared the effects of oral iodine supplements with other vitamins and/or minerals versus only other vitamins and/or minerals (exact same formulation of other vitamins/minerals, but no iodine) (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). </p> </section> <section id="CD011761-sec-0105"> <h6 class="title">Comparison 5</h6> <p>Three trials compared the effects of any injected iodine supplement versus same supplement without iodine or no treatment/placebo (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). </p> </section> <section id="CD011761-sec-0106"> <h6 class="title">Comparison 6</h6> <p>Three trials compared the effects of any injected iodine‐only supplement versus no intervention or placebo (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). </p> </section> <section id="CD011761-sec-0107"> <h6 class="title">Comparison 7</h6> <p>No studies compared an injected iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals (exact same formulation of other vitamins/minerals, but no iodine). Because of this, the trials (and data) are the same for comparisons 5 and 6, therefore we have only reported comparison 5. </p> <p>See <a href="./references#CD011761-sec-0295" title="">Characteristics of included studies</a> for a detailed description of the trials. </p> </section> </section> </section> <section id="CD011761-sec-0108"> <h4 class="title">Excluded studies</h4> <p>We excluded 48 trials. The main reason for excluding studies was that they were not randomised or quasi‐randomized trials. Some randomised trials, or trials where it was unclear whether randomisation was used, were excluded because they compared different iodine doses (without a placebo or a no treatment control) or assessed iodized salt (<a href="./references#CD011761-bbs2-0017" title="AntonangeliL , MaccheriniD , CavaliereR , DiGiulioC , ReinhardtB , PincheraA , et al. Comparison of two different doses of iodide in the prevention of gestational goiter in marginal iodine deficiency: a longitudinal study. European Journal of Endocrinology2002;147(1):29‐34. ">Antonangeli 2002</a>; <a href="./references#CD011761-bbs2-0036" title="MohammedH , MarquisG , AboudF , BougmaK , SamuelA . A cluster RCT evaluating the effect of iodized salt on infant development in amhara region of Ethiopia. FASEB Journal2015;29(1 Suppl):LB264. ">Mohammed 2015</a>; <a href="./references#CD011761-bbs2-0046" title="RomanoR , JanniniEA , PepeM , GrimaldiA , OlivieriM , SpennatiP , et al. The effects of iodoprophylaxis on thyroid size during pregnancy. American Journal of Obstetrics and Gynecology1991;164:482‐5. ">Romano 1991</a>; <a href="./references#CD011761-bbs2-0050" title="SantiagoP , VelascoI , MuelaJA , SánchezB , MartínezJ , RodriguezA , et al. Infant neurocognitive development is independent of the use of iodised salt or iodine supplements given during pregnancy. British Journal of Nutrition2013;110(5):831‐40. ">Santiago 2013</a>; <a href="./references#CD011761-bbs2-0053" title="TroshinaEA , AbdulkhabirovaFM , SekinaevaAV , Il'inAV , ArbuzovaMI , PetrovaVN , et al. Prevention of iodine deficiency diseases in pregnant and lactating women. Klinicheskaia Meditsina2010;88(5):26‐31. ">Troshina 2010</a>). </p> <p>See the <a href="./references#CD011761-sec-0296" title="">Characteristics of excluded studies</a> tables for detailed descriptions of the excluded studies and the reasons for exclusion. </p> </section> </section> <section id="CD011761-sec-0109"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD011761-sec-0110"> <h4 class="title">Allocation</h4> <section id="CD011761-sec-0111"> <h5 class="title">Random sequence generation</h5> <p>We considered five trials at low risk of selection bias for random sequence generation (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Four we deemed high risk because they used quasi‐randomization (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). The remaining trials were reportedly randomised but did not provide adequate information on how random sequences were generated, therefore we considered risk of bias in this domain unclear. </p> </section> <section id="CD011761-sec-0112"> <h5 class="title">Allocation concealment</h5> <p>We considered three trials at low risk of selection bias for allocation concealment because clinic days were the unit of randomisation or were used to assign individuals (and study staff could not have reasonably influenced the day women showed up for clinic) (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) or because randomisation was performed centrally (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>). We considered three trials at high risk because they used alternation to assign individuals, or families, to groups (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). The remaining trials did not adequately report the methods used to conceal allocation so we considered the risk to be unclear. </p> </section> </section> <section id="CD011761-sec-0113"> <h4 class="title">Blinding</h4> <section id="CD011761-sec-0114"> <h5 class="title">Blinding of participants and staff</h5> <p>We considered four trials at low risk of performance bias because a placebo was used for the control group and staff and participants were reportedly blinded to group assignment (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). We determined six trials high risk because no blinding was reported and the control group did not receive any intervention (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>) or because it was described as an "open study" (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>) or unblinded during the study due to ethical consideration to placebo group (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015)</a>. It was not possible to assess risk of bias in this domain for the other four trials due to lack of information reported (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). </p> </section> <section id="CD011761-sec-0115"> <h5 class="title">Blinding of outcome assessors</h5> <p>Risk of detection bias was mostly unclear because study authors did not adequately report this information, with the exception of two trials which we considered low risk because they specified that outcome assessors were blinded to group assignment (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C);</a><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and two trials which were considered high risk because they were described as an "open study" (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>) or because the trial was unblinded mid‐way through (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>). </p> </section> </section> <section id="CD011761-sec-0116"> <h4 class="title">Incomplete outcome data</h4> <p>Two trials were at low risk of attrition bias because of low (less than 20%) and balanced incomplete outcome data (<a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>, <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>). We determined seven trials to be a high risk because of high or imbalanced incomplete outcome data, or both (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). For the remaining studies, lack of detailed information on attrition precluded judgement (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>). </p> </section> <section id="CD011761-sec-0117"> <h4 class="title">Selective reporting</h4> <p>For most of the included trials, we did not have access to the study protocol or clinical trial registration which stated the pre‐specified outcomes, therefore the risk of reporting bias due to selective reporting was unclear. In two cases we did have access to the trial registry and were able to determine the trial to be low (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) or high (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>) risk of reporting bias, based on the information provided in the registries and the publications. In another case, we found the risk of bias to be high because baseline information was only provided for those who completed the study (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>). </p> </section> <section id="CD011761-sec-0118"> <h4 class="title">Other potential sources of bias</h4> <p>Most of the included trials appeared to be free of other potential sources of bias, though this could not be confirmed, therefore we considered this risk of bias unclear. We did however consider the risk to be high in two trials which provided iodine to women before they became pregnant, potentially affecting their probability of becoming pregnant and therefore leading to differences between groups and bias (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). </p> <p>We have included full details of 'Risk of bias’ assessments in the <a href="./references#CD011761-sec-0295" title="">Characteristics of included studies</a> tables. We have also included figures which summarize our 'Risk of bias’ assessments (<a href="#CD011761-fig-0002">Figure 2</a>; <a href="#CD011761-fig-0003">Figure 3</a>), which we used to judge study quality in the 'Summary of findings' tables (see <a href="./full#CD011761-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011761-tbl-0002">summary of findings Table 2</a>). </p> <div class="figure" id="CD011761-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD011761-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD011761-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD011761-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> </section> </section> <section id="CD011761-sec-0119"> <h3 class="title" id="CD011761-sec-0119">Effects of interventions</h3> <p>See: <a href="./full#CD011761-tbl-0001"><b>Summary of findings for the main comparison</b> Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (maternal outcomes)</a>; <a href="./full#CD011761-tbl-0002"><b>Summary of findings 2</b> Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (child outcomes)</a> </p> <p>In this review we included 14 trials involving 3154 women, though one trial did not report the number of women randomised (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). Three trials involving 417 women (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>) did not contribute data because they did not report any primary or secondary outcomes. We have organized the summary results by comparison, by primary and secondary outcomes and by maternal and child outcomes. </p> <p>See <a href="./references#CD011761-sec-0285" title="">Data and analyses</a> for detailed results on primary and secondary outcomes. We have set out below five out of the seven prespecified comparisons. None of the included trials included an assessment of comparison 7, which meant that the originally‐planned comparisons 5 and 6 were the exact same and therefore we have not reported the results from comparison 6 separately. </p> <p>For each of the comparisons and outcomes with data, we have indicated the number of studies, the number of studies contributing data and the total number of women or children included in that analysis (instead of the number randomised in case of attrition). </p> <section id="CD011761-sec-0120"> <h4 class="title">(1) Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (11 trials, 2737 participants) </h4> <p>Eleven trials contributed data involving 2737 women (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). None were considered high quality. Three other trials did not contribute any data to our analyses (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). </p> <section id="CD011761-sec-0121"> <h5 class="title">Maternal primary outcomes</h5> <section id="CD011761-sec-0122"> <h6 class="title">Hypothyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>Data from one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 365 women showed no difference in risk of hypothyroidism in pregnancy between women who received and did not receive iodine supplementation (risk ratio (average RR) 1.90; 95% confidence interval (CI) 0.57 to 6.38, low‐quality evidence) (<a href="./references#CD011761-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD011761-sec-0123"> <h6 class="title">Hypothyroidism ‐ postpartum (as defined by trial authors)</h6> <p>Among 540 women in three trials (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>), those who received iodine supplementation were as likely to be diagnosed with hypothyroidism in the postpartum period as those who did not receive any iodine (average RR 0.44; 95% CI 0.06 to 3.42, low‐quality evidence) (<a href="./references#CD011761-fig-0005" title="">Analysis 1.2</a>). We did not find evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.41). </p> </section> <section id="CD011761-sec-0124"> <h6 class="title">Preterm birth (as defined by trial authors)</h6> <p>Two trials (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 376 pregnant women reported on preterm birth, and showed no difference between groups (average RR 0.71; 95% CI 0.30 to 1.66, low‐quality evidence) (<a href="./references#CD011761-fig-0006" title="">Analysis 1.3</a>). We identified substantial heterogeneity for this outcome though (I² = 32%, Tau² = 0.13 and Chi² test for heterogeneity P = 0.23). </p> </section> <section id="CD011761-sec-0125"> <h6 class="title">Maternal adverse effect: elevated thyroid peroxidase antibodies (TPO‐ab) ‐ pregnancy (as defined by trial authors) </h6> <p>One trial with 359 women reported on elevated TPO‐ab in pregnancy (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and found no difference in risk between the iodine and control groups (average RR 0.95; 95% CI 0.44 to 2.07, low‐quality evidence) (<a href="./references#CD011761-fig-0007" title="">Analysis 1.4</a>). </p> </section> <section id="CD011761-sec-0126"> <h6 class="title">Maternal adverse effect: elevated TPO‐ab ‐ postpartum (as defined by trial authors)</h6> <p>This outcome was reported in three trials with 397 women (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Findings show no difference in the likelihood between the group that received iodine and the group that did not (average RR 1.01; 95% CI 0.78 to 1.30, low‐quality evidence) (<a href="./references#CD011761-fig-0008" title="">Analysis 1.5</a>). We did not find any evidence of statistical heterogeneity for this analysis (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.63). </p> </section> <section id="CD011761-sec-0127"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>One trial with 365 women reported on this outcome (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and found no difference between groups (average RR 1.90; 95% CI 0.57 to 6.38, low‐quality evidence) (<a href="./references#CD011761-fig-0009" title="">Analysis 1.6</a>). </p> </section> <section id="CD011761-sec-0128"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ postpartum (as defined by trial authors)</h6> <p>Data from three studies involving 543 women (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) showed that 1.6% of those who received iodine supplementation and 4.9% of those who did not had hyperthyroidism in the postpartum period (average RR 0.32; 95% CI 0.11 to 0.91, low‐quality evidence) (<a href="./references#CD011761-fig-0010" title="">Analysis 1.7</a>). There was no statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.67). </p> </section> <section id="CD011761-sec-0129"> <h6 class="title">Maternal adverse effect: digestive intolerance ‐ pregnancy (as defined by trial authors)</h6> <p>One trial with 76 women reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>) and found a higher likelihood of digestive intolerance in the iodine group whereby 33.3% of women who received iodine and 2.2% of those who did not dropped out of the study due to nausea or vomiting (average RR 15.33; 95% CI 2.70 to 113.7, very low‐quality evidence) (<a href="./references#CD011761-fig-0011" title="">Analysis 1.8</a>). </p> </section> </section> <section id="CD011761-sec-0130"> <h5 class="title">Infant/child primary outcomes</h5> <section id="CD011761-sec-0131"> <h6 class="title">Perinatal mortality (including stillbirth/fetal death and neonatal death, as defined by trial authors) </h6> <p>Two trials with 457 assessments (<a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported on this outcome, though all of the deaths occurred in one trial (<a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). In this trial there was lower perinatal mortality in the group that received iodine supplementation compared to the control group, however the difference did not reach statistical significance (average RR 0.66; 95% CI 0.42 to 1.03, low‐quality evidence) (<a href="./references#CD011761-fig-0012" title="">Analysis 1.9</a>). </p> </section> <section id="CD011761-sec-0132"> <h6 class="title">Low birthweight (less than 2500 g)</h6> <p>Two trials with 377 infants reported on this outcome (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and showed no difference between groups (average RR 0.56; 95% CI 0.26 to 1.23, low‐quality evidence) (<a href="./references#CD011761-fig-0013" title="">Analysis 1.10</a>). There was no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.62). </p> </section> <section id="CD011761-sec-0133"> <h6 class="title">Neonatal hypothyroidism or elevated thyroid‐stimulating hormone (TSH) (as defined by trial authors) </h6> <p>This outcome was reported in two trials (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 260 infant assessments, although all of the cases occurred in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). The average RR for neonatal elevated TSH in this trial was 0.58 (95% CI 0.11 to 3.12, <i>v</i>ery low‐quality evidence) (<a href="./references#CD011761-fig-0014" title="">Analysis 1.11</a>). </p> </section> <section id="CD011761-sec-0134"> <h6 class="title">Neonatal adverse effect ‐ elevated TPO‐ab (as defined by trial authors)</h6> <p>One study with 108 assessments (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) reported on this outcome and showed no difference between infants whose mothers received iodine and those who did not (average RR 0.61; 95% CI 0.07 to 5.70, very low‐quality evidence) (<a href="./references#CD011761-fig-0015" title="">Analysis 1.12</a>). In this trial, all of the neonates with elevated TPO‐ab were born to women with elevated TPO‐ab at baseline. </p> </section> <section id="CD011761-sec-0135"> <h6 class="title">Neonatal adverse effect ‐ hyperthyroidism (as defined by trial authors)</h6> <p>No trials reported this outcome.</p> </section> </section> <section id="CD011761-sec-0136"> <h5 class="title">Maternal secondary outcomes</h5> <section id="CD011761-sec-0137"> <h6 class="title">Spontaneous miscarriage (as defined by trial authors)</h6> <p>Three trials (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with information on 645 pregnancies showed a similar likelihood of spontaneous miscarriage (average RR 1.31; 95% CI 0.64 to 2.69) and no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.64) (<a href="./references#CD011761-fig-0016" title="">Analysis 1.13</a>). </p> </section> <section id="CD011761-sec-0138"> <h6 class="title">Maternal goitre ‐ pregnancy (assessed by any method)</h6> <p>Two studies (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 486 women showed no difference in likelihood of goitre in pregnancy (average RR 1.00; 95% CI 0.33 to 3.06) however we found significant heterogeneity for this outcome (I² = 53%, Tau² = 0.35 and Chi² test for heterogeneity P = 0.14) (<a href="./references#CD011761-fig-0017" title="">Analysis 1.14</a>). </p> </section> <section id="CD011761-sec-0139"> <h6 class="title">Maternal goitre ‐ postpartum (assessed by any method)</h6> <p>Postpartum goitre was reported in two trials (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Data from 370 women showed no evidence of difference (average RR 1.17; 95% CI 0.64 to 2.16) though we did identify substantial heterogeneity (I² = 33%, Tau² = 0.10 and Chi² test for heterogeneity P = 0.22) (<a href="./references#CD011761-fig-0018" title="">Analysis 1.15</a>). </p> </section> <section id="CD011761-sec-0140"> <h6 class="title">Maternal thyroid volume ‐ pregnancy (in mL) (assessed by any method)</h6> <p>This outcome was reported in three trials with 496 participants, all of which reported median thyroid volume so no meta‐analysis was performed (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). In two trials, findings showed lower median thyroid volume in the iodine compared to the no‐iodine groups (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>) (<a href="#CD011761-tbl-0004">Table 2</a>). <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>, however, found similar thyroid volumes in both groups. </p> <div class="table" id="CD011761-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Maternal thyroid volume ‐ pregnancy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroid volume (mL)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.73, range: 5.4–15.5 (n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10.13, range: 4.2–25.5 (n = 46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 11.1 (n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 12.4 (n = 26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.0, IQR: 7.0, 9.1 (n = 176)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.1, IQR: 7.1, 9.4 (n = 190)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>Assessed in the 3rd trimester.<br/> <sup>2</sup>Assessed at 37 weeks' gestation. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>3</sup>Assessed at 30 weeks' gestation. Intention‐to‐treat analysis. </p> </div> </div> </section> <section id="CD011761-sec-0141"> <h6 class="title">Maternal thyroid volume ‐ postpartum (in mL) (assessed by any method)</h6> <p>Four trials with 457 women reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and most used median thyroid volume, so we did not perform a meta‐analysis. Three of the studies showed similar postpartum thyroid volumes between the iodine and no iodine groups (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). (<a href="#CD011761-tbl-0005">Table 3</a>). One trial, however, reported a lower median thyroid volume (by 1.2 mL) in the iodine group (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>). </p> <div class="table" id="CD011761-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maternal thyroid volume ‐ postpartum</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroid volume (mL)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.5, range: 3.8–13.8 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.7, range: 6.6–18.9 (n = 18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 20.5, SD: 8.5 (n = 38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 20.0, SD: 10.5 (n = 70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10.2 (n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10 (n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 7.3, IQR: 5.8, 9.0 (n = 129)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 7.2, IQR: 6.1, 8.4 (n = 135)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>Assessed at 3 months postpartum.<br/> <sup>2</sup>Assessed by ultrasound on average at 11 days postpartum. Mean and SD extracted from figure.<br/> <sup>3</sup>Assessed at 12 months postpartum. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>4</sup>Assessed at 6 weeks postpartum. </p> </div> </div> </section> <section id="CD011761-sec-0142"> <h6 class="title">Maternal thyroglobulin (Tg) ‐ pregnancy (in μg/L)</h6> <p>This outcome was reported in four studies with 562 women (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) all of which reported median Tg, so we did not perform a meta‐analysis. In all four trials, median Tg in pregnancy was lower in the group which received iodine compared to the no‐iodine group; the difference ranged from 2.1 µg/L to 7.5 µg/L (<a href="#CD011761-tbl-0006">Table 4</a>). </p> <div class="table" id="CD011761-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Maternal thyroglobulin ‐ pregnancy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroglobulin (in µg/L)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 17.5, range: 2.5–56.2 (n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 19.6, range: 3.8–98.6 (n = 46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 14.1, IQR: 5.0, 21.5 (n = 42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 19.4, IQR: 8.2, 33.5 (n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.2 (n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 16.7 (n = 26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.78, IQR: 5.46, 18.10 (n = 176)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 11.90, IQR: 6.35, 22.30 (n = 190)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>Assessed in the 3rd trimester.<br/> <sup>2</sup>Assessed at 35 weeks' gestation.<br/> <sup>3</sup>Assessed at 37 weeks' gestation. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>4</sup>Assessed at 30 weeks' gestation. </p> </div> </div> </section> <section id="CD011761-sec-0143"> <h6 class="title">Maternal Tg ‐ postpartum (in μg/L)</h6> <p>Four trials involving 457 women (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) reported this outcome, mostly as median Tg, therefore we did not perform a meta‐analysis. All four trials showed that women who received iodine had lower postpartum Tg levels compared to those who did not (<a href="#CD011761-tbl-0007">Table 5</a>). The difference between groups ranged from 1.57 µg/L to 11.6 µg/L. </p> <div class="table" id="CD011761-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Maternal thyroglobulin ‐ postpartum</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroglobulin (in µg/L)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 11.5, range: 4.4–37 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 23.1, range: 3.0–45.5 (n = 18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 8.3, SD: 10.9 (n = 38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 13.5, SD: 19.3 (n = 70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 4.7 (n = 24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10.3 (n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 7.94, IQR: 4.89, 15.30 (n = 129)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.51, IQR: 4.79, 15.90 (n = 135)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>Assessed at 3 months postpartum.<br/> <sup>2</sup>Assessed on average at 11 days postpartum.<br/> <sup>3</sup>Assessed at 12 months postpartum. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>4</sup>Assessed at 6 weeks postpartum. </p> </div> </div> </section> <section id="CD011761-sec-0144"> <h6 class="title">Insufficient iodine intake ‐ pregnancy (median urinary iodine concentration (UIC) less than 150 μg/L) </h6> <p>Two studies with 432 participants reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Results show that women who received iodine supplements had a lower likelihood of insufficient iodine intake in pregnancy compared to those who did not receive any iodine. In the iodine group, 33.3% of women had inadequate iodine intake in pregnancy compared to 53.2% in the control group (average RR 0.64; 95% CI 0.51 to 0.80) (<a href="./references#CD011761-fig-0019" title="">Analysis 1.16</a>). There was no evidence of statistical heterogeneity for this outcome (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.56). </p> </section> <section id="CD011761-sec-0145"> <h6 class="title">Insufficient iodine intake ‐ postpartum (breastfeeding: median UIC less than 100 μg/L)</h6> <p>Results from two trials (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 425 women showed that iodine supplementation reduced the likelihood of having insufficient iodine intake in the postpartum period (average RR 0.81; 95% CI 0.70 to 0.93), with no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.90) (<a href="./references#CD011761-fig-0020" title="">Analysis 1.17</a>). </p> </section> <section id="CD011761-sec-0146"> <h6 class="title">Excessive iodine intake (pregnancy only: median UIC greater than or equal to 500 μg/L)</h6> <p>One trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 356 women reported that 7.0% of women who received iodine supplements and 1.6% of women who did not had excessive iodine intake during pregnancy (average RR 4.33; 95% CI 1.24 to 15.07) (<a href="./references#CD011761-fig-0021" title="">Analysis 1.18</a>). </p> </section> </section> <section id="CD011761-sec-0147"> <h5 class="title">Infant/child secondary outcomes</h5> <section id="CD011761-sec-0148"> <h6 class="title">Small‐for‐gestational age (as defined by trial authors)</h6> <p>This outcome was reported in two trials (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 377 infants that showed no evidence of difference between groups (average RR 1.26; 95% CI 0.77 to 2.05) (<a href="./references#CD011761-fig-0022" title="">Analysis 1.19</a>). There was no substantial heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.83). </p> </section> <section id="CD011761-sec-0149"> <h6 class="title">Congenital anomalies (including cretinism, as defined by trial authors)</h6> <p>Two trials (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>), which assessed 875 children, showed a lower frequency of congenital anomalies in the iodine group compared to the control group, 1.7% versus 6.4%, respectively, though all of the cases came from one trial (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>) (average RR 0.27; 95% CI 0.12 to 0.60) (<a href="./references#CD011761-fig-0023" title="">Analysis 1.20</a>). In six out of seven cases in the iodine group and five out of 26 cases in the control group, the mothers received the treatment during pregnancy. The other mothers received treatment before pregnancy. </p> </section> <section id="CD011761-sec-0150"> <h6 class="title">Growth (anthropometric Z scores)</h6> <p>No trials reported on this outcome.</p> </section> <section id="CD011761-sec-0151"> <h6 class="title">Neonatal goitre (assessed by any method)</h6> <p>This outcome was reported in three trials (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) that assessed 684 neonates. Findings showed a lower likelihood of enlarged thyroid gland in the neonates in the iodine group compared to the control group (average RR 0.11; 95% CI 0.02 to 0.56) (<a href="./references#CD011761-fig-0024" title="">Analysis 1.21</a>) with no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.76). </p> </section> <section id="CD011761-sec-0152"> <h6 class="title">Neonatal thyroid volume (in mL) (assessed by any method)</h6> <p>Three trials with assessments of 359 neonates (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) showed lower thyroid volume in the iodine compared to the control group. The MD was ‐0.34 mL (95% CI ‐0.58 to ‐0.11) though there was evidence of statistical heterogeneity (I² = 93%, Tau² = 0.04 and Chi² test for heterogeneity P &lt; 0.00001) (<a href="./references#CD011761-fig-0025" title="">Analysis 1.22</a>). </p> </section> <section id="CD011761-sec-0153"> <h6 class="title">Insufficient neonatal iodine intake (median UIC less than 100 μg/L)</h6> <p>One trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>), which assessed 159 neonates, found a higher likelihood of insufficient iodine intake in the iodine compared to the control group (average RR 2.14; 95% CI 1.04 to 4.37) (<a href="./references#CD011761-fig-0026" title="">Analysis 1.23</a>). </p> </section> <section id="CD011761-sec-0154"> <h6 class="title">Neonatal mental or motor development (as defined by trial authors)</h6> <p>One study (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) reported scores from the Neonatal Behavioral Assessment Scales in median and IQR for 149 neonates (<a href="#CD011761-tbl-0008">Table 6</a>). Out of the eight sub‐scales, three showed higher median scores in the iodine group compared to the control group, one showed a higher score in the control group, and three showed equal scores in both groups. </p> <div class="table" id="CD011761-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Neonatal behavioural assessment scales scores assessed at 6 weeks postpartum (Zimmerman 2009)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>Control</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IQR</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IQR</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Habituation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.4, 8.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.8, 8.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Social‐interactive</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.4, 8.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.0, 8.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Motor system</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.3, 6.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.2, 6.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>State organization</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(2.8, 4.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(3.0, 4.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>State regulation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(3.3, 4.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(2.6, 4.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Autonomic system</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.0, 7.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.3, 7.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reflexes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(1.8, 4.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(2.0, 4.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplementary items</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.3, 8.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.1, 8.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>IQR: interquartile range</p> </div> </div> </section> <section id="CD011761-sec-0155"> <h6 class="title">Child mental or motor development (as defined by trial authors)</h6> <p>Data from two trials (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>), which measured 174 children, showed a higher IQ score in the group whose mothers received iodine compared to those who did not. The MD was 11.21 points (95% CI 7.96 to 14.46) (<a href="./references#CD011761-fig-0027" title="">Analysis 1.24</a>) with no statistical heterogeneity (I² = 0%, Tau² = 0.00; Chi² test for heterogeneity P = 0.70). These findings were combined using MD because the same instrument, the Brunet‐Lézine scale, was used in both trials. </p> <p>One trial (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported on child cognitive, language development, motor, social‐emotional and adaptive behaviour scores for 53 children at 18 months of age assessed by the Bayley scales of infant and toddler development (Bayley‐Ⅲ). Scores were similar in both groups (<a href="./references#CD011761-fig-0028" title="">Analysis 1.25</a>; <a href="./references#CD011761-fig-0029" title="">Analysis 1.26</a>; <a href="./references#CD011761-fig-0030" title="">Analysis 1.27</a>; <a href="./references#CD011761-fig-0031" title="">Analysis 1.28</a>; <a href="./references#CD011761-fig-0032" title="">Analysis 1.29</a>). The same trial also reported moderate and severe developmental delays based on the cognitive, language and motor scores and found no significant differences between groups (<a href="./references#CD011761-fig-0033" title="">Analysis 1.30</a>; <a href="./references#CD011761-fig-0034" title="">Analysis 1.31</a>; <a href="./references#CD011761-fig-0035" title="">Analysis 1.32</a>; <a href="./references#CD011761-fig-0036" title="">Analysis 1.33</a>; <a href="./references#CD011761-fig-0037" title="">Analysis 1.34</a>; <a href="./references#CD011761-fig-0038" title="">Analysis 1.35</a>). </p> </section> <section id="CD011761-sec-0156"> <h6 class="title">Infant death (death in the first year of life)</h6> <p>No trials reported on this outcome.</p> <p><b>Other outcomes</b> </p> <p>We also extracted data on urinary and breast milk iodine concentration following supplementation (<a href="#CD011761-tbl-0003">Table 1</a>). Average UIC was generally higher in the intervention than the control groups, however this was not the case for all studies and in some cases depended on the timing of assessment (e.g. higher in the iodine group during pregnancy but not postpartum <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a> and <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>) and the group assessed (e.g. higher among intervention women but lower among intervention neonates, compared to controls (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>)). With the exception of one trial (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>), in each study where breast milk iodine concentration was assessed, levels were higher in the iodine compared to the control groups (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>). </p> </section> </section> </section> <section id="CD011761-sec-0157"> <h4 class="title">(2) Any oral iodine supplement versus same supplement without iodine or no treatment/placebo (eight trials, 1274 participants) </h4> <p>Eight trials involving 1274 women were included in this comparison (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). None were considered high quality. Three other trials did not contribute any data to our analyses (<a href="./references#CD011761-bbs2-0005" title="KampeO , JanssonR , KarlssonFA . Effects of L‐thyroxine and iodide on the development of autoimmune postpartum thyroiditis. Journal of Clinical Endocrinology &amp; Metabolism1990;70(4):1014‐8. ">Kämpe 1990</a>; <a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a>; <a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a>). </p> <section id="CD011761-sec-0158"> <h5 class="title">Maternal primary outcomes</h5> <section id="CD011761-sec-0159"> <h6 class="title">Hypothyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>Data from one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 365 women showed no difference in risk of hypothyroidism in pregnancy between women who received and did not receive iodine supplementation (average RR 1.90; 95% CI 0.57 to 6.38) (<a href="./references#CD011761-fig-0039" title="">Analysis 2.1</a>). </p> </section> <section id="CD011761-sec-0160"> <h6 class="title">Hypothyroidism ‐ postpartum (as defined by trial authors)</h6> <p>Among 540 women in three trials (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>), those who received oral iodine supplementation were as likely to be diagnosed with hypothyroidism in the postpartum period compared to those who did not receive any iodine (average RR 0.44; 95% CI 0.06 to 3.42) (<a href="./references#CD011761-fig-0040" title="">Analysis 2.2</a>). We did not find evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.41). </p> </section> <section id="CD011761-sec-0161"> <h6 class="title">Preterm birth (as defined by trial authors)</h6> <p>Two trials (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 376 women reported on preterm birth, and showed no difference between groups (average RR 0.71; 95% CI 0.30 to 1.66) though there was statistical heterogeneity ((I² = 32%, Tau² = 0.13 and Chi² test for heterogeneity P = 0.23) (<a href="./references#CD011761-fig-0041" title="">Analysis 2.3</a>). </p> </section> <section id="CD011761-sec-0162"> <h6 class="title">Maternal adverse effect: elevated TPO‐ab ‐ pregnancy (as defined by trial authors)</h6> <p>One trial with 359 women reported on elevated thyroid peroxidase antibodies in pregnancy (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and found no difference in risk between the oral iodine and control groups (average RR 0.95; 95% CI 0.44 to 2.07) (<a href="./references#CD011761-fig-0042" title="">Analysis 2.4</a>). </p> </section> <section id="CD011761-sec-0163"> <h6 class="title">Maternal adverse effect: elevated TPO‐ab ‐ postpartum (as defined by trial authors)</h6> <p>This outcome was reported in three trials with 397 women (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Findings show no difference in the likelihood between the group which received oral iodine and the group which did not receive any iodine (average RR 1.01; 95% CI 0.78 to 1.30) (<a href="./references#CD011761-fig-0043" title="">Analysis 2.5</a>). We did not find any evidence of statistical heterogeneity for this analysis (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.63). </p> </section> <section id="CD011761-sec-0164"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>One trial with 365 women reported on this outcome (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and found no difference between groups (average RR 1.90; 95% CI 0.57 to 6.38) (<a href="./references#CD011761-fig-0044" title="">Analysis 2.6</a>). </p> </section> <section id="CD011761-sec-0165"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ postpartum (as defined by trial authors)</h6> <p>Data from three studies involving 543 women (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) showed that 1.6% of those who received oral iodine supplementation and 4.9% of those who did not had hyperthyroidism in the postpartum period (average RR 0.32, 95% CI 0.11 to 0.91) (<a href="./references#CD011761-fig-0045" title="">Analysis 2.7</a>). There was no statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.67). </p> </section> <section id="CD011761-sec-0166"> <h6 class="title">Maternal adverse effect: digestive intolerance ‐ pregnancy (as defined by trial authors)</h6> <p>One trial with 76 women reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>) and found a higher likelihood of digestive intolerance in the group which received oral iodine supplementation compared to those who did not. One‐third of women (33.3%) in the iodine group and 2.2% of women in the control group dropped out of the study due to nausea or vomiting (average RR 15.33; 95% CI 2.70 to 113.70) (<a href="./references#CD011761-fig-0046" title="">Analysis 2.8</a>). </p> </section> </section> <section id="CD011761-sec-0167"> <h5 class="title">Infant/child primary outcomes</h5> <section id="CD011761-sec-0168"> <h6 class="title">Perinatal mortality (including stillbirth/fetal death and neonatal death, as defined by trial authors) </h6> <p>One trial with 58 assessments (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported no events in either group (<a href="./references#CD011761-fig-0047" title="">Analysis 2.9</a>). </p> </section> <section id="CD011761-sec-0169"> <h6 class="title">Low birthweight (less than 2500 g)</h6> <p>Two trials with 377 infants reported on this outcome (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and showed no difference between groups (average RR 0.56; 95% CI 0.26 to 1.23) (<a href="./references#CD011761-fig-0048" title="">Analysis 2.10</a>). </p> </section> <section id="CD011761-sec-0170"> <h6 class="title">Neonatal hypothyroidism or elevated TSH (as defined by trial authors)</h6> <p>This outcome was reported in two trials (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 260 infant assessments. All of the cases though occurred in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>); the average RR for neonatal elevated TSH in this trial was 0.58 (95% CI 0.11 to 3.12) (<a href="./references#CD011761-fig-0049" title="">Analysis 2.11</a>). </p> </section> <section id="CD011761-sec-0171"> <h6 class="title">Neonatal adverse effect ‐ elevated TPO‐ab (as defined by trial authors)</h6> <p>One study with 108 assessments (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) reported on this outcome and showed no difference between infants whose mothers received oral iodine and those who did not (average RR 0.61; 95% CI 0.07 to 5.70) (<a href="./references#CD011761-fig-0050" title="">Analysis 2.12</a>). In this trial, all of the neonates with elevated TPO‐ab were born to women with elevated TPO‐ab at baseline. </p> </section> <section id="CD011761-sec-0172"> <h6 class="title">Neonatal adverse effect ‐ hyperthyroidism (as defined by trial authors)</h6> <p>No trials reported this outcome.</p> </section> </section> <section id="CD011761-sec-0173"> <h5 class="title">Maternal secondary outcomes</h5> <section id="CD011761-sec-0174"> <h6 class="title">Spontaneous miscarriage (as defined by trial authors)</h6> <p>Three trials (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with information on 645 pregnancies showed a similar likelihood of spontaneous miscarriage (average RR 1.31; 95% CI 0.64 to 2.69) and no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.64)) (<a href="./references#CD011761-fig-0051" title="">Analysis 2.13</a>). </p> </section> <section id="CD011761-sec-0175"> <h6 class="title">Maternal goitre ‐ pregnancy (assessed by any method)</h6> <p>Two studies (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 486 women showed no difference in likelihood of goitre in pregnancy (average RR 1.00; 95% CI 0.33 to 3.06) however we found significant heterogeneity for this outcome (I² = 53%, Tau² = 0.35 and Chi² test for heterogeneity P = 0.14) (<a href="./references#CD011761-fig-0052" title="">Analysis 2.14</a>). </p> </section> <section id="CD011761-sec-0176"> <h6 class="title">Maternal goitre ‐ postpartum (assessed by any method)</h6> <p>Postpartum enlarged thyroid gland or goitre was reported in two trials (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Data from 370 women showed no evidence of difference (average RR 1.17; 95% CI 0.64 to 2.16) though we did identify substantial heterogeneity (I² = 33%, Tau² = 0.10 and Chi² test for heterogeneity P = 0.22) (<a href="./references#CD011761-fig-0053" title="">Analysis 2.15</a>). </p> </section> <section id="CD011761-sec-0177"> <h6 class="title">Maternal thyroid volume ‐ pregnancy (in mL) (assessed by any method)</h6> <p>This outcome was reported in three trials with 496 participants, all of which reported median thyroid volume so no meta‐analyses was performed (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). In two trials, findings showed lower median thyroid volume in the oral iodine compared to the no iodine groups (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>) (<a href="#CD011761-tbl-0004">Table 2</a>). Zimmermann and colleagues however found similar thyroid volumes in both groups (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). </p> </section> <section id="CD011761-sec-0178"> <h6 class="title">Maternal thyroid volume ‐ postpartum (in mL) (assessed by any method)</h6> <p>Four trials with 457 women reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and most used median thyroid volume so we did not perform a meta‐analysis. Three of the studies showed similar postpartum thyroid volumes between the oral iodine and no iodine groups (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). (<a href="#CD011761-tbl-0005">Table 3</a>). One trial however reported a lower median thyroid volume (by 1.2 mL) in the iodine group (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>). </p> </section> <section id="CD011761-sec-0179"> <h6 class="title">Maternal Tg ‐ pregnancy (in μg/L)</h6> <p>This outcome was reported in four studies with 562 women (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) all of which reported median Tg so we did not perform a meta‐analysis. In all four trials, median Tg in pregnancy was lower in the group which received oral iodine compared to the no iodine group; the difference ranged from 2.1 to 7.5 µg/L (<a href="#CD011761-tbl-0006">Table 4</a>). </p> </section> <section id="CD011761-sec-0180"> <h6 class="title">Maternal Tg ‐ postpartum (in μg/L)</h6> <p>Four trials involving 457 women (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a> reported this outcome, mostly as median Tg therefore we did not perform a meta‐analysis. All four trials showed that women who received oral iodine supplements had lower postpartum Tg levels compared to those who did not (<a href="#CD011761-tbl-0007">Table 5</a>). The difference between groups ranged from 1.57 to 11.6 µg/L. </p> </section> <section id="CD011761-sec-0181"> <h6 class="title">Insufficient iodine intake ‐ pregnancy (median UIC less than 150 μg/L)</h6> <p>Two studies with 432 participants reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Results show that women who received oral iodine supplements had a lower likelihood of insufficient iodine intake in pregnancy compared to the comparison group; 33.3% of women in the iodine group had inadequate iodine intake compared to 53.2% in the control group (average RR 0.64; 95% CI 0.51 to 0.80) (<a href="./references#CD011761-fig-0054" title="">Analysis 2.16</a>). There was no evidence of statistical heterogeneity for this outcome (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.56). </p> </section> <section id="CD011761-sec-0182"> <h6 class="title">Insufficient iodine intake ‐ postpartum (breastfeeding: median UIC less than 100 μg/L)</h6> <p>Results from two trials (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 425 women show that iodine supplementation reduced the likelihood of having insufficient iodine intake in the postpartum period (average RR 0.81; 95% CI 0.70 to 0.93) with no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.90) (<a href="./references#CD011761-fig-0055" title="">Analysis 2.17</a>). </p> </section> <section id="CD011761-sec-0183"> <h6 class="title">Excessive iodine intake (pregnancy only: median UIC greater than or equal to 500 μg/L)</h6> <p>One trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 356 women showed that 7.0% of women who oral received iodine supplements and 1.6% of women who did not had excessive iodine intake during pregnancy (average RR 4.33; 95% CI 1.24 to 15.07) (<a href="./references#CD011761-fig-0056" title="">Analysis 2.18</a>). </p> </section> </section> <section id="CD011761-sec-0184"> <h5 class="title">Infant/child secondary outcomes</h5> <section id="CD011761-sec-0185"> <h6 class="title">Small‐for‐gestational age (as defined by trial authors)</h6> <p>This outcome was reported in two trials (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 377 infants which showed no evidence of difference between groups (average RR 1.26, 95% CI 0.77 to 2.05). There was no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.83) (<a href="./references#CD011761-fig-0057" title="">Analysis 2.19</a>). </p> </section> <section id="CD011761-sec-0186"> <h6 class="title">Congenital anomalies (including cretinism, as defined by trial authors)</h6> <p>One trial with 57 infants (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported this outcome, with no cases of congenital anomalies in either group (<a href="./references#CD011761-fig-0058" title="">Analysis 2.20</a>). </p> </section> <section id="CD011761-sec-0187"> <h6 class="title">Growth (anthropometric Z scores)</h6> <p>No trials reported on this outcome.</p> </section> <section id="CD011761-sec-0188"> <h6 class="title">Neonatal goitre (assessed by any method)</h6> <p>This outcome was reported in two trials (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) which assessed 228 neonates. Findings showed a lower likelihood of enlarged thyroid gland in the neonate following oral iodine supplementation in the mother (average RR 0.11; 95% CI 0.02 to 0.56), with no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.76) (<a href="./references#CD011761-fig-0059" title="">Analysis 2.21</a>). </p> </section> <section id="CD011761-sec-0189"> <h6 class="title">Neonatal thyroid volume (in mL) (assessed by any method)</h6> <p>Three trials with assessments of 359 neonates (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) showed lower thyroid volume in the oral iodine compared to the control group. The MD was ‐0.34 mL (95% CI ‐0.58 to ‐0.11) though there was evidence of statistical heterogeneity (I² = 93%, Tau² = 0.04 and Chi² test for heterogeneity P = 0.00001) (<a href="./references#CD011761-fig-0060" title="">Analysis 2.22</a>). </p> </section> <section id="CD011761-sec-0190"> <h6 class="title">Insufficient neonatal iodine intake (median UIC less than 100 μg/L)</h6> <p>One trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) which assessed 159 neonates found a higher likelihood of insufficient iodine intake in the oral iodine compared to the control group (average RR 2.14; 95% CI 1.04 to 4.37) (<a href="./references#CD011761-fig-0061" title="">Analysis 2.23</a>). </p> </section> <section id="CD011761-sec-0191"> <h6 class="title">Neonatal mental or motor development (as defined by trial authors)</h6> <p>One study (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) reported scores from the Neonatal Behavioral Assessment Scales in median and IQR for 149 neonates (<a href="#CD011761-tbl-0008">Table 6</a>). Out of the eight sub‐scales, three showed higher median scores in the oral iodine group compared to the control group, one showed a higher score in the control group, and three showed equal scores in both groups. </p> <p><i>Child mental or motor development (as defined by trial authors)</i> </p> <p>One trial (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported on child cognitive, language development, motor, social‐emotional and adoptive behaviour scores for 53 children at 18 months of age assessed by the Bayley scales of infant and toddler development (Bayley‐Ⅲ). Scores were similar in both groups (<a href="./references#CD011761-fig-0062" title="">Analysis 2.24</a>; <a href="./references#CD011761-fig-0063" title="">Analysis 2.25</a>; <a href="./references#CD011761-fig-0064" title="">Analysis 2.26</a>; <a href="./references#CD011761-fig-0065" title="">Analysis 2.27</a>; <a href="./references#CD011761-fig-0066" title="">Analysis 2.28</a>). This trial also reported moderate and severe developmental delays based on the cognitive, language and motor scores and found no significant differences between groups (<a href="./references#CD011761-fig-0067" title="">Analysis 2.29</a>; <a href="./references#CD011761-fig-0068" title="">Analysis 2.30</a>; <a href="./references#CD011761-fig-0069" title="">Analysis 2.31</a>; <a href="./references#CD011761-fig-0070" title="">Analysis 2.32</a>; <a href="./references#CD011761-fig-0071" title="">Analysis 2.33</a>; <a href="./references#CD011761-fig-0072" title="">Analysis 2.34</a>). </p> </section> <section id="CD011761-sec-0192"> <h6 class="title">Infant death (death in the first year of life)</h6> <p>No trials reported on this outcome.</p> </section> </section> </section> <section id="CD011761-sec-0193"> <h4 class="title">(3) Oral iodine‐only supplement versus no intervention or placebo (five trials, 580 participants) </h4> <p>Five studies involving 580 women were included in this comparison (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>; <a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>), all of which contributed data. None were assessed as high quality. </p> <section id="CD011761-sec-0194"> <h5 class="title">Maternal primary outcomes</h5> <section id="CD011761-sec-0195"> <h6 class="title">Hypothyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>No trials reported on this outcome.</p> </section> <section id="CD011761-sec-0196"> <h6 class="title">Hypothyroidism ‐ postpartum (as defined by trial authors)</h6> <p>Among 340 women in three trials (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>), those who received oral iodine‐only supplementation were as likely to be diagnosed with hypothyroidism in the postpartum period as those who did not receive any iodine (average RR 0.91; 95% CI 0.10 to 8.60) (<a href="./references#CD011761-fig-0073" title="">Analysis 3.1</a>). We did not find evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.32). </p> </section> <section id="CD011761-sec-0197"> <h6 class="title">Preterm birth (as defined by trial authors)</h6> <p>One trial with 58 assessments (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) showed no difference in the likelihood of preterm birth for women who received oral supplements with iodine only compared to those who received no iodine (average RR 1.25; 95% CI 0.37 to 4.19) (<a href="./references#CD011761-fig-0074" title="">Analysis 3.2</a>). </p> </section> <section id="CD011761-sec-0198"> <h6 class="title">Maternal adverse effect: elevated TPO‐ab ‐ pregnancy (as defined by trial authors)</h6> <p>No trial reported on this outcome.</p> </section> <section id="CD011761-sec-0199"> <h6 class="title">Maternal adverse effect: elevated TPO‐ab ‐ postpartum (as defined by trial authors)</h6> <p>This outcome was reported in two trials with 162 women (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>). Findings showed no difference between the group which received oral iodine‐only and the group which did not receive any iodine (average RR 0.62; 95% CI 0.15 to 2.51) (<a href="./references#CD011761-fig-0075" title="">Analysis 3.3</a>). We did not find any evidence of statistical heterogeneity for this analysis (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.52). </p> </section> <section id="CD011761-sec-0200"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>No trial reported on this outcome.</p> </section> <section id="CD011761-sec-0201"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ postpartum (as defined by trial authors)</h6> <p>Two trials involving 286 women (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) reported postpartum hyperthyroidism. This event occurred only in one trial though (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>) and there was no difference in the likelihood of postpartum hyperthyroidism between groups (average RR 0.29; 95% CI 0.01 to 7.06) (<a href="./references#CD011761-fig-0076" title="">Analysis 3.4</a>). </p> </section> <section id="CD011761-sec-0202"> <h6 class="title">Maternal adverse effect: digestive intolerance ‐ pregnancy (as defined by trial authors)</h6> <p>No trial reported on this outcome.</p> </section> </section> <section id="CD011761-sec-0203"> <h5 class="title">Infant/child primary outcomes</h5> <section id="CD011761-sec-0204"> <h6 class="title">Perinatal mortality (including stillbirth/fetal death and neonatal death, as defined by trial authors) </h6> <p>One trial with 58 assessments (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported no events in either group (<a href="./references#CD011761-fig-0077" title="">Analysis 3.5</a>). </p> </section> <section id="CD011761-sec-0205"> <h6 class="title">Low birthweight (less than 2500 g)</h6> <p>One trial (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported this outcome with 58 neonates, showing no difference between groups (average RR 0.33; 95% CI 0.04 to 3.02) (<a href="./references#CD011761-fig-0078" title="">Analysis 3.6</a>). </p> </section> <section id="CD011761-sec-0206"> <h6 class="title">Neonatal hypothyroidism or elevated TSH (as defined by trial authors)</h6> <p>One trial with 41 assessments (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported on this outcome and showed no events in either group (<a href="./references#CD011761-fig-0079" title="">Analysis 3.7</a>), </p> </section> <section id="CD011761-sec-0207"> <h6 class="title">Neonatal adverse effect ‐ elevated TPO‐ab (as defined by trial authors)</h6> <p>One study with 108 assessments (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) reported on this outcome and showed no difference between groups (average RR 0.61; 95% CI 0.07 to 5.70) (<a href="./references#CD011761-fig-0080" title="">Analysis 3.8</a>). </p> </section> <section id="CD011761-sec-0208"> <h6 class="title">Neonatal adverse effect ‐ hyperthyroidism (as defined by trial authors)</h6> <p>No trials reported this outcome.</p> </section> </section> <section id="CD011761-sec-0209"> <h5 class="title">Maternal secondary outcomes</h5> <section id="CD011761-sec-0210"> <h6 class="title">Spontaneous miscarriage (as defined by trial authors)</h6> <p>This outcome was reported in one trial with 58 pregnant women (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>), which showed no difference in likelihood of spontaneous miscarriage between the oral iodine‐only and no iodine groups (average RR 3.00; 95% CI 0.13 to 70.74) (<a href="./references#CD011761-fig-0081" title="">Analysis 3.9</a>). </p> </section> <section id="CD011761-sec-0211"> <h6 class="title">Maternal goitre ‐ pregnancy (assessed by any method)</h6> <p>One study involving 120 women (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>) reported on goitre in pregnancy and found no difference between groups (average RR 0.60; 95% CI 0.23 to 1.55) (<a href="./references#CD011761-fig-0082" title="">Analysis 3.10</a>). </p> </section> <section id="CD011761-sec-0212"> <h6 class="title">Maternal thyroid size ‐ goitre postpartum (assessed by any method)</h6> <p>Postpartum goitre was reported in one trial (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>). Data from 108 women showed no evidence of difference between groups (average RR 1.01; 95% CI 0.73 to 1.39) (<a href="./references#CD011761-fig-0083" title="">Analysis 3.11</a>). </p> </section> <section id="CD011761-sec-0213"> <h6 class="title">Maternal thyroid volume ‐ pregnancy (in mL) (assessed by any method)</h6> <p>One trial with 54 women (<a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>) reported on this outcome. Median thyroid volume in the oral iodine‐only group was lower, by 1.3 mL, than in the no‐iodine group (<a href="#CD011761-tbl-0004">Table 2</a>). </p> </section> <section id="CD011761-sec-0214"> <h6 class="title">Maternal thyroid volume ‐ postpartum (in mL) (assessed by any method)</h6> <p>Two trials including 157 women reported on this outcome (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>). Findings show similar median thyroid volume in the iodine‐only supplementation group and the no‐iodine group (<a href="#CD011761-tbl-0005">Table 3</a>). </p> </section> <section id="CD011761-sec-0215"> <h6 class="title">Maternal Tg ‐ pregnancy (μg/L)</h6> <p>This outcome was reported in one trial with 54 women (<a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>) which showed 45% lower postpartum Tg levels in the iodine‐only group compared to the group that received no iodine (<a href="#CD011761-tbl-0006">Table 4</a>). </p> </section> <section id="CD011761-sec-0216"> <h6 class="title">Maternal Tg ‐ postpartum (μg/L)</h6> <p>Two trials involving 157 women (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>; <a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>) reported on this outcome. We did not perform a meta‐analysis because one trial reported median Tg. Results from these studies show lower postpartum Tg levels in the iodine‐only supplementation group compared to the no‐iodine group (<a href="#CD011761-tbl-0007">Table 5</a>). In one trial mean Tg was 5.2 μg/L lower (<a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) and in the other median Tg was 5.6 μg/L lower (<a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a>). </p> </section> <section id="CD011761-sec-0217"> <h6 class="title">Insufficient iodine intake ‐ pregnancy (median UIC less than 150 μg/L)</h6> <p>No trial reported on this outcome.</p> </section> <section id="CD011761-sec-0218"> <h6 class="title">Insufficient iodine intake ‐ postpartum (breastfeeding: median UIC less than 100 μg/L)</h6> <p>Results from one trial (<a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a>) with 175 women show that those who received oral iodine‐only supplements were less likely to have inadequate iodine intake in the postpartum period compared to those who received no iodine (average RR 0.81; 95% CI 0.69 to 0.96) (<a href="./references#CD011761-fig-0084" title="">Analysis 3.12</a>). </p> </section> <section id="CD011761-sec-0219"> <h6 class="title">Excessive iodine intake (pregnancy only: median UIC greater than or equal to 500 μg/L)</h6> <p>No trial reported on this outcome.</p> </section> </section> <section id="CD011761-sec-0220"> <h5 class="title">Infant/child secondary outcomes</h5> <section id="CD011761-sec-0221"> <h6 class="title">Small‐for‐gestational age (as defined by trial authors)</h6> <p>One trial with 58 neonates (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported this outcome (average RR 1.50; 95% CI 0.27 to 8.32) (<a href="./references#CD011761-fig-0085" title="">Analysis 3.13</a>). </p> </section> <section id="CD011761-sec-0222"> <h6 class="title">Congenital anomalies (including cretinism, as defined by trial authors)</h6> <p>One trial with 57 infants (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported on congenital anomalies and showed no cases in either group (<a href="./references#CD011761-fig-0086" title="">Analysis 3.14</a>). </p> </section> <section id="CD011761-sec-0223"> <h6 class="title">Growth (anthropometric Z scores)</h6> <p>No trial reported on this outcome.</p> </section> <section id="CD011761-sec-0224"> <h6 class="title">Neonatal goitre (assessed by any method)</h6> <p>Two trials with 228 neonates (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) reported on this outcome and showed a lower likelihood of neonatal goitre in the oral iodine‐only supplementation group compared to the control group (average RR 0.11; 95% CI 0.02 to 0.56) (<a href="./references#CD011761-fig-0087" title="">Analysis 3.15</a>). We found no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.76). </p> </section> <section id="CD011761-sec-0225"> <h6 class="title">Neonatal thyroid volume (in mL) (assessed by any method)</h6> <p>This outcome was reported in two studies with 228 assessments (<a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a>; <a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a>) which showed a lower neonatal thyroid volume, by 0.53 mL, in the oral iodine‐only group in comparison to the control group (95% CI ‐1.02 to ‐0.03) (<a href="./references#CD011761-fig-0088" title="">Analysis 3.16</a>). However there was significant statistical heterogeneity (I² = 91%, Tau² = 0.12 and Chi² test for heterogeneity P = 0.0007). </p> </section> <section id="CD011761-sec-0226"> <h6 class="title">Insufficient neonatal iodine intake (median UIC less than 100 μg/L)</h6> <p>No trial reported on this outcome.</p> <p><i>Child mental or motor development (as defined by trial authors)</i> </p> <p>One trial (<a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a>) reported on child cognitive, language development, motor, social‐emotional and adaptive behaviour scores at 18 months of age for 53 children assessed by the Bayley scales of infant and toddler development (Bayley‐Ⅲ). Scores were similar in both groups (<a href="./references#CD011761-fig-0089" title="">Analysis 3.17</a>; <a href="./references#CD011761-fig-0090" title="">Analysis 3.18</a>; <a href="./references#CD011761-fig-0091" title="">Analysis 3.19</a>; <a href="./references#CD011761-fig-0092" title="">Analysis 3.20</a>; <a href="./references#CD011761-fig-0093" title="">Analysis 3.21</a>). The same trial also reported moderate and severe developmental delays based on the cognitive, language and motor scores and found no significant differences between groups (<a href="./references#CD011761-fig-0094" title="">Analysis 3.22</a>; <a href="./references#CD011761-fig-0095" title="">Analysis 3.23</a>; <a href="./references#CD011761-fig-0096" title="">Analysis 3.24</a>; <a href="./references#CD011761-fig-0097" title="">Analysis 3.25</a>; <a href="./references#CD011761-fig-0098" title="">Analysis 3.26</a>; <a href="./references#CD011761-fig-0099" title="">Analysis 3.27</a>). </p> </section> <section id="CD011761-sec-0227"> <h6 class="title">Infant death (death in the first year of life)</h6> <p>No trial reported on this outcome.</p> </section> </section> </section> <section id="CD011761-sec-0228"> <h4 class="title">(4) Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals (exact same formulation of other vitamins/minerals, but no iodine) (three trials, 694 participants) </h4> <p>Three studies involving 694 women were included in this comparison (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>); all three contributed data. None were assessed as high quality. </p> <section id="CD011761-sec-0229"> <h5 class="title">Maternal primary outcomes</h5> <section id="CD011761-sec-0230"> <h6 class="title">Hypothyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>Data from one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 365 women showed no difference in risk of hypothyroidism in pregnancy between women who received supplements containing iodine and other vitamins/minerals and those who received only the other vitamins/minerals (average RR 1.90; 95% CI 0.57 to 6.38) (<a href="./references#CD011761-fig-0100" title="">Analysis 4.1</a>). </p> </section> <section id="CD011761-sec-0231"> <h6 class="title">Hypothyroidism ‐ postpartum (as defined by trial authors)</h6> <p>One study (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 254 women reported on this outcome and found no evidence of difference in the likelihood of postpartum hypothyroidism between groups (average RR 0.97; 95% CI 0.06 to 15.32) (<a href="./references#CD011761-fig-0101" title="">Analysis 4.2</a>). </p> </section> <section id="CD011761-sec-0232"> <h6 class="title">Preterm birth (as defined by trial authors)</h6> <p>Only one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 318 women reported on preterm birth, and showed no difference between groups (average RR 0.51; 95% CI 0.23 to 1.14) (<a href="./references#CD011761-fig-0102" title="">Analysis 4.3</a>). </p> </section> <section id="CD011761-sec-0233"> <h6 class="title">Maternal adverse effect: elevated TPO‐ab ‐ pregnancy (as defined by trial authors)</h6> <p>One trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 359 women showed no difference between groups (average RR 0.95; 95% CI 0.44 to 2.07) (<a href="./references#CD011761-fig-0103" title="">Analysis 4.4</a>). </p> </section> <section id="CD011761-sec-0234"> <h6 class="title">Maternal adverse effect: elevated TPO‐ab ‐ postpartum (as defined by trial authors)</h6> <p>This outcome was reported in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 235 women, which showed no difference between groups (average RR 1.03; 95% CI 0.79 to 1.33) (<a href="./references#CD011761-fig-0104" title="">Analysis 4.5</a>). </p> </section> <section id="CD011761-sec-0235"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ pregnancy (as defined by trial authors)</h6> <p>One trial with 365 women reported on this outcome (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and found no difference between groups (average RR 1.90; 95% CI 0.57 to 6.38) (<a href="./references#CD011761-fig-0105" title="">Analysis 4.6</a>). </p> </section> <section id="CD011761-sec-0236"> <h6 class="title">Maternal adverse effect: hyperthyroidism ‐ postpartum (as defined by trial authors)</h6> <p>This outcome was reported in one trial involving 257 women (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) (average RR 0.35; 95% CI 0.12 to 1.06) (<a href="./references#CD011761-fig-0106" title="">Analysis 4.7</a>). </p> </section> <section id="CD011761-sec-0237"> <h6 class="title">Maternal adverse effect: digestive intolerance ‐ pregnancy (as defined by trial authors)</h6> <p>One trial with 76 women reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>) and found a higher likelihood of digestive intolerance in the group that received oral iodine supplementation with other micronutrients compared to those who received only other micronutrients. One third of women (33.3%) in the iodine group and 2.2% of women in the control group dropped out of the study due to nausea or vomiting (average RR 15.33, 95% CI 2.07 to 113.70; participants = 76) (<a href="./references#CD011761-fig-0107" title="">Analysis 4.8</a>). </p> </section> </section> <section id="CD011761-sec-0238"> <h5 class="title">Infant/child primary outcomes</h5> <section id="CD011761-sec-0239"> <h6 class="title">Perinatal mortality (including stillbirth/fetal death and neonatal death, as defined by trial authors) </h6> <p>No trial reported on this outcome.</p> </section> <section id="CD011761-sec-0240"> <h6 class="title">Low birthweight (less than 2500 g)</h6> <p>One study with 319 infants reported on this outcome (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and showed no difference between groups (average RR 0.61; 95% CI 0.27 to 1.39) (<a href="./references#CD011761-fig-0108" title="">Analysis 4.9</a>). </p> </section> <section id="CD011761-sec-0241"> <h6 class="title">Neonatal hypothyroidism or elevated TSH (as defined by trial authors)</h6> <p>This outcome was reported in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 219 infant assessments; the average RR for neonatal elevated TSH was 0.58 (95% CI 0.11 to 3.12) (<a href="./references#CD011761-fig-0109" title="">Analysis 4.10</a>). </p> </section> <section id="CD011761-sec-0242"> <h6 class="title">Neonatal adverse effect ‐ elevated TPO‐ab (as defined by trial authors)</h6> <p>No trials reported this outcome.</p> </section> <section id="CD011761-sec-0243"> <h6 class="title">Neonatal adverse effect ‐ hyperthyroidism (as defined by trial authors)</h6> <p>No trials reported this outcome.</p> </section> </section> <section id="CD011761-sec-0244"> <h5 class="title">Maternal secondary outcomes</h5> <section id="CD011761-sec-0245"> <h6 class="title">Spontaneous miscarriage (as defined by trial authors)</h6> <p>Two trials (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with information on 587 pregnancies showed a similar likelihood of spontaneous miscarriage (average RR 1.26; 95% CI 0.60 to 2.62) and no evidence of statistical heterogeneity (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.43) (<a href="./references#CD011761-fig-0110" title="">Analysis 4.11</a>). </p> </section> <section id="CD011761-sec-0246"> <h6 class="title">Maternal goitre ‐ pregnancy (assessed by any method)</h6> <p>One trial with 366 women (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) showed no difference between groups (average RR 1.89; 95% CI 0.56 to 6.34) (<a href="./references#CD011761-fig-0111" title="">Analysis 4.12</a>). </p> </section> <section id="CD011761-sec-0247"> <h6 class="title">Maternal goitre ‐ postpartum (assessed by any method)</h6> <p>This outcome was reported in one study (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) involving 262 women. Results showed no difference between women who received oral iodine with other micronutrients and those who received only other micronutrients (average RR 2.06; 95% CI 0.64 to 6.68) (<a href="./references#CD011761-fig-0112" title="">Analysis 4.13</a>). </p> </section> <section id="CD011761-sec-0248"> <h6 class="title">Maternal thyroid volume ‐ pregnancy (in mL) (assessed by any method)</h6> <p>Two trials (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 442 participants reported median prenatal thyroid volume so we did not perform a meta‐analysis. Values were similar in both groups in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and 0.4 mL lower in the group receiving iodine with other micronutrients compared to the no‐iodine group in the other trial (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>) (<a href="#CD011761-tbl-0004">Table 2</a>). </p> </section> <section id="CD011761-sec-0249"> <h6 class="title">Maternal thyroid volume ‐ postpartum (in mL) (assessed by any method)</h6> <p>Two trials (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 300 women reported median postpartum thyroid volume, so we did not perform a meta‐analysis for this outcome. Findings showed similar values in both groups in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and 1.2 mL lower thyroid volume in the group that received iodine with other micronutrients compared to the no‐iodine group in the other trial (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>)(<a href="#CD011761-tbl-0005">Table 3</a>). </p> </section> <section id="CD011761-sec-0250"> <h6 class="title">Maternal Tg ‐ pregnancy (μg/L)</h6> <p>This outcome was reported in three studies (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 508 women. All three trials reported median Tg therefore we did not perform a meta‐analysis. In each of these trials, prenatal Tg concentrations were lower in women who received iodine supplements with other micronutrients compared to those who received no iodine (<a href="#CD011761-tbl-0006">Table 4</a>). Differences ranged from 2.1 μg/L to 5.3 μg/L. </p> </section> <section id="CD011761-sec-0251"> <h6 class="title">Maternal Tg ‐ postpartum (μg/L)</h6> <p>Two trials involving 300 women (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) reported median postpartum Tg. In both of these studies, Tg concentrations were lower in the group receiving iodine plus other micronutrients than in the no‐iodine group (<a href="#CD011761-tbl-0007">Table 5</a>), in one study by 1.57 μg/L (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and in another by 11.6 μg/L (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>). </p> </section> <section id="CD011761-sec-0252"> <h6 class="title">Insufficient iodine intake ‐ pregnancy (median UIC less than 150 μg/L)</h6> <p>Two studies with 432 participants reported on this outcome (<a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a>; <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). Results show that women who received iodine supplements with other micronutrients had a lower likelihood of insufficient iodine intake in pregnancy compared to those who received only other micronutrients (average RR 0.64; 95% CI 0.51 to 0.80) (<a href="./references#CD011761-fig-0113" title="">Analysis 4.14</a>). There was no evidence of statistical heterogeneity for this outcome (I² = 0%, Tau² = 0.00 and Chi² test for heterogeneity P = 0.56). </p> </section> <section id="CD011761-sec-0253"> <h6 class="title">Insufficient iodine intake ‐ postpartum (breastfeeding: median UIC less than 100 μg/L)</h6> <p>Findings from one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 250 women showed no clear difference of having insufficient iodine intake postpartum (average RR 0.80; 95% CI 0.61 to 1.04) (<a href="./references#CD011761-fig-0114" title="">Analysis 4.15</a>). </p> </section> <section id="CD011761-sec-0254"> <h6 class="title">Excessive iodine intake (pregnancy only: median UIC greater than or equal to 500 μg/L)</h6> <p>One study with 356 women reported on this outcome (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) and found a greater likelihood of excessive iodine intake in pregnancy in women who received iodine and other vitamins/minerals compared to those who received only other vitamins/minerals (average RR 4.33; 95% CI 1.24 to 15.07) (<a href="./references#CD011761-fig-0115" title="">Analysis 4.16</a>). </p> </section> </section> <section id="CD011761-sec-0255"> <h5 class="title">Infant/child secondary outcomes</h5> <section id="CD011761-sec-0256"> <h6 class="title">Small‐for‐gestational age (as defined by trial authors)</h6> <p>This outcome was reported in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) with 319 assessments which showed no evidence of difference between groups (average RR 1.24; 95% CI 0.74 to 2.06) (<a href="./references#CD011761-fig-0116" title="">Analysis 4.17</a>). </p> </section> <section id="CD011761-sec-0257"> <h6 class="title">Congenital anomalies (including cretinism, as defined by trial authors)</h6> <p>No trials reported on this outcome.</p> </section> <section id="CD011761-sec-0258"> <h6 class="title">Growth (anthropometric Z scores)</h6> <p>No trials reported on this outcome.</p> </section> <section id="CD011761-sec-0259"> <h6 class="title">Neonatal goitre (assessed by any method)</h6> <p>No trials reported on this outcome.</p> </section> <section id="CD011761-sec-0260"> <h6 class="title">Neonatal thyroid volume (in mL) (assessed by any method)</h6> <p>This outcome was reported in one trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) which assessed 131 neonates and found a trend towards lower thyroid volume in the group whose mothers received iodine with other micronutrients compared to those who received only other micronutrients (MD ‐0.09; 95% CI ‐0.18 to ‐0.00) (<a href="./references#CD011761-fig-0117" title="">Analysis 4.18</a>). </p> </section> <section id="CD011761-sec-0261"> <h6 class="title">Insufficient neonatal iodine intake (median UIC less than 100 μg/L)</h6> <p>One trial (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>), which assessed 159 neonates, found a higher likelihood of insufficient iodine intake in the iodine compared to the control group (average RR 2.14; 95% CI 1.04 to 4.37) (<a href="./references#CD011761-fig-0118" title="">Analysis 4.19</a>). </p> </section> <section id="CD011761-sec-0262"> <h6 class="title">Neonatal mental or motor development (as defined by trial authors)</h6> <p>One study (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>) reported scores from the Neonatal Behavioral Assessment Scales for 149 neonates in median and IQR (<a href="#CD011761-tbl-0008">Table 6</a>). Out of the eight sub‐scales, three showed higher median scores in the oral iodine group compared to the control group, one showed a higher score in the control group, and three showed equal scores in both groups. </p> </section> <section id="CD011761-sec-0263"> <h6 class="title">Infant death (death in the first year of life)</h6> <p>No trials reported on this outcome.</p> </section> </section> </section> <section id="CD011761-sec-0264"> <h4 class="title">(5) Any injected iodine supplement versus same supplement without iodine or no treatment/placebo (three trials,1463 participants) </h4> <p>Three trials were included in this comparison (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>), all of which contributed data. One trial did not report the number of women randomised (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>). None of the studies were assessed as high quality. </p> <section id="CD011761-sec-0265"> <h5 class="title">Maternal primary outcomes</h5> <p>None of the trials reported on this review's maternal primary outcomes (hypothyroidism during pregnancy or postpartum; preterm birth or any adverse effect in pregnancy or postpartum). </p> </section> <section id="CD011761-sec-0266"> <h5 class="title">Infant/child primary outcomes</h5> <section id="CD011761-sec-0267"> <h6 class="title">Perinatal mortality (including stillbirth/fetal death and neonatal death, as defined by trial authors) </h6> <p>One trial with 399 assessments (<a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>) reported on this outcome and found a trend towards lower perinatal mortality in the injected‐iodine compared to the control group (average RR 0.66; 95% CI 0.42 to 1.03) (<a href="./references#CD011761-fig-0119" title="">Analysis 5.1</a>). </p> <p>No trials reported on this review's other infant primary outcomes (low birthweight, hypothyroidism or elevated TSH or any adverse effect). </p> </section> </section> <section id="CD011761-sec-0268"> <h5 class="title">Maternal secondary outcomes</h5> <p>No trials reported on the prespecified maternal secondary outcomes (spontaneous miscarriage, maternal goitre during pregnancy or postpartum, thyroid volume ‐ pregnancy or postpartum, Tg ‐ pregnancy or postpartum, insufficient or excessive iodine intake during pregnancy or postpartum). </p> </section> <section id="CD011761-sec-0269"> <h5 class="title">Infant/child secondary outcomes</h5> <section id="CD011761-sec-0270"> <h6 class="title">Congenital anomalies (including cretinism, as defined by trial authors)</h6> <p>One study (<a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>), which assessed 818 children, showed a lower frequency of congenital anomalies in the injected iodine group compared to the control group (average RR 0.27; 95% CI 0.12 to 0.60) (<a href="./references#CD011761-fig-0120" title="">Analysis 5.2</a>). </p> </section> <section id="CD011761-sec-0271"> <h6 class="title">Neonatal goitre (assessed by any method)</h6> <p>One trial with 465 neonates (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>) reported on this outcome; no events were found in either group (<a href="./references#CD011761-fig-0121" title="">Analysis 5.3</a>). </p> </section> <section id="CD011761-sec-0272"> <h6 class="title">Mental or motor development (as defined by trial authors)</h6> <p>Data from two trials (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>), which measured 174 children, showed a higher IQ score, by 11.21 points on average, in the injected iodine compared to the control group (95% CI 7.96 to 14.46), with no statistical heterogeneity (I² = 0%, Tau² = 0.00; Chi² test for heterogeneity P = 0.70) (<a href="./references#CD011761-fig-0122" title="">Analysis 5.4</a>). </p> <p>No trials reported on any of the other infant/child prespecified secondary outcomes (growth, small‐for‐gestational age, thyroid volume, insufficient neonatal iodine intake or infant death). </p> </section> </section> </section> <section id="CD011761-sec-0273"> <h4 class="title">(6) Injected iodine‐only supplement versus no intervention or placebo (three trials)</h4> <p>All of the trials included in comparison 5 reported using injected iodine‐only supplements (<a href="./references#CD011761-bbs2-0006" title="KevanyJ , Fierro‐BenitezR , PretellEA , StanburyJB . Prophylaxis and treatment of endemic goiter with iodized oil in rural Ecuador and Peru. American Journal of Clinical Nutrition1969;22(12):1597‐607. PretellE , PalaciosP , TelloL , WanM , UtigerR , StanburyJB . Iodine deficiency and the maternal/fetal relationship. In: DunnJT , Medeiros‐NetoGA editor(s). Endemic Goiter and Cretinism: Continuing Threats to World Health. Washington, DC: PAHO, 1974:143‐55. PretellEA , CaceresA . Impairment of mental development by iodine deficiency and its correction. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication, 1994:187–91. PretellEA , MoncloaF , SalinasR , Guerra‐GarciaR , KawanoA , GutierrezL , et al. Endemic goiter in rural Peru: effect of iodized oil on prevalence and size of goiter and on thyroid iodine metabolism in known endemic goitrous populations. Chapter 34. Endemic Goiter, Report of the Meeting of the PAHO Scientific Group on Research in Endemic Goiter; 1968 June 27‐29, Puebla, Mexico. Washington DC: PAHO, 1969:419‐437. PretellEA , TorresT , ZentenoV , CornejoM . Prophylaxis of endemic goiter with iodized oil in rural Peru. Advances in Experimental Medicine and Biology1972;30:249‐65. ">Kevany 1969</a>; <a href="./references#CD011761-bbs2-0011" title="ConnollyKJ , PharoahPO , HetzelBS . Fetal iodine deficiency and motor performance during childhood. Lancet1979;2(8153):1149‐51. PharoahP , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. International Journal of Epidemiology2012;41(3):589‐92. PharoahPO , ButtfieldIH , HetzelBS . The effect of iodine prophylaxis on the incidence of endemic cretinism. Advances in Experimental Medicine and Biology1972;30:201‐21. PharoahPO , ConnollyKJ , EkinsRP , HardingAG . Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clinical Endocrinology1984;21(3):265‐70. PharoahPO , EllisSM , EkinsRP , WilliamsES . Maternal thyroid function, iodine deficiency and fetal development. Clinical Endocrinology1976;5(2):159‐66. PharoahPOD , ButtfieldIH , HetzelBS . Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy. Lancet1971;I:308‐10. PharoahPOD , ConnollyKJ . A controlled trial of iodinated oil for the prevention of endemic cretinism: a long‐term follow‐up. International Journal of Epidemiology1987;16:68‐73. PharoahPOD , ConnollyKJ . Effects of maternal iodine supplementation during pregnancy. Archives of Disease in Childhood1991;66:145‐7. ">Pharoah 1971 (C)</a>; <a href="./references#CD011761-bbs2-0013" title="Moreno‐ReyesR , SwennenB , GilliesJ , ThillyCH . Oral iodized oil in the prevention of neonatal hypothyroidism. Annales d'Endocrinologie1991;52:58. ThillyCH , DelangeF , LagasseR , BourdouxP , RamioulL , BerquistH , et al. Fetal hypothyroidism and maternal thyroid status in severe endemic goiter. Journal of Clinical Endocrinology and Metabolism1978;47:354‐60. ThillyCH , LagasseR , RogerG , BourdouxP , ErmansAM . Impaired fetal and postnatal development and high perinatal death‐rate in a severe iodine deficient area. In: Thyroid research VIII. Proceedings of the Eighth International Thyroid Congress. Sydney, Australia: Oxford, UK: Pergamon, February 3‐8, 1980:20‐3. ThillyCH , RogerG , LagasseR , TshibanguD , VanderpasJB , BerquistH , et al. Fetomaternal relationship, fetal hypothyroidism, and psychomotor retardation. In Role of Cassava in the etiology of endemic goitre and cretinism. International Development Research Centre. Ottawa, Canada, 1980:111–82. ThillyCH , SwennenB , Moreno‐ReyesR , HindletJY , BourdouxP , VanderpasJB . Maternal, fetal, and juvenile hypothyroidism, birth weight and infant mortality in the etiopathogenesis of the IDD spectra in Zaire and Malawi. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency: Cognitive, Behavioral, Neuromotor and Educative Aspects. New York: Cognizant Communication Corporation, 1994:241‐50. VanderpasJ , ThillyCH . Endemic neonatal, infantile and juvenile hypothyroidism in Ubangi, Northern Zaire: clinical consequences and prevention. In: StanburyJB editor(s). The Damaged Brain of Iodine Deficiency. New York: Cognizant Communication, 1994:209‐24. ">Thilly 1978</a>). Therefore the findings for comparison 6 are the same as for comparison 5 and are not repeated here. </p> </section> <section id="CD011761-sec-0274"> <h4 class="title">(7) Injected iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals (exact same formulation of other vitamins/minerals, but no iodine) (no trials) </h4> <p>No studies were included in this comparison.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011761-sec-0275" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011761-sec-0275"></div> <section id="CD011761-sec-0276"> <h3 class="title" id="CD011761-sec-0276">Summary of main results</h3> <p>This review evaluates the effects of oral or injected iodine supplementation alone or in combination with other micronutrients prior to, during, or following pregnancy. It includes 14 trials, though only 11 (with over 2700 women) contributed data. Eight of these 11 trials compared iodine alone versus no treatment or placebo (five oral and three injected) and three compared iodine with other vitamins/minerals compared to only other vitamins/minerals (all oral). We did not identify any studies that used injected iodine with other vitamins/minerals compared to only other vitamins/minerals. </p> <p>We have summarized the primary outcome findings along with an overall assessment of quality of evidence in 'Summary of findings' tables (<a href="./full#CD011761-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011761-tbl-0002">summary of findings Table 2</a>). </p> <p>In comparison to the group that received no iodine, those who received iodine had a lower likelihood of postpartum hyperthyroidism (1.6% versus 4.9% in three trials, low‐quality evidence) and a higher likelihood of digestive intolerance in pregnancy (33.3% versus 2.2% in one trial, very low‐quality evidence). Both hyperthyroidism and digestive intolerance were considered potential adverse effects. Those who received iodine supplementation also had a lower likelihood of perinatal mortality (11.9% versus 18.2% in two trials, low‐quality evidence), though this finding was not statistically significant. For the remaining primary outcomes, there were no clear differences between groups. </p> <p>For secondary outcomes, in comparison to the group which received no iodine, those who received iodine supplementation had lower likelihood of insufficient iodine intake in pregnancy (two trials) and the postpartum period (two trials), greater likelihood of excessive iodine intake in pregnancy (one trial), lower likelihood of congenital anomalies (two trials), lower likelihood of neonatal goitre (three trials), lower neonatal thyroid volume (three trials), higher likelihood of neonatal insufficient iodine intake (one trial) and higher child mental development score (two trials). </p> <p>No trials reported on infant/child growth or infant death and we found evidence of no effect for the remaining secondary outcomes. </p> <p>Our findings, both those showing an effect and those showing no effect, must be interpreted with caution due to the low number of studies contributing data and small sample sizes. </p> </section> <section id="CD011761-sec-0277"> <h3 class="title" id="CD011761-sec-0277">Overall completeness and applicability of evidence</h3> <p>This review included data from 11 randomised or quasi‐randomized controlled trials that have taken place in 13 countries since the 1960s. We consider this evidence base to be limited, both in the number of trials and included women and in the outcomes of interest reported. The majority of primary outcomes were reported in only one or two trials. Where we identified substantial statistical heterogeneity, we were unable to perform any of the planned subgroup analyses because of insufficient data. None of the included trials were assessed as high quality and the quality of evidence for all of the primary outcomes was considered low or very low. </p> <p>Iodine supplementation in women who may become pregnant, and pregnant or breastfeeding women generally aims to prevent and/or treat iodine deficiency and its consequences, both in the woman and her child. Our review has shown that iodine supplementation may decrease the risk of postpartum hyperthyroidism and increase the likelihood of experiencing nausea or vomiting in pregnancy. Evidence for these outcomes came from trials which took place in areas with mild to moderate iodine deficiency. These findings must be interpreted cautiously; the postpartum findings were driven by findings from one study and the digestive intolerance results came from one trial. There was an indication of decreased risk of perinatal mortality, though the difference between groups was not statistically significant and all of the events occurred in one trial which took place in a setting with severe iodine deficiency. </p> <p>We have also demonstrated that iodine supplementation may affect indicators of iodine intake and iodine or thyroid status in women and their children ‐ mostly positively with the exception of an increased risk of excessive intake in pregnancy and higher likelihood of insufficient neonatal intake. We also identified evidence for prevention of cretinism in a severely iodine‐deficient area and mixed findings on mental development indicators, with positive effects in studies that took place in settings with severe deficiency. We had planned on performing subgroup analyses, including by baseline iodine status, however we did not identify enough trials to perform these additional analyses for any of the included outcomes. </p> <p>The importance of routine iodine supplementation for important outcomes in pregnancy and postpartum and in children under two still needs to be demonstrated. To our knowledge there are five planned, ongoing or unpublished trials which may be eligible for inclusion in this review, in addition to data not yet published for the Indian component of the <a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a> trial (see <a href="./references#CD011761-sec-0298" title="">Characteristics of ongoing studies</a>). We expect that when reported, these trials will help fill some of the evidence gaps identified in this review. This review should be updated to incorporate the new findings once they are published. </p> </section> <section id="CD011761-sec-0278"> <h3 class="title" id="CD011761-sec-0278">Quality of the evidence</h3> <p>The overall risk of bias was unclear in most of the trials. Methods for sequence generation and allocation concealment were either not specified or considered at high risk of selection bias for most trials. Similarly, most trials did not describe blinding of personnel, participants and outcome assessors or the methods were considered at high risk of performance or detection bias. For most of the outcomes however, lack of blinding would be unlikely to influence results, though we cannot rule out this possibility. All but two studies were considered at either high risk of attrition bias due to incomplete outcome data or unclear risk because this information was not provided. For reporting and other bias, we generally did not have enough information to classify trials as high or low risk. </p> <p>We assessed the quality of the evidence using GRADE and judged the evidence for comparison 1, any supplement containing iodine compared with same supplement without iodine or no treatment/placebo, for maternal primary outcomes (<a href="./full#CD011761-tbl-0001">summary of findings Table for the main comparison</a>), and child primary outcomes (<a href="./full#CD011761-tbl-0002">summary of findings Table 2</a>) (no outcomes beyond the neonatal period were reported in the included trials). For maternal outcomes, the quality of evidence was judged as low for maternal hypothyroidism during pregnancy, postpartum, preterm, elevated TPO‐ab during pregnancy and postpartum, hyperthyroidism during pregnancy and postpartum. Digestive intolerance was judged as very low‐quality evidence. For child outcomes, the quality of evidence was judged as low to very low for perinatal mortality, low birthweight, neonatal hypothyroidism or elevated TSH, and neonatal elevated TPO‐ab. The main reasons for downgrading were design limitations, wide confidence intervals and small event size. </p> </section> <section id="CD011761-sec-0279"> <h3 class="title" id="CD011761-sec-0279">Potential biases in the review process</h3> <p>We aimed to minimize bias at each stage of the review process. Two review authors independently assessed eligibility for inclusion, carried out data extraction and assessed risk of bias. However we recognize that this type of review requires many subjective judgements and others undertaking the same review may have made different decisions, particularly regarding eligibility and risk of bias. </p> <p>We attempted to use a systematic and transparent process to assess the quality of the evidence relating to specific outcomes and produce 'Summary of findings' tables. Two review authors independently assessed the evidence for each quality domain for each outcome. Any disagreements were discussed and we involved a third review author where necessary. We planned to use funnel plots to assess publication bias but we were not able to do this for any of the outcomes due to the limited number of studies contributing data. We also relied mostly on published literature and did not systematically search for grey literature. </p> </section> <section id="CD011761-sec-0280"> <h3 class="title" id="CD011761-sec-0280">Agreements and disagreements with other studies or reviews</h3> <p>Zhou and colleagues conducted a systematic review on the effects of iodine supplementation during pregnancy or the periconceptional period on child growth and development as well as pregnancy outcomes and thyroid function, and included randomised or quasi‐randomized controlled trials (<a href="./references#CD011761-bbs2-0126" title="ZhouSJ , AndersonAJ , GibsonRA , MakridesM . Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials. American Journal of Clinical Nutrition2013;98(5):1241‐54. [DOI: 10.3945/ajcn.113.065854] ">Zhou 2013</a>). Our findings are consistent with the authors' conclusions that there was a lack of high‐quality evidence on the effect of supplementation on child growth and cognition. </p> <p>Taylor and colleagues undertook a systematic review on the impact of iodine supplementation in settings with mild‐to‐moderate iodine deficiency (<a href="./references#CD011761-bbs2-0115" title="TaylorPN , OkosiemeOE , DayanCM , LazarusJH . Therapy of endocrine disease: impact of iodine supplementation in mild‐to‐moderate iodine deficiency: systematic review and meta‐analysis. European Journal of Endocrinology2013;170(1):R1‐15. ">Taylor 2013</a>). They included observational studies and randomised controlled trials of maternal iodine supplementation in pregnancy. Of the trials, they found that most showed a positive impact on maternal Tg levels and maternal thyroid volume, no evidence of negative effect on maternal TPO‐ab, and lower thyroid volume in neonates of women who received iodine. We found similar results, with the exception of maternal thyroid volume, where our findings were mixed. </p> <p>Zimmermann and colleagues conducted a narrative systematic review/systematic literature search on the effects of iodine deficiency in pregnancy and infancy, and included trials on supplementation before and during pregnancy (<a href="./references#CD011761-bbs2-0133" title="ZimmermannMB . The effects of iodine deficiency in pregnancy and infancy. Paediatric and Perinatal Epidemiology2012;26(Suppl 1):108‐17. ">Zimmermann 2012a</a>). The authors concluded that in moderate to severely iodine‐deficient areas, iodine supplementation prevented cretinism, increased birthweight, reduced perinatal and infant death and improved child cognition. They also concluded that mild deficiency could impair thyroid function but that effects on child cognitive or neurologic function were uncertain. This review reached different conclusions to ours, however this may be explained by its design; it did not specify criteria for study inclusion and included non‐randomized trials as well as studies with different comparisons. </p> <p>An additional review and meta‐analysis looked at iodine and mental development of young children and included randomised and non‐randomized supplementation trials (in mothers or infants, or both) and prospective cohort studies stratified by mother or infant iodine status (<a href="./references#CD011761-bbs2-0075" title="BougmaK , AboudFE , HardingKB , MarquisGS . Iodine and mental development of children 5 years old and under: a systematic review and meta‐analysis. Nutrients2013;5(4):1384‐416. [DOI: 10.3390/nu5041384] ">Bougma 2013</a>). Findings showed a positive impact of iodine, regardless as to the study design, ranging from 6.9 to 10.2 IQ points, whereas our findings on child development were mixed. </p> <p>Angermayr and Clar conducted a Cochrane Review on the effects of iodine supplementation for preventing iodine deficiency disorders in children and found that most trials resulted in increased urinary iodine excretion, an overall tendency towards reduction of goitre and mixed results for cognitive, psychomotor and physical development (<a href="./references#CD011761-bbs2-0072" title="AngermayrL , ClarC . Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD003819.pub2] ">Angermayr 2004</a>). Less than 2% of children studied showed adverse effects and these effects were largely minor and transient. Most trials included in this review used iodized oil and most were considered low quality. </p> <p>In the Cochrane Review on iodine supplementation for preventing mortality and adverse neurodevelopmental outcomes in preterm infants, Ibrahim and colleagues found only one eligible trial to include (<a href="./references#CD011761-bbs2-0094" title="IbrahimM , SinnJ , McGuireW . Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD005253.pub2] ">Ibrahim 2006</a>). This trial was underpowered for mortality and did not assess neurodevelopment. It showed no effect of iodine on T3, T4 or thyrotropin or the incidence of chronic lung disease. Our review did not include any of these outcomes. </p> <p>Aburto and colleagues performed a review on the effect and safety of salt iodization for prevention of iodine deficiency disorders, which included over 80 studies of various designs (<a href="./references#CD011761-bbs2-0070" title="AburtoN , AbudouM , CandeiasV , WuT . Effect and safety of salt iodization to prevent iodine deficiency disorders: a systematic review with meta‐analyses. http://apps.who.int/iris/bitstream/10665/148175/1/9789241508285_eng.pdf (accessed 23 February 2017). Geneva: World Health Organization, 2014:1‐151. ">Aburto 2014</a>). Findings showed that iodized salt increased intelligence quotient and urinary iodine excretion and reduced the risk of goitre, cretinism, low intelligence and low urinary iodine excretion. There was no effect found on hypothyroidism, considered by authors as a potential adverse effect, and inconsistent results for hyperthyroidism. </p> <p>A Cochrane Review on point‐of‐use fortification of foods with multiple‐micronutrient powders for women during pregnancy identified one eligible trial that included iodine in the formulation, along with six other nutrients (<a href="./references#CD011761-bbs2-0113" title="SuchdevPS , Peña‐RosasJP , De‐RegilLM . Multiple micronutrient powders for home (point‐of‐use) fortification of foods in pregnant women. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD011158.pub2] ">Suchdev 2015</a>). The comparison was tablets with the same formulation, therefore the findings are not relevant for discussion here. Similarly, the Haider and Bhutta Cochrane Review on multiple‐micronutrient supplementation for women during pregnancy included trials that compared multiple‐micronutrient supplements with supplements containing iron and folic acid, iron only, or placebo (<a href="./references#CD011761-bbs2-0087" title="HaiderBA , BhuttaZA . Multiple‐micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews2015, Issue 11. [DOI: 10.1002/14651858.CD004905.pub4] ">Haider 2015</a>). </p> <p>Some of our findings were unexpected. The evidence that iodine supplementation reduced the likelihood of hyperthyroidism in the postpartum period came mainly from one trial, which took place in women with mild iodine deficiency in Thailand (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). We are not certain of a mechanism to explain this relationship. It is possible that iodine supplementation helped to prevent postpartum thyroiditis, a feature of which is often hyperthyroidism (<a href="./references#CD011761-bbs2-0111" title="Stagnaro‐GreenA . Approach to the patient with postpartum thyroiditis. Journal of Clinical Endocrinology and Metabolism2012;97(2):334‐42. ">Stagnaro‐Green 2012</a>). Other available evidence however suggests that iodine has no effect on or aggravates postpartum thyroiditis. We also found, with data from the same trial, that iodine supplementation increased the likelihood of insufficient iodine intake in neonates (as indicated by UIC) (<a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a>). This finding is also unexpected and we are not aware of a plausible explanation. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011761-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD011761-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD011761-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD011761-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 1 Maternal hypothyroidism ‐ pregnancy." data-id="CD011761-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 1 Maternal hypothyroidism ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 2 Maternal hypothyroidism ‐ postpartum." data-id="CD011761-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 2 Maternal hypothyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 3 Preterm birth." data-id="CD011761-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy." data-id="CD011761-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum." data-id="CD011761-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 6 Maternal adverse effect: hyperthyroidism ‐ pregnancy." data-id="CD011761-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 6 Maternal adverse effect: hyperthyroidism ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 7 Maternal adverse effect: hyperthyroidism ‐ postpartum." data-id="CD011761-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 7 Maternal adverse effect: hyperthyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 8 Maternal adverse effect: digestive intolerance ‐ pregnancy." data-id="CD011761-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 8 Maternal adverse effect: digestive intolerance ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 9 Perinatal mortality." data-id="CD011761-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 9 Perinatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 10 Low birthweight." data-id="CD011761-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 10 Low birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 11 Neonatal hypothyroidism or elevated TSH." data-id="CD011761-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 11 Neonatal hypothyroidism or elevated TSH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 12 Neonatal adverse effect: elevated thyroid peroxidase antibodies." data-id="CD011761-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 12 Neonatal adverse effect: elevated thyroid peroxidase antibodies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 13 Spontaneous miscarriage." data-id="CD011761-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 13 Spontaneous miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 14 Maternal goitre ‐ pregnancy." data-id="CD011761-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 14 Maternal goitre ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 15 Maternal goitre ‐ postpartum." data-id="CD011761-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 15 Maternal goitre ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 16 Maternal insufficient iodine intake ‐ pregnancy." data-id="CD011761-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 16 Maternal insufficient iodine intake ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 17 Maternal insufficient iodine intake ‐ postpartum." data-id="CD011761-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 17 Maternal insufficient iodine intake ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 18 Maternal excessive iodine intake ‐ pregnancy." data-id="CD011761-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 18 Maternal excessive iodine intake ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 19 Small‐for‐gestational age." data-id="CD011761-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 19 Small‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 20 Congenital anomalies." data-id="CD011761-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 20 Congenital anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 21 Neonatal goitre." data-id="CD011761-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 21 Neonatal goitre. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 22 Neonatal thyroid volume (in mL)." data-id="CD011761-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 22 Neonatal thyroid volume (in mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 23 Neonatal insufficient iodine intake." data-id="CD011761-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 23 Neonatal insufficient iodine intake. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 24 Child mental or motor development (IQ points)." data-id="CD011761-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 24 Child mental or motor development (IQ points). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 25 Child mental or motor development (cognitive score)." data-id="CD011761-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 25 Child mental or motor development (cognitive score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 26 Child mental or motor development (language score)." data-id="CD011761-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 26 Child mental or motor development (language score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 27 Child mental or motor development (motor score)." data-id="CD011761-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 27 Child mental or motor development (motor score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 28 Child mental or motor development (social‐emotional score)." data-id="CD011761-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 28 Child mental or motor development (social‐emotional score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 29 Child mental or motor development (adaptive behaviour score)." data-id="CD011761-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 29 Child mental or motor development (adaptive behaviour score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 30 Child mental or motor development (cognitive score &lt; 85)." data-id="CD011761-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 30 Child mental or motor development (cognitive score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 31 Child mental or motor development (cognitive score &lt; 70)." data-id="CD011761-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 31 Child mental or motor development (cognitive score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 32 Child mental or motor development (language score &lt; 85)." data-id="CD011761-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 32 Child mental or motor development (language score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 33 Child mental or motor development (language score &lt; 70)." data-id="CD011761-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 33 Child mental or motor development (language score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 34 Child mental or motor development (motor score &lt; 85)." data-id="CD011761-fig-0037" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 34 Child mental or motor development (motor score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 35 Child mental or motor development (motor score &lt; 70)." data-id="CD011761-fig-0038" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Any supplement containing iodine versus same supplement without iodine or no intervention/placebo, Outcome 35 Child mental or motor development (motor score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 1 Maternal hypothyroidism ‐ pregnancy." data-id="CD011761-fig-0039" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 1 Maternal hypothyroidism ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 2 Maternal hypothyroidism ‐ postpartum." data-id="CD011761-fig-0040" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 2 Maternal hypothyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 3 Preterm birth." data-id="CD011761-fig-0041" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy." data-id="CD011761-fig-0042" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum." data-id="CD011761-fig-0043" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 6 Maternal adverse effect: hyperthyroidism ‐ pregnancy." data-id="CD011761-fig-0044" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 6 Maternal adverse effect: hyperthyroidism ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 7 Maternal adverse effect: hyperthyroidism ‐ postpartum." data-id="CD011761-fig-0045" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 7 Maternal adverse effect: hyperthyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 8 Maternal adverse effect: digestive intolerance ‐ pregnancy." data-id="CD011761-fig-0046" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 8 Maternal adverse effect: digestive intolerance ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 9 Perinatal mortality." data-id="CD011761-fig-0047" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 9 Perinatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 10 Low birthweight." data-id="CD011761-fig-0048" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 10 Low birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 11 Neonatal hypothyroidism or elevated TSH." data-id="CD011761-fig-0049" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 11 Neonatal hypothyroidism or elevated TSH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 12 Neonatal adverse effect: elevated thyroid peroxidase antibodies." data-id="CD011761-fig-0050" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 12 Neonatal adverse effect: elevated thyroid peroxidase antibodies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 13 Spontaneous miscarriage." data-id="CD011761-fig-0051" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 13 Spontaneous miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 14 Maternal goitre ‐ pregnancy." data-id="CD011761-fig-0052" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 14 Maternal goitre ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 15 Maternal goitre ‐ postpartum." data-id="CD011761-fig-0053" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 15 Maternal goitre ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 16 Maternal insufficient iodine intake ‐ pregnancy." data-id="CD011761-fig-0054" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 16 Maternal insufficient iodine intake ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 17 Maternal insufficient iodine intake ‐ postpartum." data-id="CD011761-fig-0055" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 17 Maternal insufficient iodine intake ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 18 Maternal excessive iodine intake ‐ pregnancy." data-id="CD011761-fig-0056" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 18 Maternal excessive iodine intake ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 19 Small‐for‐gestational age." data-id="CD011761-fig-0057" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 19 Small‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 20 Congenital anomalies." data-id="CD011761-fig-0058" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.20</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 20 Congenital anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 21 Neonatal goitre." data-id="CD011761-fig-0059" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.21</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 21 Neonatal goitre. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 22 Neonatal thyroid volume (in mL)." data-id="CD011761-fig-0060" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.22</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 22 Neonatal thyroid volume (in mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 23 Neonatal insufficient iodine intake." data-id="CD011761-fig-0061" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.23</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 23 Neonatal insufficient iodine intake. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 24 Child mental or motor development (cognitive score)." data-id="CD011761-fig-0062" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.24</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 24 Child mental or motor development (cognitive score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 25 Child mental or motor development (language score)." data-id="CD011761-fig-0063" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.25</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 25 Child mental or motor development (language score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 26 Child mental or motor development (motor score)." data-id="CD011761-fig-0064" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.26</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 26 Child mental or motor development (motor score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 27 Child mental or motor development (social‐emotional score)." data-id="CD011761-fig-0065" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.27</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 27 Child mental or motor development (social‐emotional score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 28 Child mental or motor development (adaptive behaviour score)." data-id="CD011761-fig-0066" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.28</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 28 Child mental or motor development (adaptive behaviour score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 29 Child mental or motor development (cognitive score &lt; 85)." data-id="CD011761-fig-0067" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.29</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 29 Child mental or motor development (cognitive score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 30 Child mental or motor development (cognitive score &lt; 70)." data-id="CD011761-fig-0068" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.30</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 30 Child mental or motor development (cognitive score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-31.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 31 Child mental or motor development (language score &lt; 85)." data-id="CD011761-fig-0069" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.31</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 31 Child mental or motor development (language score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 32 Child mental or motor development (language score &lt; 70)." data-id="CD011761-fig-0070" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.32</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 32 Child mental or motor development (language score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 33 Child mental or motor development (motor score &lt; 85)." data-id="CD011761-fig-0071" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.33</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 33 Child mental or motor development (motor score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-002-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-002-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 34 Child mental or motor development (motor score &lt; 70)." data-id="CD011761-fig-0072" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.34</div> <div class="figure-caption"> <p>Comparison 2 Any oral iodine supplement versus same supplement without iodine or no intervention/placebo, Outcome 34 Child mental or motor development (motor score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-002-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 1 Maternal hypothyroidism ‐ postpartum." data-id="CD011761-fig-0073" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 1 Maternal hypothyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 2 Preterm birth." data-id="CD011761-fig-0074" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 2 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 3 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum." data-id="CD011761-fig-0075" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 3 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 4 Maternal adverse effect: hyperthyroidism ‐ postpartum." data-id="CD011761-fig-0076" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 4 Maternal adverse effect: hyperthyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 5 Perinatal mortality." data-id="CD011761-fig-0077" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 5 Perinatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 6 Low birthweight." data-id="CD011761-fig-0078" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 6 Low birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 7 Neonatal hypothyroidism or elevated TSH." data-id="CD011761-fig-0079" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 7 Neonatal hypothyroidism or elevated TSH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 8 Neonatal adverse effect: elevated thyroid peroxidase antibodies." data-id="CD011761-fig-0080" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 8 Neonatal adverse effect: elevated thyroid peroxidase antibodies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 9 Spontaneous miscarriage." data-id="CD011761-fig-0081" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 9 Spontaneous miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 10 Maternal goitre ‐ pregnancy." data-id="CD011761-fig-0082" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 10 Maternal goitre ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 11 Maternal goitre ‐ postpartum." data-id="CD011761-fig-0083" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 11 Maternal goitre ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 12 Maternal insufficient iodine intake ‐ postpartum." data-id="CD011761-fig-0084" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 12 Maternal insufficient iodine intake ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 13 Small‐for‐gestational age." data-id="CD011761-fig-0085" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 13 Small‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 14 Congenital anomalies." data-id="CD011761-fig-0086" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 14 Congenital anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 15 Neonatal goitre." data-id="CD011761-fig-0087" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 15 Neonatal goitre. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 16 Neonatal thyroid volume (in mL)." data-id="CD011761-fig-0088" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 16 Neonatal thyroid volume (in mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 17 Child mental or motor development (cognitive score)." data-id="CD011761-fig-0089" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 17 Child mental or motor development (cognitive score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 18 Child mental or motor development (language score)." data-id="CD011761-fig-0090" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 18 Child mental or motor development (language score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 19 Child mental or motor development (motor score)." data-id="CD011761-fig-0091" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 19 Child mental or motor development (motor score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 20 Child mental or motor development (social‐emotional score)." data-id="CD011761-fig-0092" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 20 Child mental or motor development (social‐emotional score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 21 Child mental or motor development (adaptive behaviour score)." data-id="CD011761-fig-0093" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.21</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 21 Child mental or motor development (adaptive behaviour score). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 22 Child mental or motor development (cognitive score &lt; 85)." data-id="CD011761-fig-0094" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.22</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 22 Child mental or motor development (cognitive score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 23 Child mental or motor development (cognitive score &lt; 70)." data-id="CD011761-fig-0095" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.23</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 23 Child mental or motor development (cognitive score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 24 Child mental or motor development (language score &lt; 85)." data-id="CD011761-fig-0096" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.24</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 24 Child mental or motor development (language score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 25 Child mental or motor development (language score &lt; 70)." data-id="CD011761-fig-0097" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.25</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 25 Child mental or motor development (language score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 26 Child mental or motor development (motor score &lt; 85)." data-id="CD011761-fig-0098" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.26</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 26 Child mental or motor development (motor score &lt; 85). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-003-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-003-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 27 Child mental or motor development (motor score &lt; 70)." data-id="CD011761-fig-0099" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.27</div> <div class="figure-caption"> <p>Comparison 3 Oral iodine‐only supplement versus no intervention or placebo, Outcome 27 Child mental or motor development (motor score &lt; 70). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-003-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 1 Maternal hypothyroidism ‐ pregnancy." data-id="CD011761-fig-0100" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 1 Maternal hypothyroidism ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 2 Maternal hypothyroidism ‐ postpartum." data-id="CD011761-fig-0101" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 2 Maternal hypothyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 3 Preterm birth." data-id="CD011761-fig-0102" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 3 Preterm birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy." data-id="CD011761-fig-0103" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum." data-id="CD011761-fig-0104" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 6 Maternal adverse effect: hyperthyroidism ‐ pregnancy." data-id="CD011761-fig-0105" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 6 Maternal adverse effect: hyperthyroidism ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 7 Maternal adverse effect: hyperthyroidism ‐ postpartum." data-id="CD011761-fig-0106" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 7 Maternal adverse effect: hyperthyroidism ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 8 Maternal adverse effect: digestive intolerance ‐ pregnancy." data-id="CD011761-fig-0107" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 8 Maternal adverse effect: digestive intolerance ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 9 Low birthweight." data-id="CD011761-fig-0108" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 9 Low birthweight. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 10 Neonatal hypothyroidism or elevated TSH." data-id="CD011761-fig-0109" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.10</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 10 Neonatal hypothyroidism or elevated TSH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 11 Spontaneous miscarriage." data-id="CD011761-fig-0110" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.11</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 11 Spontaneous miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 12 Maternal goitre ‐ pregnancy." data-id="CD011761-fig-0111" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.12</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 12 Maternal goitre ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 13 Maternal goitre ‐ postpartum." data-id="CD011761-fig-0112" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.13</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 13 Maternal goitre ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 14 Maternal insufficient iodine intake ‐ pregnancy." data-id="CD011761-fig-0113" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.14</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 14 Maternal insufficient iodine intake ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 15 Maternal insufficient iodine intake ‐ postpartum." data-id="CD011761-fig-0114" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.15</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 15 Maternal insufficient iodine intake ‐ postpartum. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 16 Maternal excessive iodine intake ‐ pregnancy." data-id="CD011761-fig-0115" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.16</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 16 Maternal excessive iodine intake ‐ pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 17 Small‐for‐gestational age." data-id="CD011761-fig-0116" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.17</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 17 Small‐for‐gestational age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 18 Neonatal thyroid volume (in mL)." data-id="CD011761-fig-0117" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.18</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 18 Neonatal thyroid volume (in mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-004-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-004-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 19 Neonatal insufficient iodine intake." data-id="CD011761-fig-0118" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.19</div> <div class="figure-caption"> <p>Comparison 4 Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine, Outcome 19 Neonatal insufficient iodine intake. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-004-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 1 Perinatal mortality." data-id="CD011761-fig-0119" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 1 Perinatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 2 Congenital anomalies." data-id="CD011761-fig-0120" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 2 Congenital anomalies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 3 Neonatal goitre." data-id="CD011761-fig-0121" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 3 Neonatal goitre. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011761-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/urn:x-wiley:14651858:media:CD011761:CD011761-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_t/tCD011761-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 4 Child mental or motor development (IQ points)." data-id="CD011761-fig-0122" src="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Any injected iodine supplement versus same supplement without iodine or no treatment/placebo, Outcome 4 Child mental or motor development (IQ points). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/media/CDSR/CD011761/image_n/nCD011761-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011761-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (maternal outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (maternal outcomes) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women during the preconception, pregnancy and postpartum period<br/> <b>Setting:</b> Denmark, Germany, Morocco, New Zealand, Thailand, Zaire<br/> <b>Intervention:</b> any supplement containing iodine<br/> <b>Comparison:</b> same supplement without iodine or no treatment/placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with same supplement without iodine or no treatment/placebo</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any supplement containing iodine</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal hypothyroidism ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 1.90<br/> (0.57 to 6.38) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>365<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 134) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal hypothyroidism ‐ postpartum</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.44<br/> (0.06 to 3.42) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>540<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4 per 1000<br/> (1 to 34) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>11 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 1000<br/> (1 to 37) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Preterm birth</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.71<br/> (0.30 to 1.66) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>376<br/> (2 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>111 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/> (33 to 184) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>122 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 1000<br/> (37 to 202) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.95<br/> (0.44 to 2.07) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>359<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (30 to 142) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>68 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000<br/> (30 to 142) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: elevated TPO‐ab ‐ postpartum</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 1.01<br/> (0.78 to 1.30) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>397<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>301 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>304 per 1000<br/> (235 to 391) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>77 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>78 per 1000<br/> (60 to 100) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: hyperthyroidism ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 1.90<br/> (0.57 to 6.38) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>365<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 134) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000<br/> (12 to 135) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: hyperthyroidism ‐ postpartum</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.32<br/> (0.11 to 1.91) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>543<br/> (3 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2, 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 1000<br/> (5 to 45) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 1000<br/> (1 to 7) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Maternal adverse effect: digestive intolerance ‐ pregnancy</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average</p> <p>RR 15.33<br/> (2.07 to 113.70) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>76<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>2, 5</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>22 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>333 per 1,000<br/> (45 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>25 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>383 per 1000</p> <p>(52 to 1,000)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>TPO‐ab</b>: thyroid peroxidase antibodies </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>One study with design limitations (high risk for attrition bias).<br/> <i><sup>2</sup> </i> Wide confidence interval.<br/> <sup>3</sup>Most studies contributing data had design limitations (high risk for attrition bias and unclear for selection bias).<br/> <sup>4</sup>Most studies contributing data had design limitations (high risk for attrition bias and selection bias).<br/> <sup>5</sup>One study with high risk of blinding and attrition bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (maternal outcomes)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011761-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (child outcomes)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (child outcomes) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> women during the preconception, pregnancy and postpartum period<br/> <b>Setting:</b> Germany, New Zealand, Thailand, Zaire<br/> <b>Intervention:</b> any supplement containing iodine<br/> <b>Comparison:</b> same supplement without iodine or no treatment/placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="center" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with same supplement without iodine or no treatment/placebo</b> </p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with any supplement containing iodine</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Perinatal mortality</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.66<br/> (0.42 to 1.03) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>399<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>1, 2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""></td> </tr> <tr class="table-header separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>208 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>137 per 1000<br/> (87 to 214) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>208 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>137 per 1000<br/> (87 to 214) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Low birthweight</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.56<br/> (0.26 to 1.23) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>377<br/> (2 RCTs) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> Low <sup>2, 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>90 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1000<br/> (24 to 111) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>96 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>54 per 1000<br/> (25 to 118) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Neonatal hypothyroidism or elevated TSH</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.58<br/> (0.11 to 3.12) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>219<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>2, 3, 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (4 to 106) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>34 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 1000<br/> (4 to 106) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Neonatal adverse effect: elevated TPO‐ab</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Average RR 0.61<br/> (0.07 to 5.70) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>108<br/> (1 RCT) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> Very low <sup>2, 4, 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (3 to 244) </p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>43 per 1000</p> </td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000<br/> (3 to 245) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>Child adverse effect: hyperthyroidism</p> </td> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>See comments</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>No trials reported this outcome</p> </td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="center" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>TPO‐ab</b> : thyroid peroxidase antibodies; <b>TSH</b>: thyroid‐stimulating hormone </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Design limitations (high risk of attrition bias and unclear for selection bias).<br/> <sup>2</sup>Wide confidence interval.<br/> <sup>3</sup>One study had design limitations (high risk for attrition bias).<br/> <sup>4</sup>One study with design limitations (high risk for selection bias).<br/> <sup>5</sup>Small number of events. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no treatment/placebo (child outcomes)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011761-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Urinary iodine concentration and breast milk iodine concentration following prepregnancy, pregnancy or postpartum iodine supplementation</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Setting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Intervention timing</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Intervention description</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Timing of assessment</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Urinary iodine concentration</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Breast milk iodine concentration</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0001" title="BouhouchRR , BouhouchS , CherkaouiM , AboussadA , StincaS , HaldimannM , et al. Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double‐blind, randomised, placebo‐controlled trial. Lancet. Diabetes &amp; Endocrinology2014;2(3):197‐209. BouhouchRR , BouhouchS , StincaS , CherkaouiM , AboussadA , AnderssonM , et al. Infant iodine supplementation and motor and cognitive development: a randomized controlled trial. FASEB Journal2013;27:346.1. ">Bouhouch 2014 (C)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Southern Morocco</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iodine: single dose oral 400 mg, control: single dose placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 37 μg/L, IQR: 22‐77 (n = 119)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 30 μg/L, IQR: 18‐61 (n = 115)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 58 μg/L, IQR: 34‐135 (n = 94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 39 μg/L, IQR 24‐62 (n = 81)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 39.4 μg/L, IQR: 23.5‐66.7 (n = 94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 26.2 μg/L, IQR: 17.7‐42.7 (n = 81)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Nice, France</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Iodine: daily dose 150 μg of iodine, control: vitamin mix but no iodine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baseline: before 12 weeks of amenorrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 111 μg/L, IQR: 28‐399 (n = 32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 103 μg/L, IQR: 14‐355 (n = 54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 3rd trimester</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 160.5 μg/L, IQR: 18‐358 (n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 76 μg/L, IQR: 16‐303 (n = 46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 58 μg/L, IQR: 34‐135 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 58 μg/L, IQR: 34‐135 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0003" title="GlinoerD . Maternal thyroid function in pregnancy. Journal of Endocrinological Investigation1993;16:374‐8. GlinoerD , DeNayerP , DelangeF , LemoneM , ToppetV , SephlM , et al. A randomized trial for the treatment of mild iodine deficiency during pregnancy: maternal and neonatal effects. Journal of Clinical Endocrinology and Metabolism1995;80:258‐69. ">Glinoer 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Brussels, Belgium</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine: single dose 1 mL iodized oil, control: multivitamin injection no iodine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 3‐6 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 77 μg/L, SEM: +/‐ 8 (n = 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 43 μg/L, SEM: +/‐ 4 (n = 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 61 μg/L, SEM: +/‐10, (n = 60)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 29 μg/L, SEM: +/‐2, (n = 60)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Berlin, Germany</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Daily dose oral 300 µg KI, control: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: mean 11 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 104.5 μg/dl, IQR: NR (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: In fig only (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.3 μg/dl, IQR: In fig only (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 6.5 μg/dl, IQR: In fig only (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0008" title="MulrineHM , SkeaffSA , FergusonEL , GrayAR , ValeixP . Breast‐milk iodine concentration declines over the first 6 mo postpartum in iodine‐deficient women. American Journal of Clinical Nutrition2010;92(4):849‐56. SkeaffS . A randomised double‐blind, placebo‐controlled intervention trial to study the effect of iodine supplementation on breast milk iodine concentration and iodine status in lactating women and their breast‐fed infants. Australian Clinical Trials Register (www.actr.org.au) (accessed 6 December 2005). ">Mulrine 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Dunedin, New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iodine: daily 75 or 150 µg/d iodine, control: placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 24 weeks (75 µg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 78 μg/L, 25th 75th %: 50,126 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 34 μg/L, 25th 75th %: 26, 57 (n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 24 weeks (150 µg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 84 μg/L, 25th‐75th %: 60,157 (n = 19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 34 μg/L, 25th 75th %: 26,57 (n = 21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In figure only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In figure only</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p><a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Aalborg, Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>Pregnancy or pregnancy and postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine: daily oral 150 µg elemental iodine and micronutrient supplement, control: micronutrient supplement no iodine </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 35 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 86 μg/24 h, 25th‐75th %: 66–147 (n = 22) pregnancy and postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 88 μg/24 h, 25th 75th %: 68‐123 (n = 24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 83 μg/24 h, 25th 75th %: 54–145 (n = 20) pregnancy only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 50 μg/L, 25th 75th %: 35‐101 (n = 22) pregnancy and postpartum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 51 μg/L, 25th 75th %: 30–80 (n = 20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 52 μg/L, 25th 75th %: 36–81 (n = 20) pregnancy only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>East Jutland, Denmark</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Iodine: daily drops 200 μg iodine, control: no treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 37 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 106 μg/L, 95 %: NR (n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 54 μg/L, 95 %: NR (n = 26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 56 μg/L, 95 %: NR (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 54 μg/L, 95 %: NR (n = NR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 41 μg/L, 95 %: 31‐74 (n = 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 28 μg/L, 95 %: 19‐46 (n = 26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 64 μg/L, 95 %: 34‐70 (n = 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 27 μg/L, 95 %: 21‐56 (n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD011761-bbs2-0012" title="SilvaJE , SilvaS . Interrelationships among serum thyroxine, triiodothyronine, reverse triiodothyronine, and thyroid‐stimulating hormone in iodine‐deficient pregnant women and their offspring: effects of iodine supplementation. Journal of Clinical Endocrinology and Metabolism1981; Vol. 52, issue 4:671‐7. ">Silva 1981</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Eastern Greater</p> <p>Santiago, Chile</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Iodine: daily drops approximately 300 µg iodine, control: no intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 15‐40 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 376 μg iodine/g creatinine, SD: 456 (n = 36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 56 μg iodine/g creatinine, SD: 25 (n = 10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: at delivery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 493 μg iodine/g creatinine, SD: 586 (n = not specified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 127 μg iodine/g creatinine, SD: 94 (n = not specified)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0014" title="ZhouJ . Pregnancy iodine and neurodevelopment in kids (PINK). Australian New Zealand Clinical Trials Register (www.anzctr.org.au) (accessed 21 May 2010). ZhouSJ , SkeaffS , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. Effect of iodine supplementation in pregnancy on childhood development: results from a randomised controlled trial (RCT). Journal of Paediatrics and Child Health2015; Vol. 51, issue Suppl 1:34. ZhouSJ , SkeaffSA , RyanP , DoyleLW , AndersonPJ , KornmanL , et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo‐controlled trial. Trials2015;16:563. [PUBMED: 26654905] ">Zhou 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adelaide, New Zealand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine: daily tablet 150 μg iodine, control: placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 106.0 (84.0‐146.0), n = 19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 124.0 (76.0‐155.0), n = 22</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Bangkok, Thailand</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Pregnancy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>Iodine: daily 200 µg iodine and multivitamin‐mineral tablets, control: multivitamin‐mineral tablets with no iodine </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pregnancy: 30 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 233.3 μg/L, IQR: 140.0, 314.8 (n = 171)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 154.6 μg/L, IQR: 107.9, 212.4 (n = 185)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postpartum: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 115.5 μg/L, IQR: 73.0, 155.3 (n = 129)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 93.6 μg/L, IQR: 60.3, 159.8 (n = 135)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neonatal: 6 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 168.7 μg/L, IQR: 97.7, 305.7 (n = 83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 193.3 μg/L, IQR: 136.7, 303.5 (n = 76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>IQR: interquartile range<br/> KI: potassium iodide<br/> NR: not reported<br/> SD: standard deviation<br/> SEM: standard error of the mean </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Urinary iodine concentration and breast milk iodine concentration following prepregnancy, pregnancy or postpartum iodine supplementation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011761-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Maternal thyroid volume ‐ pregnancy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroid volume (mL)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.73, range: 5.4–15.5 (n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10.13, range: 4.2–25.5 (n = 46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 11.1 (n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 12.4 (n = 26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.0, IQR: 7.0, 9.1 (n = 176)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.1, IQR: 7.1, 9.4 (n = 190)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>1</sup>Assessed in the 3rd trimester.<br/> <sup>2</sup>Assessed at 37 weeks' gestation. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>3</sup>Assessed at 30 weeks' gestation. Intention‐to‐treat analysis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Maternal thyroid volume ‐ pregnancy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011761-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maternal thyroid volume ‐ postpartum</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroid volume (mL)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 8.5, range: 3.8–13.8 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.7, range: 6.6–18.9 (n = 18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 20.5, SD: 8.5 (n = 38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 20.0, SD: 10.5 (n = 70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10.2 (n = 25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10 (n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 7.3, IQR: 5.8, 9.0 (n = 129)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 7.2, IQR: 6.1, 8.4 (n = 135)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>1</sup>Assessed at 3 months postpartum.<br/> <sup>2</sup>Assessed by ultrasound on average at 11 days postpartum. Mean and SD extracted from figure.<br/> <sup>3</sup>Assessed at 12 months postpartum. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>4</sup>Assessed at 6 weeks postpartum. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Maternal thyroid volume ‐ postpartum</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011761-tbl-0006"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Maternal thyroglobulin ‐ pregnancy</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroglobulin (in µg/L)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 17.5, range: 2.5–56.2 (n = 30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 19.6, range: 3.8–98.6 (n = 46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0009" title="NohrSB , JorgensenA , PedersenKM , LaurbergP . Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody‐positive women living in an area with mild to moderate deficiency: is iodine supplementation safe?. Journal of Clinical Endocrinology and Metabolism2000;85(9):3191‐8. ">Nohr 2000</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 14.1, IQR: 5.0, 21.5 (n = 42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 19.4, IQR: 8.2, 33.5 (n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.2 (n = 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 16.7 (n = 26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.78, IQR: 5.46, 18.10 (n = 176)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median 11.90, IQR: 6.35, 22.30 (n = 190)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>1</sup>Assessed in the 3rd trimester.<br/> <sup>2</sup>Assessed at 35 weeks' gestation.<br/> <sup>3</sup>Assessed at 37 weeks' gestation. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>4</sup>Assessed at 30 weeks' gestation. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Maternal thyroglobulin ‐ pregnancy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011761-tbl-0007"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Maternal thyroglobulin ‐ postpartum</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Study</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Thyroglobulin (in µg/L)</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No iodine</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0002" title="Brucker‐DavisF . Assessment of thyroid function throughout pregnancy with and without iodine supplementation. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2009. Brucker‐DavisF . Effect of iodine supplementation and during pregnancy on neuropsychological development of children assessed at 2 years old. ClinicalTrials.gov (clinicaltrials.gov/) [accessed 22 May 2015]2010. Brucker‐DavisF , Ganier‐ChauliacF , GalJ , Panaia‐FerrariP , PaciniP , FenichelP , et al. Neurotoxicant exposure during pregnancy is a confounder for assessment of iodine supplementation on neurodevelopment outcome. Neurotoxicology and Teratology2015;51:45‐51. Brucker‐DavisF , Panaia‐FerrariP , GalJ , FenichelP , HieronimusS . Iodine supplementation throughout pregnancy does not prevent the drop in FT4 in the second and third trimesters in women with normal initial thyroid function. European Thyroid Journal2013;2(3):187‐94. HiéronimusS , FerrariP , GalJ , BerthierF , AzoulayS , BongainA , et al. Relative impact of iodine supplementation and maternal smoking on cord blood thyroglobulin in pregnant women with normal thyroid function. European Thyroid Journal2013;1(4):264‐73. ">Brucker‐Davis 2013</a><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 11.5, range: 4.4–37 (n = 18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 23.1, range: 3.0–45.5 (n = 18)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0007" title="LiesenkotterKP , GopelW , BognerU , StachB , GrutersA . Earliest prevention of endemic goiter by iodine supplementation during pregnancy. European Journal of Endocrinology1996;134(4):443‐8. ">Liesenkotter 1996</a><sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 8.3, SD: 10.9 (n = 38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean: 13.5, SD: 19.3 (n = 70)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0010" title="PedersenKM , LaurbergP , IversenE , KnudsenPR , GregersenHE , RasmussenOS , et al. Amelioration of some pregnancy‐associated variations in thyroid function by iodine supplementation. Journal of Clinical Endocrinology and Metabolism1993;77:1078‐83. ">Pedersen 1993</a><sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 4.7 (n = 24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 10.3 (n = 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011761-bbs2-0004" title="GowachirapantS . Effects of iodine supplementation in mild‐to‐moderately iodine‐deficient pregnant women on thyroid function, pregnancy outcomes and newborn development in Thailand [Doctoral dissertation]. Wageningen: Wageningen University, 2014. Melse‐BoonstraA , GowachirapantS , JaiswalN , WinichagoonP , SrinivasanK , ZimmermannMB . Iodine supplementation in pregnancy and its effect on child cognition. Journal of Trace Elements in Medicine and Biology2012;26:134–6. ">Gowachirapant 2014</a><sup>4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 7.94, IQR: 4.89, 15.30 (n = 129)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median: 9.51, IQR: 4.79, 15.90 (n = 135)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><sup>1</sup>Assessed at 3 months postpartum.<br/> <sup>2</sup>Assessed on average at 11 days postpartum.<br/> <sup>3</sup>Assessed at 12 months postpartum. Median estimated from figure. No estimate of range or distribution was provided. Total was not provided so was assumed.<br/> <sup>4</sup>Assessed at 6 weeks postpartum. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Maternal thyroglobulin ‐ postpartum</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011761-tbl-0008"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Neonatal behavioural assessment scales scores assessed at 6 weeks postpartum (Zimmerman 2009)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Outcome</p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>Iodine</p> </td> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p>Control</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IQR</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IQR</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>n</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Habituation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.4, 8.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.6</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.8, 8.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Social‐interactive</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7.4</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.4, 8.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>66</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.9</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.0, 8.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Motor system</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.3, 6.6)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.2, 6.4)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>State organization</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(2.8, 4.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.8</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(3.0, 4.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>State regulation</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(3.3, 4.5)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(2.6, 4.7)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Autonomic system</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(6.0, 7.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.3, 7.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reflexes</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(1.8, 4.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.0</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(2.0, 4.0)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Supplementary items</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.7</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.3, 8.3)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6.3</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(5.1, 8.1)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>IQR: interquartile range</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Neonatal behavioural assessment scales scores assessed at 6 weeks postpartum (Zimmerman 2009)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/full#CD011761-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011761-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no intervention/placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal hypothyroidism ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.9 [0.57, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal hypothyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>540</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.06, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.30, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.44, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.78, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal adverse effect: hyperthyroidism ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.9 [0.57, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal adverse effect: hyperthyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>543</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.11, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal adverse effect: digestive intolerance ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.33 [2.07, 113.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.42, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Low birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.26, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal hypothyroidism or elevated TSH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.11, 3.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal adverse effect: elevated thyroid peroxidase antibodies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.07, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Spontaneous miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>645</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.64, 2.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal goitre ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>486</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.33, 3.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Maternal goitre ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.64, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Maternal insufficient iodine intake ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.51, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Maternal insufficient iodine intake ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.70, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Maternal excessive iodine intake ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.33 [1.24, 15.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.77, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Congenital anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>875</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.12, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Neonatal goitre <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>684</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.02, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Neonatal thyroid volume (in mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.58, ‐0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Neonatal insufficient iodine intake <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [1.04, 4.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Child mental or motor development (IQ points) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.21 [7.96, 14.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Child mental or motor development (cognitive score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐7.88, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Child mental or motor development (language score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐7.08, 5.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Child mental or motor development (motor score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [‐4.02, 7.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Child mental or motor development (social‐emotional score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐8.25, 9.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Child mental or motor development (adaptive behaviour score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐6.40, 9.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Child mental or motor development (cognitive score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Child mental or motor development (cognitive score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Child mental or motor development (language score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.21, 4.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Child mental or motor development (language score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Child mental or motor development (motor score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.08, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Child mental or motor development (motor score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any supplement containing iodine versus same supplement without iodine or no intervention/placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011761-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any oral iodine supplement versus same supplement without iodine or no intervention/placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal hypothyroidism ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.9 [0.57, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal hypothyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>540</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.06, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>376</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.30, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.44, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.78, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal adverse effect: hyperthyroidism ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.9 [0.57, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal adverse effect: hyperthyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>543</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.11, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal adverse effect: digestive intolerance ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.33 [2.07, 113.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Perinatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Low birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.26, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal hypothyroidism or elevated TSH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>260</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.11, 3.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Neonatal adverse effect: elevated thyroid peroxidase antibodies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.07, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Spontaneous miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>645</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.64, 2.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal goitre ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>486</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.33, 3.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Maternal goitre ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.64, 2.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Maternal insufficient iodine intake ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.51, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Maternal insufficient iodine intake ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.70, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Maternal excessive iodine intake ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.33 [1.24, 15.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.77, 2.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Congenital anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Neonatal goitre <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.02, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Neonatal thyroid volume (in mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.58, ‐0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Neonatal insufficient iodine intake <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [1.04, 4.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Child mental or motor development (cognitive score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐7.88, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Child mental or motor development (language score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐7.08, 5.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Child mental or motor development (motor score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [‐4.02, 7.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Child mental or motor development (social‐emotional score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐8.25, 9.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Child mental or motor development (adaptive behaviour score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐6.40, 9.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Child mental or motor development (cognitive score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Child mental or motor development (cognitive score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Child mental or motor development (language score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.21, 4.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Child mental or motor development (language score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Child mental or motor development (motor score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.08, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Child mental or motor development (motor score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any oral iodine supplement versus same supplement without iodine or no intervention/placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011761-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Oral iodine‐only supplement versus no intervention or placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal hypothyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.10, 8.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.37, 4.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.15, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal adverse effect: hyperthyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.01, 7.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Low birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.04, 3.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Neonatal hypothyroidism or elevated TSH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Neonatal adverse effect: elevated thyroid peroxidase antibodies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.07, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Spontaneous miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 70.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Maternal goitre ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.23, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Maternal goitre ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.73, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Maternal insufficient iodine intake ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>175</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.69, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.27, 8.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Congenital anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Neonatal goitre <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.02, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Neonatal thyroid volume (in mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.53 [‐1.02, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Child mental or motor development (cognitive score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.30 [‐7.88, 3.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Child mental or motor development (language score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐7.08, 5.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Child mental or motor development (motor score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [‐4.02, 7.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Child mental or motor development (social‐emotional score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐8.25, 9.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Child mental or motor development (adaptive behaviour score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐6.40, 9.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Child mental or motor development (cognitive score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Child mental or motor development (cognitive score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Child mental or motor development (language score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.21, 4.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Child mental or motor development (language score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Child mental or motor development (motor score &lt; 85) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.08, 1.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Child mental or motor development (motor score &lt; 70) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.89 [0.12, 67.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Oral iodine‐only supplement versus no intervention or placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011761-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Maternal hypothyroidism ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.9 [0.57, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Maternal hypothyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.06, 15.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Preterm birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.23, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.44, 2.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Maternal adverse effect: elevated thyroid peroxidase antibodies ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.79, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Maternal adverse effect: hyperthyroidism ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.9 [0.57, 6.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Maternal adverse effect: hyperthyroidism ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.12, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Maternal adverse effect: digestive intolerance ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>15.33 [2.07, 113.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Low birthweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.27, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Neonatal hypothyroidism or elevated TSH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.11, 3.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Spontaneous miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>587</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.60, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Maternal goitre ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.89 [0.56, 6.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Maternal goitre ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.06 [0.64, 6.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Maternal insufficient iodine intake ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>432</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.51, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Maternal insufficient iodine intake ‐ postpartum <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.61, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Maternal excessive iodine intake ‐ pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.33 [1.24, 15.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Small‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.74, 2.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Neonatal thyroid volume (in mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.18, ‐0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Neonatal insufficient iodine intake <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.14 [1.04, 4.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Oral iodine supplement with other vitamins and/or minerals versus only other vitamins and/or minerals but no iodine</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011761-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Any injected iodine supplement versus same supplement without iodine or no treatment/placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Perinatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>399</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.42, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Congenital anomalies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>818</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.12, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neonatal goitre <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Child mental or motor development (IQ points) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>174</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.21 [7.96, 14.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Any injected iodine supplement versus same supplement without iodine or no treatment/placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011761.pub2/references#CD011761-tbl-0013">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011761.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011761-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011761-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011761-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011761-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011761-note-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011761-note-0005">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD011761-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011761-note-0002">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011761-note-0021">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011761\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011761\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011761\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011761\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011761\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011761.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011761.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011761.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011761.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011761.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715086798"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011761.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715086802"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011761.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7e82ca371bde',t:'MTc0MDcxNTA4Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 